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Abstract 
Abstract 
The increased appreciation of combinatorial synthesis as a valuable tool in the drug 
discovery process has led to the recent escalation in research into solid phase 
synthesis techniques. The use of multiple parallel solid phase syntheses has been 
described as an efficient method of lead compound optimisation. This method is 
explored for the generation of analogues of a substituted acrylic acid, identified from 
random screening, in order to increase receptor affinity. The optimised solution phase 
synthesis of the lead compound via a Horner-Wadsworth-Emmons reaction is 
reported. The synthetic route is then described for the solid phase synthesis of a 
simple analogue. Attempts have been made towards the multiple parallel solid phase 
syntheses of a range of substrates. 
Alternative methods for facile product purification as alternatives to covalent 
binding to a polymeric resin have recently been researched. The affinity of tetrabenzo 
[a, c,g, i]fiuorene (Tbf) for charcoal has already been described as a useful method for 
the purification of peptides and proteins, and this property has been harnessed, for the 
first time, for application to general organic synthesis. An efficient solution-solid 
phase synthesis of the quinolone antibacterial, Ciprofioxacin, is described, in which 
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Chapter 1: Introduction 
1.1 Overview 
Synthetic organic chemistry is a science which has a huge variety of applications. 
Research in this field concentrates on many areas: the development of new synthetic 
methodologies; the adaptation of existing organic reactions to asymmetry; the 
application of organic transformations to the synthesis of natural products. 
Additionally, there is overlap of organic chemistry with other disciplines, such as the 
investigation of transition metal complexes, the use of enzymes to afford desired 
molecular transformations, or in the optimisation of the properties of materials and 
fuel efficiency. 
The synthetic chemist has been highly innovative in developing his field and the 
invention employed is seemingly endless. However, demonstration of the practical 
application of an area of research is often detailed in terms of leading towards a 
compound which occurs naturally in plants or animals, or especially one which 
exhibits a human therapeutic effect. It is in covering the overlap of chemistry with 
biology that synthetic organic chemistry is perceived to be of the greatest benefit and 
hence much research is geared towards obtaining these objectives. 
The pharmaceutical industry is substantially driven by synthetic organic chemistry, 
and vice versa. Potential drug candidates must be discovered, and this has 
traditionally involved the individual synthesis of many thousands of molecules by 
medicinal chemists. A lead compound which exhibits suitable biological activity may 
then be structurally altered to have the optimum possible activity and selectivity. The 
pharmaceutical business, as well as providing undoubted benefit to the treatment of 
disease, is a multi-billion dollar business and so relies heavily on the innovation shown 
by chemists to sustain a steady flow of new drug compounds. It is not surprising, 
therefore, that publications of research in organic chemistry often include possible 
applications to the pharmaceutical industry. 
1 
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The entire process of lead compound generation and optimisation can take several 
years to accomplish and is likely to require the synthesis of thousands of compounds. 
A procedure which makes this stage of drug development more efficient will therefore 
be highly beneficial in terms of time and cost. The synthesis of many compounds in an 
automated fashion during these early stages is a much more attractive proposition 
than synthesising compounds individually. It is in this area that combinatorial 
chemistry' can provide an easier method of generating the numbers of compounds 
which require testing for early stage drug development. 
Combinatorial techniques generally involve the use of solid phase organic synthesis 
(SPOS). 2  The advantages of synthesising compounds on an insoluble polymeric 
support greatly increases the ability of chemists to handle large numbers of 
compounds simultaneously, and has also opened the door for research in a wide 
variety of other areas. 
1.2 Solid Phase Synthesis 
The use of an insoluble solid support for organic reactions was first successfully 
performed by Merrifield' in 1963, who synthesised a tetrapeptide by attaching the C-
terminus of the first amino acid in the sequence to a chioromethylated copolymer of 
styrene (PS) and divinylbenzene (DVB). The polymer effectively acted as a carboxyl 
protecting group, allowing the remaining amino acids to be coupled sequentially until 
the desired peptide was synthesised (Figure 1.1). Merrifield demonstrated that 
purification of the growing peptide chain could be achieved after the coupling of each 
amino acid in a straightforward manner. The insolubility of the solid support (resin) 
meant that purification was accomplished by simple filtration, with impurities and 
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Figure 1.1: Merr?field's Solid Phase Peptide Synthesis. 
Merrifield envisaged that the purification advantages of synthesis on a resin would 
ultimately lend itself to automation. Indeed, soon afterwards, he published details of 
an automatic peptide synthesiser. 4 Its efficiency was demonstrated by the synthesis of 
the nonapeptide, bradykinin, which was synthesised in greater yield and in less time 
than possible by manual synthesis.' Automation has since enabled the chemical 
synthesis of many peptides which otherwise would have been inaccessible by manual 
means, such as ubiquitin, 6 MCP-1 7 and interleukin-3. 8 More generally, the technique 
has been employed successfully in the synthesis of a number of other polypeptides, 9 
oligonucleotides 1° and oligosaccharides.' 1 
1.2.1 The Solid Support 
The principle of SPOS lies in the binding of an organic molecule to an insoluble 
support via a suitable spacer or linker group. The PS-DVB resin used by Merrifield is 
still the polymer of choice for many researchers. This type of resin has proved to be 
highly robust and its properties can be altered depending on the degree of cross-
linking (usually 1-5%). 
One reason that the PS-DVB support has proved so popular is because of its 
favourable swelling properties - particularly in non-polar aprotic solvents such as 
9 
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dichioromethane (DCM) and toluene. The ability of a resin to swell in solvent is one 
of its most important properties, as only when the resin is highly swollen do the 
functional sites in the resin beads become available for reaction with reagents 
dissolved in the solvent. Investigations have shown that >99% of the functionalised 
sites are situated within the interior of a polymer bead, 12  and so high solvation levels 
are crucial for efficient reactions. 
With virtually all of the early developments in solid phase techniques being focused 
on polypeptide synthesis, larger and larger peptides and proteins were soon 
synthesised. Problems were observed in the synthesis of these long chain proteins and 
it was thought that the hydrophobic nature of polystyrene was a cause of this. 
Furthermore, the cross-linked nature of the polymer means that steric effects are likely 
to impinge on the couplings. To counteract this, and to increase reaction rates and 
yields, a polystyrene based polymer containing a large hydrophilic polyethylene glycol 
(PEG) unit was devised" (Figure 1.2). 
SC /CH2— O — (CH2CH2O) — R 
PEG spacer 
polystyrene 
backbone 	MW (PEG) - 3000 
Figure 1.2: The TentaGel Polymer Support. 
The PEG spacer group of the new polymer (TentaGel), was optimal at a molecular 
weight of approximately 3000, and so constituted around 70% of the overall polymer 
matrix. This meant that the PEG group had a major influence over the overall 
properties of the polymer and its greater mobility was designed to create an 
environment which was more "solution-like" for the growing peptide chain. The 
swelling properties of TentaGel resins have been found to be more uniform than PS-




Solvent PS-i %DVB PS-PEG (MWPEG3300) 
water - 2.5 
methanol 0.95 2.5 
acetonitrile 2.0 3.0 
DMF 3.5 3.2 
toluene 5.3 3.1 
DCM 5.2 3.0 
Table 1.1: Swelling Ratios of PS-DVB and PS-PEG in Various Solvents. 
Increased reaction rates of amino acid coupling reactions indicated that the PEG 
group was indeed creating a favourable environment. As well as the PEG having 
greater hydrophilicity than PS-DVB polymers, the TentaGel resins tend to be more 
monodisperse ie. the beads are of a uniform size. Commercially available PS-DVB 
resin beads have large differences in diameter, and overall reaction time is governed 
by the swelling of the largest of these. 13  TentaGel, consisting of more uniform, and 
smaller particles overcomes this problem. 
One disadvantage of TentaGel, however, is its comparatively low level of 
functionalisation, or loading. Typical loading levels for PS-DVB resins are 
approximately 1.0mmollg, whilst TentaGel is in the range 0.2-0.3mmollg. This is due 
to the difficulty in preventing both ends of the PEG group from binding with the PS 
backbone during synthesis, particularly for long chains (MW>800). This has been 
overcome in one case where a short PEG unit (MW-200, loading— 1. 8mmol/g) has 
been appended to PS and has been used in the synthesis of quinazoline-2,4-diones. 14 
Recent comparisons have been carried out between TentaGel and PS-DVB 
supports in general organic synthesis. 12,11  Yan investigated a series of reactions 
including oxidation, ester formation, hydrazone formation and amide formation/ring 
opening. TPAP/NMO' 6 oxidation was found to proceed faster on TentaGel than on 
PS-DVB. This supports the argument that the "solution-like" and more polar 
properties of TentaGel create a more favourable environment for the TPAP salt to 
react. However, that TentaGel will always increase reaction rates compared to PS 
resins is not supported by the evidence from amide forming/ring opening reactions 
5 
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(Figure 1.3). In these reactions, the reaction rate is almost twenty times faster on PS-





Figure 1.3: Ring-opening Reaction on PS-DVB and TentaGel Supports. 
With much drug research focusing on asymmetric synthesis, Burgess has compared 
two different PS-DVB resins (Merrifield {chloromethylated] and Wang 
fijnctionalised' 7) with TentaGel in enantio selective alkylation reactions" (Figure 1.4). 
Of these, the Wang PS-DVB (see Section 1.2.2) resin gave the highest yields and 
enantiomeric excesses whilst the TentaGel supported substrates gave reduced yields 
of product over time. Similar experiments performed with a slightly different auxiliary 
on Merrifield resin" also showed the applicability of PS-resins to asymmetric 
synthesis. 






Figure 1.4: Asymmetric Alkylation Reactions onPS-DVB and TentaGel Supports. 
Overall, Yan suggests 12  that no single polymer type favours all reactions, and that 
any swollen resin bead (the weight of which is up to 80% solvent) behaves exactly 
like another solvent, with the rate of reaction being affected by the polymeric matrix 
much like the effect of different solvents on reaction rate. 19  
6 
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Perhaps of more consequence than the nature of the polymer backbone itself 
regarding SPOS is the degree and nature of flinctionalisation which the polymer 
presents to reagents in solution. 
1. 2.2 Functionalising the Solid Support 
In order that organic molecules can be bound to supports, the polymer must 
possess suitable functionality. This can involve either direct ftinctionalisation of the 
polymer itself, 20  or more commonly, the polymer is derivatised with a suitable linker 
or spacer group. In either case, binding the organic compound to the resin must 
proceed in a straightforward manner. The bond with the resin must be stable to the 
proposed reaction conditions, and cleavage of the product from the resin on 
completion of the synthesis must proceed under conditions which will not degrade the 
compound. For example, Merrifield 3 employed orthogonal acid and base conditions to 
cleave amino protecting groups and resin products respectively (see Figure 1.1). 
Early examples of functionalised polymers 211  included phosphine, trityl and boronic 
acid derivatives, but one of the first true linker systems was devised by Wang 
 17  and is 
still one of the most popular PS-DVB resins used today (Figure 1.5). It is readily 





Merrifield Resin 	 Wang Linker 
RCO2H 	
95% TFA RCO2H 
Figure 1.5: Synthesis and Cleavage Conditions of Wang Resin. 
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As virtually all organic chemistry using polymeric supports was in polypeptide 
synthesis, most of the linker systems developed were for immobilising carboxylic 









Benzhydrylamine 22 (BHA); cleaved with 
TFMSA forming amides. 
Rink  23  acid (X'=OH) cleaved with 
AcOH/DCM forming acids; or amide 
(X=NHFmoc) cleaved with TFA!DCM 
forming amides. 
Sieber24 amide; cleaved with 1%TFA/DCM 
forming amides. 
Figure 1.6: Representative Examples of Linkers Used to Bind Carboxylic Acids to 
Resin. 
With emphasis growing in the area of non-peptide synthesis, linkers capable of 
binding other functional groups have been developed (Figure 1.7). These include the 
tritylchloride25 linker, 1, which is capable of binding nucleophiles, and Ellman' s 




X= H, CI 
Figure 1.7: Examples of Other Linkers Used in SPOS. 
The acid sensitivity of the trityl chloride linker is both useful and a disadvantage in 
SPOS. Mild acid cleavage means that acid-sensitive molecular fragments are likely to 
remain unaffected during the cleavage step, but likewise, resin cleavage may occur at 
unwanted steps in the reaction scheme. Ellman's DHP linker, 2, effectively acts as a 
hydroxy protecting group and has been used in Janda's synthesis of prostaglandin E 2 
methyl ester .27  Many different linkers for SPOS are now widely commercially 
available 2' but research continues into tailoring linker technology to cater for 
different requirements. 
1. 2.3 Safety-Catch Linkers 
One of the most important aspects of linker technology is the question of lability. It 
is crucial that the linker gives quantitative release of the organic molecule from the 
resin on completion of the reaction sequence. However, the conditions for cleavage 
should be mild enough so as not to cause degradation of the released molecule. To 
assist in successfully achieving these aims, the "safety-catch" principle was exploited 
by Kenner . 29 This technique involves the labilisation of an otherwise stable bond at the 
appropriate moment by a specific chemical modification (Figure 1.8). A sulphonamide 
linker on PS-DVB used in peptide synthesis, was stable to base as well as the TFA 
conditions used for the N-terminal I-butyloxycarbonyl (Boc) protecting group 
cleavage of 3. After N-methylation using diazomethane, 4 was cleaved rapidly with 











CH3 R 1 0 
4 
TFA 	O. 0 	H R2 
	CH2N2 
r ç.S..N).NyLNH 
R 1 0 
0OH 	
'NH + 
CH3 	 R 0 
5 
Figure 1.8: Peptide Synthesis Using Kenner 's Safely-catch Linker. 
Eliman developed this system '30 6, and concentrated on using nucleophilic amines 
to initiate cleavage of amides (Figure 1.9). Carboxylic acids were anchored to the 
linker, which was then activated by cyanomethylation to give 7. Cleavage with 
primary or secondary aliphatic/aromatic amines gave amides in near quantitative 
yields, without the need for excess amine. Indeed, when an equimolar mixture of five 
amines was added, equal quantities of the corresponding cleaved amides were 
obtained. 
0\ ,0 




N YC' 	 0 6 
BrCH2CN 	 R2R3NH R3NAR1 
0- N -01 DIEA 	 CN 	92-98% 
0 7 
Figure 1.9: ElIman 's Safely-catch Sulphonamide Linker with Amine Cleavage. 
Problems were experienced in the cyanomethylation step using substrates 
possessing electronegative a-substituents. An aliphatic variant of the linker was found 
to be more activated giving comparable amide yields upon amine cleavage. 
10 
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Recently, other variations of the safety-catch linker have been devised by Hulme, 31 
forming acids or methyl esters by cleavage with hydroxide and methoxide 
respectively. 
1. 2.4 Traceless Linkers 
In all of the cases so far discussed, appropriate (polar) functionality must be 
present in a molecule to allow binding to a resin. Invariably, the same, or slightly 
modified functionality is recovered upon cleavage. Often, strongly polar groups can 
have a detrimental effect on the pharmacokinetics or bioavailability of a drug 
substance, and so much interest has evolved in so-called "traceless" linkers. Using this 
technique, compounds can be synthesised by solid phase techniques with no trace of 
the attachment point. 
The first traceless linkers used silicon-aryl bonds, but these generally relied on 
harsh cleavage conditions (eg BY) to permit cleavage of the silicon-aromatic carbon 
bond . 3 2 - 3 -'  A silyl linker, 8, which can be cleaved under milder conditions was 
developed by Hone34 (Figure 1.10). Isoxazole, 9, was synthesised in good overall 
yield using this improved linker. 
	
MeO)0 	 MeO 
0 	
Br  (HO)2B 	CHO 
J:~Ir 	 rl.%— N 
0
—NSI pd (PPh 
H 	
6 DME, Na2CO3 O
O CHO 
8 	 MeO 
1. cyclopropyla mine, AcOH, 	 N° 	° 
Na2 SO4, THF. 	 o 	 ci 
2. Na(OAc)3BH, THF 	
NH 	
DIEA 
MeO 	 MeO 
50% TFNDCM 
Figurel.1O: Hone 's Traceless Silyl Linker. 
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As with earlier linkers of this sort, 32' 33 binding of the organic substrate to the linker 
was limited to aromatic compounds via the Stille or Suzuki coupling reactions. 
However, the milder cleavage conditions (presumably afforded by the presence of the 
amide functionality) makes Hone's linker more generally applicable. 
Traceless linkers have proved a challenging target for several research groups. Silyl 
linkers have been used for the synthesis of dienes, 35 whilst a related strategy has been 
developed by Gallop 36  using a rhodium catalysed 1,3-dipolar cycloaddition reaction to 
form furans. A novel hydrazide linker developed by Lowe 
37  (cleaved with base and 
catalytic copper(II) acetate), has also recently been published. 
A traceless method of generating amines has been devised by Morphy, 38 ' 39 which 
has the added advantage of being able to recycle the polymer. REM (generated 
Michael Addition) Resin, 10, is amine-functionalised via Michael addition. The 
tertiary amine is then quaternised, and cleavage afforded by DIEA in a Hoffman 
elimination (Figure 1.11). An improved vinyl suiphone linker 40 has been shown to be 
more base/nucleophile stable and so should be more adaptable to a wider range of 
chemistry. 









recycled 5 times 
Figure 1.11: Traceless Synthesis of A mines Using Recyclable REM Resin. 
Amines have also been the target of work by Willson . 4 ' Based on the work by 
Patel '42  he has designed an acid-sensitive SASRIN-based aldehyde resin, AMEBA 
(Acid sensitive MEthoxy BenzAldehyde), and managed to derivatise amines forming 
sulphonamides, amides, ureas and carbamates (Figure 1.12). The linker also acts in a 
safety-catch manner, as before derivatisation, resin-bound amine, 11, remains 
12 
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uncleaved in 95% TFA. However, after derivatisation, the final products may be 
cleaved in only 5% TFAIDCM. This difference in cleavage labilities led to very high 
product purities. 
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Figure 1.12: Traceless AMEBA Resin. 
1. 2.5 Other Linker Types 
One group of linkers which does not require chemical cleavage are the photolabile 
linkers. 43 Although not as commonly used because of long cleavage times and 
generally poorer chemical stability, some recent developments have been made in 
terms of substrate compatibility and cleavage conditions. The linkers generally have a 







0 	 Me  
Comments 
Original photolabile linker used for 
amino-acid synthesis; cleaved at 350nm, 
18-24h. 
Carboxylic acid synthesis; 45 cleaved at 





0 	 DMe 
Carbohydrate synthesis; 46 cleaved at 
365nm, 15h, synthesis 43% over 4 steps. 
Amide synthesis; 47 cleaved at 365nm, 3h, 
>90% (1-2h for single resin beads). 
Figure 1.13: Structure and Cleavage Properties of Photolabile Linkers. 
Dendrimers have been synthesised on resin by Bradley 48 on both polystyrene and 
PEG-based polymers. This was particularly useful for resin-loading enhancement as 
third generation amine dendrimers increased the resin loading up to 2.8mmollg. 
Bradley was able to use this resin to synthesise a dipeptide, and selectively cleave this 
without removing any of the dendrimenc linker. 
Silicon-based linkers have previously been discussed for their use as traceless 
linkers, but they have also been investigated for their labiltity to fluoride. They have 
been employed with some success in peptide synthesis by Ramage 49 and Chao, 5° with 
cleavage afforded by tetrabutlyammonium fluoride (TBAF). More recently, the 
concept has been adapted for small molecule synthesis by Flitsch and Turner, 5 ' and 
14 
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several substrates have been cleaved from a silicon based linker using TBAF or CsF. 
A silyl-based linker which possesses the unique properties of traceless tethering with 
mild fluoride cleavage was designed by Ellman and used in the synthesis of tricyclic
pyridine derivatives. 12  The mild cleavage conditions are clearly an advantage, but 
unlike other traceless silyl linkers,3 1-33  the silicon group is part of a genuine resin 
bound linker, rather than bound to the resin as part of the substrate structure (see 
Figure 1.10). 
Flitsch and Turner have also developed a linker for immobilising alcohols which 
can be cleaved with the enzyme, penicillin amidase, or mild acid (10% TFA). 53 
Although the enzyme cleavage conditions are relatively inefficient (50% cleavage), 
cleavage in mild acid is more favourable than the DHP-derived linker of Ellman 26 for 
immobilising acid labile substrates such as carbohydrates. 
1. 2.6 Analysis of Compounds on Resin 
The analysis and characterisation of organic compounds bound to resin has proved 
a great challenge. Such analysis is important for determining the level of loading of 
the linker group on resin, and for monitoring a synthesis as it proceeds. Cleavage of 
material from the resin then analysis is wasteful, but direct, on-resin analysis is often 
difficult due to interference from the polymer backbone. Elemental analysis is 
occasionally useful for compounds with an appropriate atom content (eg N, Cl, Br), 
but infra-red (IR) and nuclear magnetic resonance (nmr) techniques have now been 
adapted to maximise their potential for on-resin analysis. 
hR spectroscopy on polymer-bound compounds has been used with some success, 
particularly for identifying diagnostic stretches such as carbonyl. 12  Samples are usually 
prepared by swelling the resin in a small quantity of DCM and then crushed between 
two NaCl plates. Although much of the resultant spectrum is due to the polymer 
backbone, the presence of many functional groups can be confirmed by this method. 
A disadvantage, however, is that the technique is destructive. A non-destructive 
method is Difuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS) 
15 
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which has been used by Sofia 14  in a high throughput method of analysing resin-bound 
sugars. 
IR spectroscopy has also been used successfully in investigating the site 
isolation/interaction effects of polymers. It was originally argued that PS-DVB resins 
had a very rigid structure, in which the functionalised sites were completely isolated 
(hyperentropic effect). The mono-protection by resin of symmetrical diols 55 and 
dialdehydes56  was provided as evidence for the site isolation effect, and lB. 
spectroscopy has been used to investigate this further. Yan 57 has produced IR 
evidence which supports previous findings" that polymer-bound alcohols exhibited 
two -OH bands, corresponding to isolated (sharp) and hydrogen-bonded (broad) 
molecules. This indicated that site isolation and interaction effects were occurring. 
Furthermore, sterically hindered alcohols exhibited a stronger isolation band and 
weaker H-bonded band. 
Evidence that the functional sites of resins are mobile and not rigidly fixed comes 
from the monoprotection of diacid chlorides of various chain length 17  (Figure 1.14). 
Strong ester stretches compared to acid chloride stretches indicated that double 
binding had occurred and so significant site interaction behaviour must exist (although 
the presence of any acid chloride stretch must indicate that there is some site isolation 
effect). The chain length made no difference to the relative band intensities suggesting 
that dynamic movement of the polymer led to consistent levels of site interaction. 
00 
DoH 
acid 	C0 at 1795 cm 	
n = 26 
Figure 1.14: Polymer Site Isolation Effect Determination by JR Spectroscopy. 
Recently, nmr techniques have progressed a great deal in terms of analysing resin-
bound compounds. Gel-phase nmr (usually 13C), where the resin is swollen in an 
appropriate deuterated solvent and the usual pulse sequence applied, generally 
produces spectra which have broad aromatic and aliphatic signals due to the 
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polymeric backbone. The technique is not very sensitive, and usually requires 
thousands of scans before a reasonable spectrum is produced. However, despite 
signal-broadening, some aspects of the linker or resin-bound compounds can be 
observed. Perhaps more successful applications of the gel-phase method have been in 
obtaining 31P spectra" and ' 9F spectra" where appropriate. 
Compared with PS-DVB resins, TentaGel resins have been shown to give better 
gel-phase nmr results. 13  This is due to the PEG units in the swollen state having long 
relaxation times, and so the PS signals collapse altogether, leaving a single sharp PEG 
resonance at ö 70ppm. 
More recent advances in the quality of resin nmr spectra have been due to the 
technique of Magic Angle Spinning (MAS). This is a method which uses a specially 
designed probe which is aligned to the sample in a manner which compensates for the 
magnetic irregularities responsible for line-broadening in gel-phase spectra of 
polystyrene .61 MAS nmr has allowed a vast improvement in the quality of spectra 
obtaining good quality ' 3 C and 'H spectra. 62 '63 The technique has also extended to 
correlation spectroscopy with coupling constants being measured by 'H-'H spectra 64 
and even single-bead 13C_  'H spectra have been successfully analysed 
.61 
1.2.7 Applications of Solid Phase Synthesis 
1.2.7.1 The "Fish-hook" Principle 
In its simplest sense, a resin can be thought of as an insoluble protecting group in 
organic synthesis. Many of the early uses of resins in general organic synthesis 
involved the polymer in exactly that role, and Leznoff 66 has reported many such 
examples. He was particularly interested in the monoprotection of symmetrical 
bifunctional compounds, and recognised insoluble polymers as a way of doing this 
efficiently. Leznoff originally monoprotected symmetrical diols 55 '67 using what he 
termed the "fish-hook" principle 66,61:  the polymer acts as a fish-hook to "catch" a 
portion from the "sea" of excess diol. He was then able to protect the free hydroxyl as 
the trityl, 67 TBIP67 and acetate 55 derivatives, cleave from the resin and pursue 
syntheses as required. This proved to be a more efficient process than the solution 
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phase equivalent. For example, solution phase trityl protection formed unreacted diol, 
mono- and diprotected diols, and trityl alcohol which led to major separation 
problems. 
Monofunctional protection of symmetrical bifunctional compounds was developed 
to include the complete monoprotection of dialdehydes 56 and diacidchlorides, 69 and 
the partial diprotection of amines 70 and dihydroxy aromatics .7' Both monoprotected 
diols and aldehydes have been used in natural product synthesis, leading to insect sex 
attractants 55 and unsymmetrical carotenoids56 
(c)  (Figure 1.15). 
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Figure 1.15: Leznoff's Synthesis of Carotenoids from Monoprotected Dialdehydes. 
Solution syntheses 'of carotenoids have met with the problematic reaction of 
symmetrical aldehydes with two different Wittig reagents, either in one pot or in a 
serial manner. Both methods are low yielding, and are contaminated with symmetrical 
products. LeznoW s synthesis allows the complete monoprotection of the relevant 
dialdehyde using a resin bound diol, and reacting the corresponding acetal, 12, with 
the appropriate ylide. Acetal cleavage of 13 leads efficiently to intermediates which 
can easily be transformed to the carotenoid series. 
The fish-hook principle has been more demandingly employed to extract desired 
components from a compound mixture also containing staring materials and 
reagents .72  Using this method, Fr6chet 72 trapped a cis-cyclohexyl diol, 14, with a 
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boronic acid functionalised polymer (Figure 1.16). On completion of the binding, the 
resin-bound diol, 15, was then easily removed from the crude mixture containing 
several products, by filtration. Washing the resin with water released the diol back 
into solution. 
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Figure 1.16: Fish-hook Purification of Cyclohexyl cis-Diol. 
1.2.7.2 Resin Capture and Scavenge Techniques 
Related to the fish-hook method of purification are the methods of resin capture 
and resin scavenging. Resin capture 73 is a term which has been used to describe, like 
the fish-hook technique, the removal of the desired product at the end of a solution 
synthesis by binding to resin, making it available for further treatment. Scavenging is a 
complementary technique, and involves the use of an insoluble polymer to remove 
excess reagent, by-products and starting materials, leaving the desired compound in 
solution. 
Aminomethylated resin has proved very popular as a scavenger for the removal of 
excess isocyanates 74 acid chlorides, chloroformates and sulphonyl chlorides 
 .71  Such 
techniques have been used to extract products from Ugi four-component 
condensations, 73  and another interesting example where by-products and excess 
reagents were tagged to make them more labile to attack from amine resin. Munoz 
devised the Resin Activation/Capture (REACAP) 76 procedure, where only those resin 
bound products which have reacted as required, will participate in future steps. By 
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Figure 1.18: REA CAP Approach Towards I)ihydro-4-pyridones. 
Resin-bound hydroxy-pyridine, 16 was acylated and the resulting product reduced 
with a Grignard reagent to form enol ether, 18. Only acylated material reacts, and the 
resin is contaminated with starting material, 16, reformed by hydrolysis of 17 in the 
aqueous work-up. Resin cleavage of 18 is selective and the carboxylic acid formed 
due to incomplete hydrolysis of 17 is removed by aminomethylated polymeric 
scavenger apparently without activation. 
1.2. 7.3 Functionalised Polymers as Mechanistic Probes 
The use of functionalised polymers as a probe into reaction mechanisms and 
intermediates has been investigated by Rebek 77 (Figure 1.18). Polymers functionalised 
by two different, but potentially interactive, functional groups are combined in the 
same solvent with a potential catalysing reagent. Virtually all of the functional sites 
are held within the core of the resin beads and so will only react with each other via 
the dissolved catalyst. Rebek proved this by showing that imidazole is required for 
acyl transfer reactions of this type. Furthermore, a control experiment showed that the 
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Figure 1.18: Rebek's Three-Phase Test for Identifying Reaction Intermediates. 
1.2. 7.4 Polymer Supported Reagents 
One aspect of SPOS which has recently received increased attention is the use of 
solid supported reagents. 78 Substrates are transformed in solution by reagents which 
are bound covalently to the resin, and so are easily removed on completion of the 
reaction. The method is particularly advantageous, as no cleavage steps are required 
and the technique is applicable for reactions where recycling of the reagent is an 
advantage. 
Many examples of standard chemistry being performed by solid supported reagents 
exist, such as amide bond formation which has been facilitated by the polymer bound 
coupling reagents, HOBt 79 and carbodiimide. 80 Polymer-bound reagents can bring 
other advantages, too. For example, efficient Swern oxidations have been performed 
on PEG-bound sulphoxide, 81 20 (Figure 1.19). The sulphide, 19, formed on 
completion of the reaction, unlike the solution phase analogue, is odourless and can 
be recycled efficiently to the suiphoxide, 20, using sodium periodate. PEG has the 
advantage over PS-DVB polymers that it is soluble in most organic and aqueous 
solvents, but is insoluble in ether. This enables the chemistry to be performed 
efficiently in solution, but straightforward recovery of the reagent is afforded by 








DCC DMAP 	 19 
0 
n = 44, PEG0 	
NaIO/ R1 R2 
OH 	Et3N, (COd)2 
0 0 	R1 R2 
S t~' ~5 0'+O"tno-~M 5 
20 
Figure 1.19: Swern Oxidation Using PEG-Supported Suiphoxide. 
With much research focussing today on asymmetric synthesis, chiral auxiliaries 
have been considered prime candidates for binding to a solid support. These have 
included a "C2 symmetric" resin-bound pyrrolidine auxiliary, 82 and the more widely 
investigated chiral Evans oxazolidinones.' 5"8'83  AIim 18 and Burgess" have both 
successfully used PS-bound auxiliaries in alkylation reactions (see Figure 1.4) and 
Abel1 83  has employed an auxilliary in conjugate addition and aldol reactions (Figure 
1.20). Importantly, efficient regeneration of the auxiliary is achieved. 
Other polymer-bound reagents have also been used by Ley with great success. His 
group has modified the oxidation reagent, TPAP' 6 for use on solid support in the 
oxidation of alcohols to aldehydes and ketones 84 and hydroxylamines to nitrones. 85 
Additionally, he has further transformed the aldehydes formed upon oxidation by 
using other polymer supported reagents in aldol, 86 reductive amination 87 and Wittig 88 
reactions, in the first examples of clean, multi-step synthesis using polymer-bound 
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Figure 1.20: Resin-Supported Auxiliaries in Aldol and Michael Addition Reactions. 
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Figure: 1.21: Multi-Step Synthesis Using Polymer-Bound Reagents. 
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1.2. 7.5 Synthesis of Heterocyclic Molecules 
The examples of the use of functionalised resin in organic syntheses so far 
discussed have generally focused on specific uses of the resin in functional group 
binding or one-step transformation process. These techniques have clear benefits in 
purifying products in organic synthesis. However, the transformation of a single-step 
benefit into the serial transformation of resin-bound compounds in the multi-step 
synthesis of low molecular weight compounds is the truest test of the advances which 
SPOS offers. Using greatly increased purification rates to synthesise intermediates 
towards classes of "drug-like" or "privileged" structures will offer the greatest 
assistance to the pharmaceutical industry. 
One of the first such compounds to be synthesised entirely on the solid support 
was a small series of benzodia.zepines 89 (Figure 1.22). This synthesis involved the 
isolation of two resin-bound synthetic intermediates and a concomitant 
cyclisationlcleavage step driven efficiently by the site-isolation effect to prevent 
intermolecular interactions. 
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Figure 1.22: Benzodiazepine Synthesis by Multi-Step SPOS. 
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In recent years, there have been a very large number of examples of multi-step, 
solid-supported syntheses of small molecules in the literature. 2 ' Some examples are 
used to illustrate the ever-expanding range of specific reactions on support, whilst 
others are geared towards the synthesis of specific heterocyclic target molecules. 
Oxidation, reduction, addition, substitution, condensation, cycloaddition and 
organometallic reactions have all been illustrated in such a manner. However, the 
main driving force behind this research has been its applicability to combinatorial 
synthesis. 
1.3 Combinatorial Chemistry 
Drug discovery is traditionally initiated by the random screening of large numbers 
of compounds against a specific receptor target. This "lead generation" process may 
identify a compound which exhibits some degree of receptor affinity, and analogues of 
this compound can then be individually synthesised and assayed to determine the 
compound which achieves the maximum possible effect ("lead optimisation"). 
Alternatively, studies of the receptor site in question can also be carried out in order 
to determine a likely molecular structure which will bind most effectively. Such 
information may be used to identify the pharmacophore of high affinity compounds, 
thus aiding drug discovery by a more rational design process than mass screening. 
Whether for specifically designed structure activity relationship experiments or the 
random synthesis of many compounds, combinatorial chemistry is becoming an 
increasingly useful tool in the drug discovery process. In a definitive sense, 
combinatorial chemistry involves the synthesis of mixtures of compounds consisting 
of all the possible incorporated components or building blocks. The term is also used 
to describe (automated) multiple parallel synthesis of individual compounds. Both 
methods have the same goal - to synthesise large numbers of compounds for 
biological screening as quickly as possible. The generally accepted ideal is that the 
drug discovery process is enhanced by faster compound synthesis, and to a certain 
extent can it be thought of as a "numbers game," ie. more compounds synthesised 
should furnish more potent compounds. Coupling high throughput screening assays 
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with combinatorial methods using optimised synthetic routes, a chemist can 
potentially generate biological results on many thousands of compounds every week, 
compared to the hundred or so a single chemist could synthesise in a year. 
1.3.1 The Synthesis of Compound Mixtures 
The simultaneous synthesis of large numbers of compounds relies on robust, 
reproducible chemistry and quick purification methods. Whilst the first factor is 
almost always likely to depend to some extent on substrate variation, SPOS can 
consistently provide a very quick method of purifying compounds which is also 
amenable to automation. Additionally, efficient purification procedures enable 
reactions to be driven to completion by using excess reagents. The recent 
development of new methodologies compatible with SPOS has recently become a 
major research area, and this has greatly contributed to the whole combinatorial 
paradigm. 
Much of the initial research into combinatorial processes was carried out using 
peptides. Reliable solid phase techniques existed for the chemical synthesis of proteins 
and the accessible pool of the twenty naturally occurring amino acids provides an 
adequate source for variation eg a library of pentapeptides constituting each natural 
amino acid at every position will produce a library of 20 = 3.2 million compounds. 
Mixture generation by adding equimolar quantities of reagents to a single substrate is 
likely to have varying success due to differing reactivities of the reagents, and so a 
much more reliable technique was devised by Furka. 9° This is known as the "split and 
mix" technique, and is illustrated below for the synthesis of nine dimers formed from 
three constituent amino acids (Figure 1.23). 
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Figure 1.23: Fur/ca 's Split and Mix Method of Peptide Library Generation. 
The functionalised resin is split into three portions or pools containing different 
amino acids, A, B and C. The resin is then recombined and is once more split into 
three pools, again containing the constituent amino acids. The resulting nine 
compounds have been formed using six coupling reactions over two steps, and can be 
recombined for analysis or kept as three separate sublibraries. 
The potential number of peptides which can be synthesised in this manner is 
extremely high. However, it is recognised that peptides themselves have limited 
therapeutic value due to their poor bioavailability, and so attention has shifted recently 
to adapting library methodology for the generation of small molecules. The split and 
mix technique of library generation has recently been used to generate mixtures of low 
molecular weight molecules, such as 4-thiazolidinones, 91 pyridinium salts92 and 
mercaptoacyl prolines. 93 The 4-thiazolidinone library (Figure 1.24) was synthesised 
using 5 Fmoc-protected amino acids (AA, R 3)  on TentaGel resin. These were pooled 
together and separated into five equal portions and each reacted with a different 
aldehyde (R'). Recombining, mixing and splitting again into five pools, followed by 
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reaction of each with a mercaptoacid (R), led to the final cyclised products. These 
were cleaved from the resin forming the corresponding acids (XO) or amides 
(X=NH). A portion of each of the carboxylic acids was esterified giving a total of 
three libraries. Each library consisted of a total of 125 (5x5x5) members as 540 
(6x 1 0x9) diasteroisomers. 
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Figure 1.24: 4-Thiazolidinone Libraries by The Split and Mix Method. 
Each of the libraries was tested for binding affinity to the COX-1 receptor which is 
associated with inflammation mediation. Active compounds were identified by a 
variation of the iterative technique developed by Houghten 94 for peptides. On 
completion of the synthesis of each library, cleavage was completed on the five 
separate pools corresponding to each of the different mercaptoacids used, and the 
biological assay conducted separately on each of the five mixtures. As the R 2 position 
in each case was known from the corresponding mercaptoacid, assay results identified 
the best substituent in this class; in this case butyl (Figure 1.25). The library was 
resynthesised, keeping the sublibraries separate after the imine formation, and reacting 
each mixture with the butyl mercaptoacid, before resin-cleavage. In this second round 
of assays, two aspects of the product structure are known (R 1 and R) and the mixture 
containing the best R' substituent identified. The final iteration involved the individual 
synthesis of the five compounds with varying amino acid (R 3) substituents and fixed 
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Figure 1.25: Iterative Approach Towards Lead Identification. 
The iterative method of identifying active compounds has been shown to be 
effective, as the resultant compound, 21, is very similar to a known COX-1 inhibitor 
(ethyl rather than methyl ester). The process also allows for product enrichment as 
fewer compounds are being synthesised during each iteration. However, resynthesis is 
time consuming and wasteful of resources. One method of overcoming these 
problems was devised by Janda, 95 who devised a technique known as recursive 
deconvolution. This method includes the removal and archiving of resin samples at 
each step prior to mixing in the normal library generation procedure. (Figure 1.26). 
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Figure 1.26: Recursive Deconvolution Method of Active Compound Identification.    
Biological testing on the two pools from Step 3 may indicate that the active 
compound has building block A in the third position. The two saved pools from Step 
2 are kept separate and reacted only with A to form (AAA, BAA) and (ABA, BBA). 
Since each pool contains only two species instead of four, a two-fold enrichment has 
been achieved. The process is continued until only one product is synthesised and the 
active sequence determined. Using this method, Janda identified a known 3-endorphin 
antibody epitope, H2N-Tyr-Gly-Gly-Phe-Leu-0O2H from a library of its constituent 
amino acids. This technique essentially minimises the amount of resynthesis that is 
required for active compound identification. 
Other methods of active compound identification have been dependent on the 
design of the library synthesis. Houghten developed the positional scanning method 96 
to overcome the time-consuming iterative techniques. The method involves the 
synthesis of multiple sublibraries, where a single position is fixed. For example, a 
hexapeptide library synthesised from 18 constituent amino acids will consist of 108 
(6x 18) sublibraries, with one position containing a fixed amino acid and the remaining 
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positions randomised. The most active compound is present only in those six 
sublibraries with the corresponding fixed-position amino acid and so will show the 
"hit". From this information, the complete sequence can be determined. However, 
there is no product enrichment process, and so the signal to noise ratio in assays is not 
improved. 
A technique known as orthogonal combinatorial chemistry has been reported by 
Tartar, 97  for the synthesis of 15,625 tripeptides. The technique involves the synthesis 
of two libraries consisting of the same compounds, but designed in a manner such that 
the sublibrary mixtures are different, hence active compounds will have different 
spatial addresses and can be identified. 
One approach, known as the "one-bead-one-compound" method, was first 
recognised by Lam, 98  and has been used in active compound identification. For these 
purposes, a resin bead can be thought of as an individual reactor, and since all the 
functional sites on the bead have identical synthetic histories in a split-and-mix library 
synthesis, a single bead will furnish only one compound. Reversible, colourimetric 
biological analysis can be performed directly on the resin bead, which can then be 
isolated and the protein identified by micro sequencing. 
A method of partial release of products from resin has been used by Gallop, 99 for 
solution-based assays in a multi-well format (Figure 1.27). In a tiered release process, 
compounds are joined to the resin with a photocleavable linker. Limited periods of 
irradiation release only 50% of the compound into solution and wells containing 
active compounds are processed further by splitting the resin into smaller portions. 
Further irradiation releases more compound from the bead, and the process is 
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Figure 1.27: Tiered Compound Release and Single Bead Isolation. 
Iterative methods of product identification are cumbersome and time-consuming 
processes. A much more efficient technique would enable direct identification of 
active compounds once the biological assay has been completed. Methods of 
appending an identification label to the resin beads are used in "encoded" or "tagged" 
combinatorial libraries. 100  Various types of tags have been used, but every method 
requires a procedure where the tags cânbe efficiently joined to the resin, are stable to 
the synthetic conditions, easily (orthogonally) cleaved from the resin and identified in 
an unambiguous manner. The detection method usually needs to have high sensitivity, 
as the tags are generally present in much lower quantities than the parent compound. 
Chemical tags in the form of nucleotides have been used as tags for peptide 
libraries.' 0 ' In what is effectively parallel combinatorial synthesis, the coupling of an 
amino acid is followed by an identifying nucleotide sequence. Biological testing 
identifies beads with compounds exhibiting interesting properties, and the "genetic" 
sequence is then cleaved. The sequence, once amplified by PCR and identified, is 
unique to one peptide sequence and so the active structure is revealed. 
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Small organic molecules have been used by Still and Ohlmeyer as tags in 
combinatorial chemistry. 102  These have been used in the synthesis of both peptide 
102(a) 
 
and small molecule 102  libraries, to identify active compounds from solution based 
assays. Substrates were loaded onto the resin, followed by the appropriate 
combination of tagging molecules via an orthogonal linking strategy. The tagging 
molecules were designed such that they could be separated by electron capture gas 
chromatography (Figure]. 28). 
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Figure 1.28: Small Molecule Tags Used in Combinatorial Synthesis. 
After each synthetic step, tags were bound to the resin in a binary encoding system 
according to which substrate had previously been used. Orthogonal cleavage of the 
tags from "active" beads, followed by analysis by ECGC, enabled identification of the 
active compound from the combination of tags detected. 
Tagging methodology has proved to be a challenging area in combinatorial 
synthesis and non-chemical methods, including laser-etching onto ceramic plates 
supporting flinctionalised polystyrene, 103 and a method using colour encoded glass 
beads and vial caps 104  have been reported. One of the most successful chemical or 
non-chemical tagging methods has been the radio frequency (RF) encoded methods of 
Nicolaou t05 and Armstrong. 106  These methods involve the containment of resin in 
porous microreactors, each containing a RF encodable chip (Figure 1.29). Split and 
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mix synthesis is performed as normal, with each pool subjected to a unique RF pulse. 
Each reactor has a different synthetic history at the end of the library synthesis, and 
this is reflected in the RF sequence held by the microchip. This information can be 
retrieved, and so the compound structure identified. The method has recently been 
used in the synthesis of a 400-member taxoid library. 
107  The potential exists for 
information such as reaction temperature or solvent conditions to be stored on the 





Figure 1.29: Microreactor Containing RF Encodable Chip. 
The combinatorial synthesis of compound mixtures, coupled with effective 
deconvolution strategies, has proved a very efficient method of synthesising and 
identifying many thousands of compounds for biological testing. Split and mix 
synthesis will readily assist the lead identification process by generating large numbers 
of compounds in a short time. However, the technique is not well suited for quick 
structure activity relationship (SAR) determination or lead optimisation, as generally 
only those compounds which exhibit strong biological activity are identified. The best 
method of completing these studies is by synthesising individual compounds, and so 
multiple parallel synthesis techniques have also been developed. 
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1.3.2 Multiple Parallel Techniques 
Although the concept of synthesising analogues of a given template structure for 
the purpose of biological testing is not new, the rapid generation of analogues has 
only recently become possible due to developments using solid phase methodologies. 
As with the generation of compound mixtures, published research into parallel 
synthesis has centred on classes of compounds which consist of "privileged" 
templates. For example, pyridine derivatives are common heterocyclic systems in 
pharmaceutical agents, and have been the subject of solid phase synthesis by 
Gordeev.' °8  He has synthesised 16 pyridines in a parallel manner using Knovenagel 
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Figure 1.30: Parallel Solid Phase Synthesis of Pyridines. 
1,4-Benzodiazepine derivatives have also proved popular substrates for SPOS, and 
have been synthesised by Ellman. 110 The original library consisted of 192 compounds, 
but an improved synthesis employing a Stille coupling reaction led to the parallel 
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Figure 1.31: Parallel Synthesis of 1,4-Benzodiazepines via Stille Coupling Reaction. 
The construction of the 1,4-ben.zodiazepine libraries has been carried out using 
specially designed equipment for solid phase synthesis. The first equipment was 
designed for the synthesis of arrays of peptides by Geyson." The equipment consists 
of polyethylene pins coated with appropriate functionalised resin, and are spaced to fit 
in a 96-well microtitre plate which houses the solvents and reagents. This equipment 
has been used directly by Ellman in his benzodiazepine synthesis and adapted for the 
synthesis of 1,320 (2,508 diastereoisomers) 1 ,4-benzodia.zepine-2, 5-diones. 2 
Equipment designed for the solid phase synthesis of compound arrays is often of a 
proprietary nature, although some methodologies, for example, Geyson' s Chiron 
mimotope assembly"""' described above is commercially available. The "teabag" 
approach is another which has been reported by for the parallel synthesis 
of peptides. In this method, porous polypropylene bags containing resin are labelled 
according to the reagents used. The teabags can be combined for common steps such 
as washing and deprotection, and active products identified from the label. 
One of the early leaders in the automated multiple parallel synthesis using solid 
phase methods, was the DiversomerTM technique devised by Parke-Davis. 
115  The 
apparatus consists of sintered pins in an addressed array (4x2 or 4x 10). The resin 
(100-800mg) is enclosed in the fritted pin, and placed in a block containing reaction 
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wells with solvent and reagents (Figure 1.32). The entire system is enclosed in a 
manifold capable of ensuring inert reaction conditions and temperature control, and a 
gasket allows for needle injections. Reagent and solvent addition is handled 
automatically by a liquid handling robot, allowing for a completely automated 
synthesis protocol. 
Figure 1.32: DiversomerTM Apparatus for Multiple Parallel SPOS. 
The DiversomerTM technique has been reported by Parke-Davis for the synthesis of 
benzodiazepines,' 15(a) hydantoins,' 
15(a) benzisothiazolones," 5 and cyclic 
dinucleotides,' 15(b)  and the synthesis of a series of quinolone antibiotics was conducted 
at Edinburgh University' 6 (Figure 1.33). The multistep solid phase synthesis followed 
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Figure 1.33: Diversomer Synthesis of Quinolone Antibiotics. 
Methods of automation have been amongst the most recent advances in solid phase 
combinatorial techniques. While research continues to be published illustrating the 
uses of SPOS in heterocyclic synthesis, interest has only recently been switched to 
other viable methods of cleanly generating compounds with biological interest. 
1.4 Library Synthesis by Techniques other than SPOS 
All of the examples of combinatorial techniques so far described have used SPOS 
to access high numbers of chemical entities. The undoubted advantage which the 
technique has in the purification of resin-bound materials has meant that it has largely 
been the method of choice. However, alternative methods have been developed, and 
may, in the future, prove to be more popular than SPOS. 
The main reason for searching for alternative methods is the fact that the use of 
polymers often restricts the conditions which can be used to complete a synthesis: 
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solvents must be chosen to allow good swelling of the resin; reaction temperature is 
limited to avoid resin breakdown; reaction times are usually longer, as reaction 
kinetics are generally slower; compound analysis of resin-bound compounds is 
problematic. Therefore, an ideal system would allow the chemistry to be performed in 
solution phase, but with the benefits which phase separation afforded by SPOS gives 
product purification. 
1.4.1 Fluorous Phase Synthesis 
For several decades, the general immiscibility of highly fluorinated compounds with 
aqueous and hydrocarbon solvents has been known. 117  However, this observation was 
only recently developed to assist in organic synthesis. Zhu"" used the specific 
solvating power of perfluorinated solvents in biphasic transesterification reactions to 
drive them to completion. Hovarth and Rabai 9 used modified phosphine catalysts 
containing a highly fluorinated 'ponytail' to hydroformylate olefins. Liquid phase 
extraction partitioned the catalyst into the fluorous phase allowing easy separation and 
recycling. 
Fluorous phase chemistry has been more powerfully utilised by Curra& 20" 2 ' in 
multiple parallel synthesis. Organic substrates are made fluorous by attaching a highly 
fluorinated tag. Reactions are then performed as normal and products purified by 
liquid-liquid extractions. Reagents and impurities partition into the aqueous or organic 
phases, whilst the desired product exists in the fluorinated layer. The tag can then be 












































Figure 1.34: Principle of Fluorous Phase Extraction Technique. 
Fluorous phase extraction has been used by Curran in the parallel synthesis of a 
small number of isoxazoles and isoxazolines. 12° Allyl or propargyl alcohols were 
'protected' with a highly fluorinated silyl group (Figure 1.35). Isolation of the 
fluorinated compound using a three-phase system (H 20 top, DCM middle and FC- 
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72122 bottom), followed by reaction with a range of nitrile oxides produced a small 
library of compounds in overall yields of 73-99% after tag removal. 
R 
+ BrS1(CH2CH2C6F13) + Et3N 
R 
p 	40Si(CH 2CH2C6F1 3)3 
+ - 
R'CN—O 
isoxazoles: R=H,  
R'Bu,Pti, Me, Pr 
73-99% 	 -0 R OH 




yOSi(CH2CH2C6F l 3)3 
R ' 
Figure 1.35: Fluorous Synthesis of Isoxazol(in)es. 
Curran has also employed the fluorous extraction technique 121  in Stille coupling 
reactions. A highly fluorinated tin species was recycled after aryl coupling, using a 
three phase system similar to that used in the cycloaddition reaction shown above. 
Inorganic salts partitioned to the upper aqueous layer, coupled products to the 
organic layer, and the recyclable tin halide in the bottom fluorous phase (Figure 1.36). 
One drawback of this reaction, however, was the required chromatographic 
separation of symmetrical biaryl coupled product observed in some cases. 
86% 	 Br2 , 98% 
C6 F 13CH2CH2M9I + CI 3SnPh 	(C6 F13CH2CH2 )3SnPh 	 (C6 F 13CH2CH2 ) 3SnBr 
Ar—R + Ar—Ar 
Ar-MgB . 	(C5 F1 3CH2CH2 )3S n-Ar 
	R-X, LICI 	
major 	minor 
2moI% PdCl 2 (P Ph 3 )2 
	 + 
(C6 F 13CH 2CH2 ) 3SnCI 
Ar = p-methoxyphenyl (74%), 
2-pyridyl (88%), 2 furyl (28%) 
	
R-X = C6 H51, p-CH 3COC6 H4 13r, 
p-NO 2 C6 H4Br, p-NO2 C6H4OTf, 
PhCH2 Br. 
Yield = 32-98% 
Figure 1.36: Fluorous Stille Coupling Reactions. 
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Curran recognises the limitations of fluorous techniques, however; by-products 
containing the fluorinated label will also be partitioned to the fluorous layer. This 
would contaminate products in the case of the isoxazole synthesis, or the recycled tin 
halide in the case of Stille couplings. However, this is really no different from resin-
bound impurities occurring from incomplete reactions, and so it is clear that great 
advantages are obtained by allowing traditional solution phase synthesis to be coupled 
with a non-chromatographic purification step. 
1. 4.2 Solution Phase Methods 
One obvious way to overcome the problems experienced when using polymeric 
supports is to use traditional solution phase methods to synthesise compound libraries. 
Clearly, conducting reactions in solution allows the enormous diversity of chemical 
reactions to be utilised to the full, but the task of purifying the products (whether 
single entities or mixtures) is the main stumbling-block. Thus, systems must be 
designed to permit straightforward purification by quick liquid-liquid or liquid-solid 
extractions. 
Although solution phase library synthesis is a relatively unexplored area of 
research, a few examples of the method have been reported. Boger et al have 
designed reaction sequences which use acid/base washes or filtration to purify 
intermediate products. 12' An anhydride template, 22, was used to synthesise a series 
of triamides' 23°  entirely in the solution phase in good yield and purity (Figure 1.37). 
The parallel synthesis of a 27 member library (3 x3 x3) was reported using manual 
acid-base washings. Suitable quantities of material (5-60mg) were obtained in high 
purity (>90%). Furthermore, the method was reported to be amenable with 
nucleophiles other than amines (alcohols, thiols) and also the use of batch solid-phase 
extraction methods in the purification step. 
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Figure 1.37: Solution Phase Synthesis of Triamide Library. 
The anhydride template, 22, was explored in more complicated split and mix 
metathesis reactions. 124  Using this method, up to 600 olefins (including E/Z isomers) 
were initially synthesised in a series of arbitrarily designed libraries, using 12 amines 
and 4 co-alkene carboxylic acids (Figure 1.38). 
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Figure 1.38: Olefin Libraries in Solution Phase. 
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As with the triarnide libraries, intermediate products were purified by liquid-liquid 
extraction techniques, yielding highly pure compounds free of contamination by 
starting materials and reagents. Products from the olefin metathesis reactions were 
purified by chromatography, taking advantage of a system which allowed 
straightforward separation of the desired dimers (either as single entities or designed 
mixtures) from the catalyst and related impurities. Using similar reaction protocols a 
series of sub-libraries totalling in excess of 100,000 related alkene derivatives was also 
synthesised. 
Solution phase synthesis has also been used to synthesise mixtures of carbamates' 25 
and amides/esters.' 26 Each was synthesised in an indexed format - a technique which 
involves the synthesis of a number of sublibraries. For example, the synthesis of 54 
carbamates' 25 from nine alcohols (A 19) and six isocyanates (116) was accomplished in 
fifteen sublibraries of the format A 1 x1 16 , A2 x1 16, ..., A9xI 6 , A 1 .9x1 1 , ..., AxI6 . By 
this method, each compound is synthesised twice in different sublibraries, and so the 
identification of possible "hits" after biological assay becomes more straightforward. 
However, neither of these indexed examples address the problem of generalised 
purification of compounds in solution phase libraries. 
1. 4.3 Soluble Polymers 
The obvious attraction of combining solution phase synthesis with filtration to 
facilitate product purification has been elegantly harnessed by Janda et al. ' 27 He used 
the soluble, linear homopolymer polyethylene glycol monomethyl ether (MeO-PEG-
OH) as a support for the synthesis of peptides and non-peptide molecules. PEG-
polymers (and hence any components bound to them) are soluble in a wide range of 
solvents, but are insoluble in ether. Using this feature to purify PEG-bound 
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Figure 1.39: Sulphonamide Synthesis Using Janda 's Soluble PEG Polymer. 
The technique was enhanced by Janda to embrace traceless linker methodology. 121 
Whereas the above example leaves amino functionality, a traceless system requires 
that effectively only a new C-H bond is formed upon cleavage of the organic fragment 
from the polymer. This requires a suitable linker group as well as appropriate cleavage 
conditions (Figure 1.4O).128 
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Figure 1.40: Traceless Sulphide Linker to Soluble Polymers. 
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The PEG-bound linker group, 23 is bound to the organic fragment to form PEG-
thioether, 24. This, along with the PEG-bound sulphone, 25, is purified by 
precipitation from ether in the normal way. The linker is activated by oxidation of the 
sulphide to the sulphone and the traceless removal of the PEG moiety achieved by 
reduction using Na/Hg to form 26. Although this scheme does not incorporate any 
synthetic transformations on the organic fragment, the aim of traceless linking has 
been adequately demonstrated. 
Janda has also recently adapted the soluble PEG polymer for use with the "fish-
hook" principle  66,61  which involves using the polymer to extract the desired 
component from a reaction mixture. The other components are removed and the 
desired molecule then released from the polymer. This technique was used to purify 
the 0-adrenergic receptor, propanolol.' 29 The method takes advantage of the known 
reversible binding of the 13-amino alcohol subunit to boranes (Figure 1.41) to 
selectively "hook" propanolol from the previously unpurified reaction mixture. 
 
MeO-PEG-OMs MeO 

















H 3B-SMe2 	(  
27 
Figure 1.41: Purification of Propanolol by the "Fish-hook" Principle. 
Propanolol was synthesised in solution without purification of intermediates and 
then selectively bound to the PEG-anchored borane, 27. Ether precipitation then 
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extracted the polymer-bound species, 28, from the reaction mixture. Propanolol was 
released from the polymer by aqueous acid, and the spent polymer removed by 
precipitation using ether. Propanolol was then isolated in 58% overall yield and 92% 
purity. Using a similar protocol, the synthesis of a series of 20 J3-amino alcohols was 
completed in 27-100% yield and >88% purity. 
1.5 The Impact of Combinatorial Chemistry 
There is no doubt that combinatorial chemistry has changed the role of medicinal 
chemists in the drug discovery process. With human genomics projects expected to 
lead to the identification of many new therapeutic targets, processes which quickly 
generate compounds which have high affinity for these potential new targets, are 
likely to be highly rewarded. High throughput screening methods designed to 
automate the routine synthesis and biological screening of many thousands of 
compounds have fuelled interest in the solid phase synthesis techniques required for 
the rapid synthesis and purification of such large numbers of compounds. 
Whilst the common belief exists that testing increased numbers of compounds 
should furnish more compounds with increased potency, discussion prevails as to 
what sort of preparation, prior to library generation, should be carried out. Issues 
such as the merits of optimising solution phase chemistry prior to solid phase library 
synthesis are frequently argued. 
The type and quantity of compounds which should be synthesised is often disputed 
and much emphasis has been placed on the choice of members for any given 
compound library - the issue of compound "diversity" remains a moot point. Although 
it is a common belief that library members should be as varied as possible, the 
combined effect of the parameters which govern how different compounds are from 
each other (shape, molecular weight, hydrophobicity, bioavailability, etc.) are rarely 
agreed. 
The biological testing of compounds as mixtures has also raised questions as to the 
reliability of producing "real" results. For example, an active mixture may simply be 
the accumulative effect of moderately active compounds, rather than one single 
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compound. Consequently, libraries of compound mixtures require robust design to 
remove "false" positives and negatives. 
With much of the development in combinatorial techniques in the pharmaceutical 
industry being of a proprietary nature, it is difficult to know how successful 
combinatorial techniques have been in genuinely assisting the drug discovery process. 
With development periods and clinical trials remaining unavoidable stages, it will be 
some years before drugs which have been discovered by true combinatorial methods 
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Chapter 2: Solid Phase Synthesis of Acrylic Acids 
2.1 Synthetic Routes to Acrylic Acids 
Acrylic acids have been a structural template of interest at Parke-Davis since the 
identification of 29 from a random screen. This indole derivative was found to be an 
antagonist of a receptor in an area of therapeutic interest at micromolar 
concentrations, and was considered to be a candidate for further investigation by the 
Diversome rTM technique (see Section 1.3.2). This would determine the structure 
activity relationship (SAR) and possibly enable lead optimisation. 
For successful generation of analogues, a general synthetic route to acrylic acids 
compatible with solid phase techniques required development. The reported synthesis 
of 29' was conducted as part of a series of analogues using Wittig chemistry (Figure 
2.1). In this synthesis, phosphorane, 30 was condensed with gramine, 31, to form 
substituted ylide, 32. Wittig reaction with aldehyde, 33, followed by ester hydrolysis, 
afforded the desired acrylic acid, 29. 
0 + 




PPh 3 + 
EtO 	- 	
N 	refiux,6h dioxane, reflux, 24h 
H 80% 	-N 






KOH, 50% ethanol 





Figure 2.1: Original Solution Phase Synthesis ofAcrylic Acid, 29. 
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The geometry of the alkene was originally tentatively assigned as E-, due to the uv 
absorbance of the product, which had a maximum absorbance of the same order of 
magnitude as trans-cinnamic acid. Crystal structure data has since confirmed this 
assignment. 2 
The Wittig reaction has been successfully carried out by solid phase synthesis on 
many occasions. Fr6chet3 and Leznoff were the first to investigate the reaction, and 
were able to reproduce solution phase results. Both methods of the reaction have been 
performed, ie a resin bound aldehyde with the ylide in solution, 3 ' 4 and the "reverse" 
Wittig, which has the ylide bound to the solid support and excess aldehyde in 
solution. 4 '' One other method of performing Wittig reactions which is exclusively 
available via SPOS, is the use of phosphine flinctionalised resins. 5 The ylide is built 
upon a resin-bound phosphine, and the reaction is then performed in the normal 
manner. This method has the added advantage that the phosphine oxide by-product 
formed on completion of the reaction remains bound to the resin, and so does not 
interfere with product purification. The various methods of performing the Wittig 
reaction using SPOS are shown in Figure 2.2. 
	
± Ph3PR1 	 + O=PPh3 	Normal Wittig 
+ 	 0 





+ H 	R1 	 + 	 Phospine 
Figure 2.2: Methods for Performing the Wittig Reaction on Solid Support. 
Two of the above methods are viable for the synthesis of 29 on solid phase. The 
"reverse" Wittig reaction could be carried out by binding the carboxyl group to Wang 
resin and forming the ylide with triphenyiphosphine. This could then be condensed 
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would form the resin bound acrylic ester, 36, which could be cleaved under standard 
conditions to form the desired acrylic acid. (Figure 2.3). The only disadvantage of this 
method is that insoluble triphenylphosphine oxide will be formed, which would be 





PPh 	 + 	gramine 




0 	OH 	 0 	OH 
33, heat 	 TFA 	H0 ___ 
CI  N 
H 	36 
Figure 2.3: SPOS of Acrylic Acids Using the Reverse Wittig Reaction. 
H 	29 
IN 
The second possible route involves the formation of a phosphine functionalised 











C N 	38 
H 
0 	OH 
Figure 2.4: Acry lic Acid Synthesis Using Resin-bound Phosphine. 
The use of the resin-bound phosphine has the advantage that the 
triphenyiphosphine oxi de by-product formed during the Wittig reaction remains bound 
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to the resin, and so does not interfere with product purification. However, ester 
hydrolysis of 34, and ultimately other library members, would have to be conducted in 
solution phase. The normal Wittig reaction is not likely to lend itself to library 
generation, as the multi-step solution phase synthesis of a range of functionalised 
ylides would be required beforehand. 
As neither form of the described Wittig reactions is ideal, two alternative 
possibilities were considered. These involve elimination and Homer-Wadsworth-
Emmons6 '7  (HWE) reactions respectively to furnish the acrylic acid functionality. The 
elimination route was chosen (Figure 2.5), as a reliable route to key t3-ketoester 
intermediates had been previously established' and used successfully by MacDonald 
and Ramage9  in the solid phase synthesis of quinolones. Furthermore a quantity of a 
suitable aryl r3-ketoester was available from related work (see Section 3.3) and could 
be used in model studies. Therefore, resin bound 13-ketoester, 39, after alkylation, 
could be selectively reduced to form hydroxy-ester, 40. Dehydration followed by resin 
cleavage would furnish the desired acrylic acid, 29. 












C1 	 C1 
N 	 NW 
40 
TFA 
Figure 2.5: Proposed Elimination Route to Acrylic Acid, 29. 
The HWE reaction has been little explored on solid phase, compared to the related 
Wittig reaction. It has been investigated using combinations of mild bases 1° and 
reactions have been followed using gel phase 31p  nmr' ° and magic angle spinning nmr 
00 
II 	 base 
'-I 	 gramine 
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techniques." The HW.E reaction involves the reaction of phosphonate esters with 
aldehydes and ketones, rather than phosphonium ylides in the Wittig reaction. This 
results in the HV'TE reaction exhibiting several advantages over the Wittig reaction. 
For example, phosphonate carbanions are known to be more nucleophilic than 
phosphonium ylides, 6  and so will generally react with a wider range of aldehydes 
and ketones under milder conditions. Alkylation of phosphonates is more readily 
achieved than ylides, 6  and so more highly substituted olefin products can be 
accessed. Finally, and of greater consequence in SPOS, the phosphate by-product 
formed during the reaction is water soluble, and so will not inhibit olefin purification. 
Therefore, resin-bound phosphonate, 41, could be alkylated to give indole 
phosphonate, 42. HWE reaction with salicylaldehyde, 33, furnishing olefin, 36, 









Figure 2.6: HWE Route to Acrylic Acid, 29. 
The elimination route and HWE route were both considered as viable alternatives 
to the Wittig reaction in achieving the solid phase synthesis of 29 and ultimately a 
library of acrylic acid analogues. However, due to potential problems of following 
reactions and analysing compounds on solid support, the optimisation of each 
synthesis in the solution phase was first attempted. It was hoped that by using 
reagents and solvents which would be compatible with solid phase methods, any 
problems could be quickly overcome, and alternatives sought if necessary. 
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2.2 Model Studies (1): Elimination Route 
The elimination route to acrylic acids was investigated using the 13-ketoester, 43, 
which was available as a precursor of investigations into the synthesis of the 
quinolone antibacterial, Ciprofloxacin (see Section 3.3). The retrosynthesis for the 
corresponding methylindole acrylic acid, 44, is shown below (Figure 2.7). 




F F 	 F aF 
N 	 N 6PNN  
H 44 	 H 45 	 H 
00 0 0 





NN 	A7 	 43 	 48 H 
N F 	F 	 F 
H 47 
Figure 2.7: Retrosynthesis of Model Acrylic Acid, 44. 
The synthesis is composed of well established chemistry; the only potential 
drawback being a lack of geometric control in the formation of the olefin. However, 
the synthesis, separation and biological assay of both E- and Z- isomers would 
perhaps generate greater understanding of the receptor site in question. One key 
synthetic point was the choice of gramine methiodide, 48, rather than unquaternised 
gramine, 31, as the alkylating agent as used in the original synthesis of 29.1  This was 
because the methiodide salt has been known to alkylate compounds with active 
methylene groups under milder conditions than gramine alone. 12 
The synthesis of gramine methiodide was carried out as reported by Geissman,' 3 
with the slow addition of gramine to neat methyl iodide (Figure 2.8). This contrasts 
with the methods reported by Brown 14  and Snyder, 
12  who added gramine to an 
excess of methyl iodide in ethanol. However, Geissman, and later Melhado,' 5 proved 
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N Me3 I 
Mel (D[~N 
61% 	 H 
48 
Figure 2.8: Synthesis of Gramine Methiodide. 
Gramine methiodide was prepared in 61% yield, and although the procedure 
required a lengthy washing and crystallisation protocol, multigram quantities could be 
made. Nmr spectroscopy indicated that none of the bis-indole product was present in 
the purified samples by comparison with reported data,' 5 regarding the chemical shift 
of the methylene and methyl protons. 
Alkylation of 3-ketoester, 43, with gramine methiodide was attempted using a 
number of amine bases compatible with solid phase chemistry. Use of the bases DBU, 
DABCO and TMG was not successful, giving a mixture of products as well as 
unreacted starting material. Reaction with triethylamine, however, proceeded 




48, Et3N, DCM 




it, 4h, 83% 
N 	46 
Figure 2.9: Alkylation and Selective Reduction to form Hydroxyester, 46. 
For full details of the synthesis of 0-ketoester, 43 see Figure 3.6. 
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Although many reagents exist for the direct dehydration of alcohols, 
16  none proved 
satisfactory in this case. Treatment of 46 with DMSO at 130°C gave only recovered 
starting material, whilst reaction with POC1 3 in pyridine 7 gave an isomeric mixture of 
products in low (--30%) yield. This product mixture was thought to contain both E-
and Z- olefins, as no conformational control was expected from the elimination 
reaction. The isomers were separated by exhaustive chromatography, and 
characterised by 'H nmr and mass spectrometry. It was clear that the products were 
not the expected olefins and were subsequently identified as the diastereomeric 
chloride, 49 (Figure 2.10). 
- 0 OH 
EtO1j( F 
F  
L 7J N> 46 
H 
Pod3, pyridine 





Figure 2.10: Action of POC1 3 on Hydroxyester to form Chloride, 49. 
The assignment of the relative configuration of the two diastereoisomers was not 
unequivocally clear, but certain information gained from the 1H nmr spectrum of each 
isomer indicated a possible solution (Figure 2.11). The resonances for proton H 1 
suggest that that of isomer 1 has an anti- relationship with H2 due to the large 
coupling constant of 9.71-1z. The corresponding coupling constant for isomer 2 is 





	Isomer 1, 49A 	 Et02CXAr Isomer 2, 49B 
2 H2 
In "H4 
H3 	 H3 
6 = 5.41ppm (1H, d, 3J n1 = 9.7Hz, H1 ) 
6 = 3.46ppm(1H, m, H2) 
6= 3.03ppm(1H, dd, 3jHH 14.2, 10.2Hz, H3) 
6 = 2.74ppm (1H, dd, 3jHH = 14.2, 4.8Hz, H.4) 
6 = 5.09ppm (1H, d, 3J = 5.9Hz, H 1 ) 
6 = 3.60ppm (1H, m, H2) 
6 = 3.40ppm (1H, dd, 3jHH = 14.5, 8.6Hz, H 3) 
6 = 3.17ppm (1H, dd, 3jHH = 14.5, 6.4Hz, 1-14) 
Figure 2.11: Assignment of Chloride Diastereoisomers by 'H AMR. 
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Methods of activating the hydroxyl functionality to the elimination process by 
transformation into a better leaving group were attempted, but synthesis of the 
corresponding acetate, tosylate and triflate of 46 were unsuccessful. One method 
which did furnish identifiable products was that of Furstner' 8 who reported the 
elimination of a secondary alcohol using methanesulphonyl chloride and a large excess 
of DMAP. Treatment of 46 under these conditions yielded two products, which were 
identified as chloride, 49B, and mesylate, 50 (Figure 2.12). Coupling constants in the 
'H nmr spectrum of 50 led to the tentative assignment of the anti- isomer. These 
reaction conditions, however, gave unreproducible product mixtures, and at no time 





2.5eq MsCI, 5eq DMAP 










Figure 2.12: Attempted Alkene Formation via Active Mesylate. 
The reasons behind such difficulties in olefin formation were not obvious, 
especially as elimination would be expected to be driven by the conjugation of the 
eliminated product. Furthermore, with the hydroxyl group in the benzylic position, 
any subsequent carbocation formed would be highly stabilised. It may be that the 
acidic indole NH- is being deprotonated under basin conditions, causing side reactions 
to occur, and that NH-protection may be required. Another possible explanation may 
be that the compound may be restricted in forming the anti-periplanar arrangement 
between the H and OH required for elimination to result. This may be represented by 
the four Newman projections of hydroxyester, 46 shown in Figure 2.13. 
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EtO2C?CH2In InH2C?,CO2Et 	C ,,CO2Et :, EtO2C?C) 
Ar'H 	 HAr 	 Hc) 
I 	 II 	 III 	 IV 
Figure 2.13: Newman Projections of the Diastereoisomers of /3-Hydroxyester, 46. 
It is possible that steric hindrance between the trifluoro aromatic (Ar) and the 
methylindolyl (CH2In) group would prevent isomers ifi and IV from aligning in the 
required fashion. Similarly, it-stacking between the aromatic groups, may make the 
overall structure more rigid, preventing the correct geometric arrangement from 
arising. 
An alternative method for elimination reactions uses the Mitsunobu reagents 
triphenylphosphine and diethyl azodicarboxylate (DEAD). The synthesis of 
dehydroaminoacids has been performed under such conditions 19 and the method was 
attempted to drive the dehydration of 46. The reaction did yield alkene, 45, as a single 





Et02CN NCO2 Et 





F " F 
LJ 5i 
H 
+ Et02CN- NCO2Et 
26% CO2 Et 
O=PPh3 + 	HN-NH 
EtO2C 
Figure 2.14: Elimination Reaction Using Milsunobu Conditions. 
Why Mitsunobu conditions should form the olefin over the other activation 
methods described is unclear. It can only be reasoned that formation of insoluble 
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triphenylphosphine oxide formed on completion of the reaction drives the process 
more than the equivalent eliminations using other activation methods. This is perhaps 
due to the charged nature of the intermediate, 51. The crude product was a 
complicated mixture, and isolation of only one geometric isomer of the alkene 
(unassigned, but shown as E-) should not suggest any inherent selectivity of the 
reaction. More effort would be required in order to investigate the Mitsunobu 
conditions further. 
In parallel studies, methods of forming the correctly flinctionalised aryl 13-ketoester 
for the ultimate synthesis of the lead acrylic acid, 29, were investigated. The acid 
chloride, 52, of 5-chiorosalicylic acid, 53, was synthesised in good yield via the 
sodium salt, using a procedure reported by Shakirov et al.2° The corresponding 13-
ketoester, 54, could not be isolated from the complex product mixture obtained on 
treatment with standard conditions 8 (Figure 2.15). 
	
O OH 	 0 OH 
HO-1~0 &(çJ NaOH, methanol Cl  
SOd2, benzene 
60°C, 3h, 80% 
Cl 	 Cl 
53 	 52 
00 
EtO'OK 	 0 0 OH 
Et3N, 
IW




Figure 2.15: Attempted Formation of /3-Keloester, 54 
The mixture of products observed from the above reaction is possibly due to the 
deprotonation of 52 by excess triethylamine. It is likely that this may be overcome by 
protecting the phenol of 53 prior to acid chloride formation. It may also be true that 
protection of the indole NH- of 13-ketoester, 47, may ultimately lead to easier 
elimination reactions, and so whilst there are many possible ways of exploring further 
the 13-ketoester route towards 29, it was clear that the general procedure was 
becoming more complex. More fundamentally, the need to individually synthesise a 
range of many 13-ketoesters in order to explore the effect of alternative aromatic 
substituents on biological effect, would be inefficient and inappropriate for rapid, solid 
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phase, library generation methods. It was therefore decided to investigate the 
proposed HWE route for the generation of acrylic acids. 
2.3 Model Studies (2): The Horner-Wadsworth-Emmons Route 
As in the 3-ketoester route, the synthesis of acrylic acid, 29, via the HWE reaction 
was first attempted in the solution phase. Experience from results of investigations 
into the failed 13-ketoester route led to optimised alkylation reactions, as well as a 
comprehensive study of phenolic protecting groups. Although it was recognised that 
efforts should be made to synthesise the lead compound, there was also a concern that 
this indole substrate was not representative of potential library members in terms of 
chemical stability. Therefore, a simpler benzyl derivative was also investigated. 
Furthermore, the outcome of the HWE reaction in terms of alkene geometry was 
unknown, and detailed solution phase analysis was expected to be required. The 
general retrosynthesis for the acrylic acids is shown in Figure 2.16. 




CI 	 CI 	 CI 
O OP 
0 0 	 0 0 
+ EtO 	P(0Et)2 	DO
OEt)2 + AICH2X 
55 
CI 	Ar 
Figure 2.16: General Retrosynthesis of Acrylic Acids via the HWE. 
The first key step, therefore, was to optimise conditions for the alkylation of 
triethyl phosphonoacetate, 55. 
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2.3.1 Phosphonate Alkylation 
Triethyl phosphonoacetate, 55, was synthesised in a straightforward manner, using 
tnethyl phosphite and ethyl bromoacetate by the Arbuzov reaction , 21 in 90% yield. 
Alkylation of the phosphonate ester was attempted using gramine methiodide under 
the same conditions as for the 3-ketoester alkylation step (see Figure 2.9). 
Unfortunately, this led only to the recovery of starting material. 
Conclusions from investigations into the elimination reaction indicated that 
protection of the indole NH may assist in controlling reactions of these substrates. 
Furthermore, Padwa22  has reported the straightforward quaternisation of NH-
protected gramine using a less time consuming and more atom-efficient procedure 
than the method of Geissman.' 3 Therefore, 1 -triisopropylsilylgramine, 56, was 
synthesised according to a procedure described by Iwao, 23 and the protected species 
quaternised forming 57. Alkylation of the phosphonate ester was then attempted using 
a range of bases (Figure 2.17). Pleasingly, the indole-protection and quaternisation 
reactions could be carried out almost quantitatively. Indeed, the complete 
transformation of gramine to 57 could be performed without isolation of the protected 
intermediate, in a yield in excess of 90%. 
NMe2 	 NMe2 	 NMe3I 
CON
1. NaH, THF, 0°C, 2h 	 4eq CH3 I, THF, rt 
2. TIPSCI, 0°C, 22h, 99% 	 4h, 100% 	 N 
H 	 ruDs 	 1]PS 
	
31 	 56 	 57 
o 	 0011 
DO 	B, toluene, reflux
EtoAOEt)2  







Figure 2.17: Gramine Protection and Attempted Phosphonate Ester Alkylation. 
Alkylation of 55 using 57, however, did not proceed and furnished either starting 
materials or a mixture of unidentified products. The range of conditions tried included 
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a series of solid phase compatible bases, as well as others which would have been 
expected to work well in solution phase (Table 2.1). 
Reaction Conditions Observed Result 
1 3eq Et3N, THF, rt, 16h, then 40°C, 24h recovered starting material 
2 1 e TMG, CH3CN,rt, 19h mixture 
3 2eq tBuOK, THF, rt, 15h unidentified product 
4 5eq NaH, THF/CH3 CN unidentified product 
5 1.6eq. NaH, TBAI (cat.) THF/CH 3 CN, rt, 26h mixture 
6 1.5eq Na, ethanol, rt, 90mins mixture 
Table 2.1: Conditions Used for Attempted Alkylation of Attempted Alkylation of 
Phosphonate Ester. 
Using the same conditions as for the 13-ketoester alkylation (entry 1), only starting 
materials were recovered. Some conditions gave complicated mixtures of products 
(entries 2, 5, 6), whilst others (entries 3 and 4) gave a product, which although 
exhibiting some features of the desired product, 1H nmr indicated that it contained too 
many aromatic protons, and could not be purified sufficiently for satisfactory 
characterisation. 
To investigate if it was the TIPS group which was affecting reactivity, the 
alkylation of 13-ketoester, 43, was attempted using the same conditions used with the 
unprotected gramine salt (see Figure 2.9). Therefore, 43 was stirred in dry THF with 
TIP S-gramine methiodide and triethylamine. Even after the addition of large excesses 
of base and prolonged reaction times, the reaction did not go to completion. In fact, 
the compounds isolated were unreacted starting material (41%) and the NH-
deprotected 13-ketoester, 47 (44%) (Figure 2.18). 
70 







2eq Et3N, THE, rt, 20h 




44% + 43, 41% 
Figure 2.18: /3-Ketoester A ikylation from TIPS-Gramine Methiodide. 
Clearly, the base must be causing TIPS-deprotection before alkylation can proceed, 
and so the mechanism of alkylation is unlikely to be straightforward nucleophilic 
substitution of methiodide by the enolate of 43. Therefore, some method of in situ 
TIPS removal, followed by nucleophilic attack, would be required in order to achieve 
alkylation of the phosphonate ester, 55. As silyl groups are commonly removed by 
treatment with the fluoride anion, it was expected that pretreatment of 57 with 
tetrabutylammonium fluoride (TBAF) followed by reaction with 55 in base would 
successfully lead to alkylated phosphonate, 59 (Figure 2.19). 
00 
NMe3 I  
00 	 EtO 0Et)2 
II II 
O:N; + 	U....P(0Et)2 	 . 
ris 55 	 59 NN 
57 	 H 
Reaction Conditions Product Yield 
1 (1) 55, 1.3eq TBAF, THF, lh (2) 55, Et3N, rt, 511 0% 
2 (1) 55/57, leq Et3N, TI-IF, rt, lOmins (2) leq TBAF, rt, lh 49% 
3 55/57, 1 e TBAF, THF, rt, I  79% (crude) 
4 55/57, 1 e TBAF, THF, 0°C, 30mins - rt, 60mins 67% (crude) 
5 55/57, 2.2eq TBAF, THF, rt, lh 92% 
Figure 2.19: Alkylation of Phosphonate Ester with in situ TIPS Deprotection. 
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It was apparent from this series of experiments, that treatment of the phosphonate 
ester, 55, with triethylamine (entries 1 and 2) prevented a clean reaction from 
occurring. Indeed, somewhat surprisingly, treatment of the reactants with TBAF alone 
was found to be the most effective method of alkylation. However, when only 1 
equivalent of reagent was employed, impurities were formed which could not be 
separated from the desired product (entries 3 and 4), and by far the cleanest and most 
efficient method was to use over 2 equivalents (entry 5) of TBAF. These conditions 
led to smooth alkylation forming 59 in excellent 92% yield. Importantly, this 
procedure should be applicable to methods of solid phase synthesis. 
The mechanism of alkylation is almost certainly initiated by fluoride cleavage of the 
TIPS group of 57, and concomitant elimination of trimethylamine forming the highly 
reactive intermediate, 60. Deprotonation of 55 by the amine or by the excess TBAF, 
followed by addition to 60 forms the indole-phosphonate, 59 (Figure 2.20). The 
intermediate, 60, has been postulated by Melhado' 5 for being involved in the 
formation of bis-indole methiodide salts in the formation of gramine methiodide (see 
Figure 2.8), and is almost certainly the reactive intermediate in the 3-ketoester 
alkylation (see Figure 2.9). 
	
RD G 	 0 0 II 	 II 0 	 yEt)2 
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Figure 2.20: Mechanism for Synthesis of Indole-phosphonate, 59. 
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Clearly, the above method of alkylating phosphonates is only useful for the 
gramine-based substrate, and is not generally applicable to substrates of the type 
ArCH2X. Therefore, a suitable, general method of forming benzyl-phosphonate, 61 
was sought. Literature precedent for the synthesis and subsequent use of 61 in the 
HWE reaction has been reported by Martinez 24 and Roques. 25 Both groups report the 
highly efficient alkylation of phosphonate ester, 55, with ben.zyl bromide, using 
sodium hydride. As the insoluble nature of sodium hydride renders it unsuitable for 
solid phase synthesis, and amine bases have already been shown not to give alkylation, 





1. 2eq NaHMDS, THF, it, 1  







Figure 2.21: Synthesis of Benzyl-phosphonate, 61 with bis-Benzyl By-product, 62. 
NaHMDS is a strong, non-nucleophilic base which is soluble in THE Alkylation of 
55 was attempted using this base and benzyl bromide, and the reaction was 
surprisingly found to give a mixture of compounds in a consistent ratio. These were 
identified as the desired ben.zyl phosphonate, 61 and the bis-benzyl product, 62. They 
could not be separated by column chromatography and so were isolated by 
preparative HPLC (Figure 2.22). 
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Figure 2.22: Analytical HPLC Trace of the Crude Mixture of 61 and 62. 
The products were formed in a consistent ratio of approximately 2.7:1 as 
determined by 'H nmr of the crude mixture, and this product ratio was found to be 
independent of the concentration of base or benzyl bromide. This would suggest that 
the second deprotonation was not a result of excess base, but, rather due to self-
deprotonation by the enolate, 63 (Figure 2.23). The newly formed enolate, 64, would 
then over-alkylate, forming 62. 
	
0 0 	 0 011 0 0  
EtO (0Et)2 + EtO 
	
P(OEt)2 	
- EtO)0Et)2 + EtO(0Et)2 
Ph 
63 	 61 	
55 	 Ph 	64 
Figure 2.23: Seif-deprotonation of Benzyl-phosphonate, 61. 
At this stage, it was unclear whether the corresponding alkylation reaction would 
be more or less likely to produce the bis-benzyl product when performed on the solid 
phase. It may be expected that the excess reactions used to drive solid phase reactions 
to completion would encourage a greater proportion of bis-benzyl product, However, 
if the self-deprotonation theory is correct, then this is less likely to occur on resin due 
to the site isolation effect (see Section 1.2.6) observed with functionalised polymers. 
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Although the presence of the bis-benzyl phosphonate is undesirable, it will play no 
further part in the synthesis, as the next step, a HWE reaction, requires deprotonation 
of the active methine in order to proceed. It was expected that unreacted 62 could be 
easily separated from alkene products by chromatography. 
2.3.2 Phenol Protecting Groups 
Previous discussion of the elimination route to acrylic acids, illustrated problems 
with the synthesis of the key 13-ketoester intermediate, 54. This is thought to be due to 
intramolecular hydrogen bonding of the salicylic acid, 53, affecting its reactivity and 
so impeding attack from nucleophiles. Furthermore, the nucleophilicity of the phenol 
itself may cause side reactions. These effects will also be observed in the 
salicylaldehyde, 33, required for the HWE reaction. The expectation that phenol 
protection would be required to allow the HWE reaction to proceed smoothly was 
confirmed by the reaction of indole-phosphonate, 59, with 33 (Figure 2.24). The only 
identifiable product from the reaction was approximately 50% recovered 






2eq tB Uc(HF 18h, it 
0 	OH 
33 65 
Figure 2.24: Attempted HWE Synthesis of Hydroxy-olefin, 65. 
For a protecting group strategy to be successful, several factors must be 
considered. The general requirements of straightforward protecting group 
incorporation and removal, and stability to reaction conditions, are important, as with 
all syntheses using protecting groups. However, of most importance was the cleavage 
strategy which would enable the most efficient overall synthesis. Since the last step in 
solid phase synthesis is the final product cleavage from the resin, the most efficient 
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protecting group strategy would employ a group which cleaved under identical 
conditions. Therefore, since Wang resin - cleaved with TFA - was the initial resin of 
choice for the synthesis of acrylic acids (see Figure 2.6), TFA labile protecting groups 
would be the most effective. Examples of protecting groups which fall into this 
category are para-methoxybenzyl (PMB), 26 methoxyethoxymethyl (MEM) 27 and 
methoxymethyl (MOM). 28  Attempts were made to protect 33 with each of these 
groups (Figure 2.25). 
O OH 
	
1 K2CO3 c one 55°C 2h 	 OMe 
2. 	 BCI,TAI,55°C,i8h. 
CI 	 CI 
33 66 
0 OH 	 0 OR 
1. NaH, THF, rt, 2h 	 R = 
	 MEM 67 89% 
2. RCI, THF, ii 	 MOM 68 100% 
CI 	 CI 
33 
Figure 2.25: Synthesis of TFA-Cleavable Phenol Protecting Groups. 
Despite several attempts, the PMIB-phenol ether, 33, could not be formed. 
Generally a complicated mixture of products was obtained, and on only one occasion 
was the desired ether observed by 'H nmr, in very low yield (2%). More success was 
achieved in forming the IVIIEM and MOM ethers, 68 and 69 respectively. These were 
both formed in very good yields, of 89% and 100% respectively. 
Other protecting groups were also synthesised, in case alternatives to the TFA-
cleavable groups were required. The t-butyldimethylsilyl (TBS), 70, and acetate, 71, 
derivatives were chosen for their mild cleavage protocols by TBAF and saponification 
respectively. This would enable straightforward cleavage, either prior to or 
subsequently after resin cleavage. The methyl ether of 33 was synthesised and 
considered a viable option as its sterically undemanding nature may enhance the 
efficiency of the HWE reaction. Aryl-methyl ethers can be cleaved under a variety of 
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conditions, including trimethylsilyl iodide 
29  or boron tribromide. 3° The synthesis of 
these alternative protected phenols is shown in Figure 2.26. 
Si 
	
O OH 	 0 O\\ 
1. imidazole, DMF, 30mins 
2. TBSCI, DMAP, DMF 
Cl 	 Cl 69 
33 o 
O OH 	 0 O 
Et3N, THF, rt, 15mins 
Ac20, DMAP, THF, I  
Cl 	 Cl 70 
33 
O OH 	 0 
1. KCO3 , acetone, rt, 1 	
1-0 2. Mel, rt, 6h 
Cl 	 Cl 7.1 
33 
51% (69% based on 
recovered starting material) 
99% 
89% 
Figure 2.26: The Synthesis of Alternative Phenol Protecting Groups. 
The cleavage conditions required for each protecting group were not tested on the 
above substrates, but rather, their suitability for the HWE reaction was investigated by 
reaction with the indole-phosphonate, 59, or benzyl-phosphonate, 61. 
2.3.3 Homer- Wadsworth-Emmons Reactions 
Generally, strong bases such as n-butyllithium, sodium hydride and potassium t-
butoxide have been employed in the HWE reaction . 7 Of these, n-butyllithium and 
sodium hydride were expected to be unsuitable for use in solid phase synthesis, and so 
initial experiments were carried out using potassium t-butoxide as base. (Milder bases 
such as DBU, triethylamine or diisopropylamine have been reported for use in the 
HWE reaction in combination with lithium or magnesium salts, 3 ' but these too were 
reasoned to be unsuitable for resin techniques.) The base used in the successful 
77 
0 	OR 
Solid Phase Synthesis of Acrylic Acids 
benzylation of the phosphonate ester, NaHIvIDS, was also investigated for use in the 
HWE reaction. 
The indole phosphonate, 59, was used in the FIWE reaction with each of the five 
protected aldehydes 67-71 (Figure 2.27). The effect of protecting the indole NH 
using the TIPS group was also investigated. Although this requires additional 
synthetic steps, it was hoped that the HWE reaction would proceed more smoothly 
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Figure 2.27: HWE Reactions Performed on Protected Salicylaldehydes. 
The results show that the MEM and methyl ether protecting groups were the most 
suitable for this sequence of EVE reactions (Table 2.2). The MEM-olefin, 72, was 
synthesised efficiently using both KOtBu and NaHMDS as base (entries 1 and 3), and 
this was a more efficient reaction than that with the MOM-salicylaldehyde (entry 2). 
Reactions involving the methoxy-salicylaldehyde, 71, were only successful when the 
stoichiometric ratio of aldehyde to excess base was greater than 1 (entries 7-9), as 
otherwise the aldehyde was being consumed by the base (possibly through directed 
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metalation). Neither the TBS nor acetate protected aldehdyes reacted to give olefins 
(entries 4 and 6). Both groups are susceptible to migration via the adjacent carbonyl 
group . 32  Indeed the product from entry 4 was a TBS protected indole derivative. 
Disappointingly, only starting materials were recovered when this substrate was used 
with the TIPS protected indole, 58 (entry 5). This double protection strategy did, 
however, help to enhance reaction with 58, reducing the reaction time to only 2 hours 
(entry 9). 
Entry Phosphonate Conditions and Product Yield Isomeric 
Ratio 
1 59 2eq KOtBu, leq 67, 20h, 77% (72) 2.2:1 
2 59 2eq KOtBu, leq 68, 20h, 48% (73) 2.2:1 
3 59 1eqNaHMDS, 1.2eq 67, 20h, 88% (72) 2.2:1 
4 59 2.2eq KOtBu, 1.1eq 69, 20mins, 0% - 
5 73 1.2eq KOtBu, leq 69, 36h, 0% - 
6 59 2.1eq KOtBu, leq 70, 20h, 0% - 
7 59 2.1eqKOtBu, 1.1eq71,20h,0% - 
8 59 1.2eqNaI-IMIDS, 1.5eq71, 16h,63% (74) 1.8:1 
9 73 1.1eq KOtBu, 1.1eq 71, 2h, 96% (75) 7:2 
Table 2.2: HWE Reactions Between Indole-phosphonates and Protected 
Salicylaldehydes. 
All of the above olefins were obtained as a mixture of E- and Z- isomers. Although 
the absolute geometry could not be determined from the data available, it was clear 
that the major isomer was consistent in all cases from 'H nmr spectra. The chemical 
shift of the alkene proton of the major alkene product in each mixture was observed at 
6-7.8ppm as a singlet. Ratios were calculated from the integrals of the ethyl group 
alkoxy protons of the two isomers. The successfully synthesised alkenes are shown in 
Figure 2.28. 
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Figure 2.28: Jndole-olefins Synthesised by the HWE Reaction. 
The HWE reaction was also attempted using the benzyl phosphonate, 61, with 
both the MIEM- and methoxy- protected aldehydes (Figure 2.29), as these had 
previously been shown to be the most successfully employed substrates. 
00 	 0 
II 	 II 
EtO 
P(OEt)2 
1.1 eq NaHMDS, THF, rt EtO 




0 0 	 0 0 	 0 	OMEM 
11 11 
P (0 Et) 2 
I - 
Eto(0Et)2 	 1. 1.2eq NaHMDS, THF, it 	EtO 
1 1105~
2. 1.5eq 67, it, lh, 76% 
CI 
61 	 77 
62 	 ratio 7:2 
—32 mol% 	—68 mol% 
Figure 2.29: HIVE Reactions With Benzyl Phosphonate and Protected 
Salicylaldehydes. 
The yields of alkenes 76 and 77 were highly satisfactory. As with the indole 
substrates, the alkenes were formed as a mixture of E- and Z- isomers, but with 
slightly greater selectivity. Also, as predicted, the mixture of mono and bis-alkylated 
phosphonates, 61 and 62 reacted cleanly as expected with MIEM aldehyde, 67, 
furnishing the corresponding alkene mixture in an efficient 76% yield, based on 
starting material composition. 
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2.3.4 Protecting Group Cleavage 
With reliable synthetic routes to several alkenes in hand, methods of efficient 
protecting group cleavage were examined. Synthetically, the most efficient route 
would be the TFA cleavage of the MEM group from alkenes 72 and 77 (Figure 2.30), 
as concomitant cleavage of substrates from Wang resin could also be achieved under 
these conditions. The MOM-ether was disregarded as a potential protecting group 
due to the much less efficient synthesis than the MEM analogue. 
The indole substrate, 72, proved to be unsuitable for protecting group cleavage 
using TFA, and only a complicated mixture of products from a dark-coloured residue 
was obtained. Although the presence of a yellow fluorescence indicated that ionised 
phenol may be present in the reaction mixture, no individual products could be 
identified. Even reducing the concentration of TFA to 1% led only to a complicated 
mixture (over 18 hours), and recovered starting material. Other methods of MEM-
cleavage reported by Corey, 33  including treatment with zinc bromide or titanium 
tetrachloride, led only to the formation of mixtures of unidentified products. 
M 















Figure 2.30: Attempted TFA -cleavage ME/vI-protected Alkenes. 
The likelihood that efficient cleavage of the MEM group of 72 was being hindered 
by the indole moiety was supported by the reaction of 77 under the same conditions. 
Complete consumption of starting material furnished olefin 79 and coumarin 80. This 
was achieved quantitatively, with the ratio of products exactly corresponding to that 
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of the starting olefin mixture. It would reasonable to expect that the Z-olefin would 
be more likely to form the coumann, and so the major isomer of the products 
obtained from the HWE reactions was likely to be the E-isomer, as expected from 
activated phosphonates of this type .34 
Assignment of the alkene geometry was confirmed from results of experiments into 
conditions promoting the cleavage of the methyl ethers, 75 and 76. Use of sufficient 
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Figure 2.31: Methyl Ether Cleavage Using BBr 3 . 
Using trivalent boron, there should only be a requirement to use one-third of a 
molar equivalent to permit cleavage to occur. However, subjecting 75 to this quantity 
of BBr3 merely served to cleave the TIPS group, with the vast majority of recovered 
material being the fully protected starting material. Indeed, only when 4 molar 
equivalents of reagent were used, was there seen to be full consumption of starting 
material, forming phenol, 34, as a single geometric isomer, and coumarin 81. 
However, this reaction was not reproducible, and often gave the coumarin as the only 
identifiable product. Unfortunately, sufficient material was not obtained to pursue this 
route towards 29. 
The geometry of the alkene double bond of 34 was the same as the major isomer of 
75 by 'H nmr, and was assigned E- as for 79. This was proved by accumulating more 
detailed nmr data, including through-space coupling by Nuclear Overhauser Effect 
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(NOE) experiments (Figure 2.32). This confirms the rationale described for the 
product ratio obtained upon MEM- cleavage of benzyl acrylate, 77. Interestingly, the 
elimination product, 45, obtained under Mitsunobu conditions (see Figure 2.14), also 
possessed the olefimc proton at 6-7.8ppm, confirming the assignment of E-geometry. 




Figure 2.32: Methylindolylacrylate 34, with H-Atoms Exhibiting Strong Through-
space Coupling. 
The relatively large quantity of the coumarins, 80 and 81, formed during methoxy-
cleavage, served to suggest that BBr 3 catalyses alkene isomerisation. Additionally, it 
is likely, given that no other products were observed by thin layer chromatography 
(TLC) over the time-scale of the reaction, that the isomerisation process is faster than 
methoxy cleavage. 
Although formation of coumarins, 80 and 81, was unexpected, it was clear that 
base-hydrolysis of these would furnish the corresponding acrylic acids. Survey of the 
literature indicated that Z-cinnamate salts would spontaneously cyclise on 
acidification ' 3 ' but that under certain conditions, isomerisation of the double bond 
would lead to the isolation of E-cinnamates (Figure 2.33). Methods reported have 
included ethanolic sodium hydroxide solution in strong light ' 3 ' aqueous sodium 
hydroxide with mercury (II) oxide36 or stirring with sodium ethoxide at 700C . 37 
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However, in the case of benzyl coumarin, 80, hydrolysis was unsuccessful and only 
starting material was recovered. 






0 	 0 
HO 	OH 
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Figure 2.33: Coumarin Hydrolysis and Isonierisation. 
With a reliable and efficient method of cleaving the MEM- group from the benzyl 
acrylate, 77, in hand, straightforward ester hydrolysis was performed in order to 
synthesise the target acrylic acid, 82. This step would not be required when cleaving 





LiOH.1-120, 50% aq ethanol 
reflux, 4h, 86% 
0 	OH 
Y  HO 5~-' Cl 1?1  
82 
Figure 2:34: Ester Hydrolysis of Benzyl-acrylate, 79. 
The efficient solution phase synthesis of acrylic acid, 82, has been achieved under 
conditions compatible with solid phase synthesis. As with all synthetic routes for 
potential compound library generation, the conditions chosen were expected to be 
compatible with a wide range of substrates and, additionally, the phenol deprotection 
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required no extra synthetic steps, thus having no detraction from the generality of the 
route. Attempts were therefore ready to be made at the solid phase synthesis of 82. 
Although, disappointingly, the indole acrylic acid, 29, could not be synthesised in 
solution phase using the methods described, it was envisaged that the indole building 
block would be suitable for library members where no deprotection steps are required. 
Indoles have successfully been cleaved from Wang resin using 50% TFA. 38 
2.3.5 Completed Solution Phase Synthesis of Indole Acrylic Acid 
Although a general route had been devised towards acrylic acids which would be 
amenable to solid phase techniques, there remained the goal of synthesising the 
original lead compound, 29. Previous protecting group strategies had been 
incompatible due to the nature of the conditions required for cleavage and clearly, 
phenol protecting groups which could be cleaved under milder conditions were more 
appropriate. 
The tetrahydopyranyl (THP) group is a hydroxyl protecting group which is readily 
cleaved in relatively mild conditions using oxalic acid. 39 Although considered as one 
of a range of possible phenol protecting groups, it was initially disregarded due to the 
lengthy, low-yielding reported synthesis of protected salicylaldehyde systems. 4° 
Furthermore, the direct protection of 5-chiorosalicylaldehyde yielded only starting 
materials. However, recently, the synthesis of THP-aldehyde, 84 has been reported by 
ortho-formylation of the phenol protected precursor. 41 
HWE reaction between 84 and 59 efficiently led to the mixture of alkenes, 85. This 
reaction was the most selective of all the HWE reactions carried out, and yielded the 
isomeric alkenes in the geometric ration of 5:1 (E:Z). THP-deprotection, followed by 
ester hydrolysis, led to the completed synthesis of 29 (Figure 2.35). This product was 
submitted for biological screening for comparison with the originally synthesised lead 
compound, and was found to be active at similar micromolar concentrations. 
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Figure 2.35: Completed Synthesis of Methylindolylaciylic Acid, 29. 
2.4 Model Studies (3): Solid Phase Synthesis 
Before initiating the synthesis of a library of acrylic acids, the solution phase 
protocol for the synthesis of the benzyl derivative, 82, was transferred to the solid 
phase to confirm the suitability of the optimised conditions. Of key interest and 
concern was that the alkylation step would yield the desired mono-phosphonate and 
not the bis-alkyl phosphonate as the major product. 
The support chosen to allow concomitant protecting group and resin cleavage, was 
Wang resin. Two possible methods for loading triethyiphosphonoacetate onto Wang 
86 
3OH 
P(OEt) 3 ,tokiene, 
))), DMF, rt, 16h 	 86 
0 
HO 	
Br DIC, DMAP (cat.), 
41 
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resin were explored (Figure 2.36). The direct method of transesterification 42 is 
reported to occur solely at the carboxylic functionality and should efficiently form 
resin-bound phosphonate, 41. However, this method presents no obvious way of 
determining the loading of the phosphonate on the resin; a synthetic method of 
performing the Arbuzov reaction on resin-bound bromoacetate, 86, could overcome 
this. The quantity of bromine could then be determined by combustion analysis, and 
hence the degree of loading could be calculated. (A recent publication by Nouvet 43 et 
al has described the efficient formation of bromoacetylated Wang resin, 86, under 
Mitsunobu conditions, claiming greater efficiency than the DIC/DMAP method 
described below.) 
OH + EtO 	
F(0Et)2 
	 10 	 0 
Wang Resin 	 55 	
41 
Figure 2.36: Two Alternative Methods of Synthesising Wang-phosphonate, 41. 
Combustion analysis of 86 indicated a composition of 5.33% (±0.6%) bromine, 
which corresponds to a loading level of 0.67mmollg (±0.07mmollg). Although this 
degree of loading is sufficient in order to obtain significant quantity of products upon 
cleavage, the relatively large error in these results prompted alternative methods of 
loading determination to be sought. 
A photometric method of loading determination involved reaction of the free sites 
of the resin with p-nitrophenolchloroformate, and then cleaving to form p-nitrophenol. 
A known quantity of this was then measured photometrically against a known 
standard. However, this method was found to give poor reproducibility, and so was 
deemed to be unsuitable. 
A general method for the quantitative determination of bromine is the Volhard 
titration. 44 Quaternisation of pyridine with 86 forms the pyridinium salt species, 87, 
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which itself forms a precipitate of silver bromide upon addition of silver nitrate 
(Figure 2.37). Excess silver nitrate is determined by titration with ammonium 
thiocyanate using ferric alum as indicator and the quantity consumed is a measure of 





86 	 87 
Figure 2.37: Sample Preparation for the Volhard Titration. 
Trial titrations on the salt formed from ethylbromoacetate and pyridine illustrated 
that the technique was accurate and reproducible. However, titration with the resin 
bound pyridinium salt, 87, failed to give any result, indicating that either the 
pyridinium salt did not form on the resin, or, more likely, that the silver nitrate could 
not react with the resin-bound substrate. The loading of bromoacetate onto the resin 
was therefore accepted as 0.67mmollg as calculated by combustion analysis. 
The solid phase synthesis of the benzylacrylic acid, 82, was completed as shown 
below in Figure 2.38. Analysis of each of the intermediates was performed directly on 
resin by IR and gel phase ' 3C and 31P nmr, which despite giving poorly resolved 
spectra, gave sufficient qualitative data for identification. The most important tool for 
qualitative analysis was the phosphorus nmr, as this was used particularly to monitor 
the success of the alkylation and HVTE reactions. 
The crucial alkylation reaction to form resin-bound benzylphosphonate, 88, was 
approached very carefully in order to determine whether or not the bis-alkylated 
product was formed. Although solid phase synthesis usually operates most efficiently 
when excess reagents are used to drive reactions to completion, the alkylation 
reaction proceeded best when only 1.1 molar equivalent of base was used with 2.5 
equivalents of benzyl bromide. This furnished a single product by 31P nmr, which was 
ultimately used to furnish 82. When 2 and 4 molar equivalents of base and benzyl 
bromide respectively were used, a different single product was formed which did not 
yield 82 upon resin cleavage. The 13 C nmr spectrum of the product from the HWE, 
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89, reaction indicated from characteristic resonances of the MIEM group, as well as an 
absence of the phosphonate methyl carbon, that the desired alkene had formed. 
However, the 31P nmr showed that some phosphonate remained, and so the reaction 
had not gone to completion. 
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Figure 2.38: Solid Phase Synthesis of Benzylacrylic Acid, 82. 
Cleavage of 89 from the resin was carried out using 90% aqueous TFA in DCM. 
HPLC of the cleavage mixture indicated that two main products were present (Figure 
2.39). The retention time of these two compounds identified them as the desired 
benzyl acrylic acid, 82, and the corresponding coumarin, 80. Purification by 
preparative HPLC, and analysis by mass spectrometry, confirmed that the major 
product was indeed 82. As expected, the conditions used to cleave the products from 
the resin had also to cleave the MIEM-protecting group. Therefore, 82 could be 
accessed on the solid phase using only four chemical steps, including cleavage. 
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benzylacrylate 
coumann 
Pure 82 after Solution Phase Synthesis 	Crude 82 after Solid Phase Synthesis 
Figure 2.39: HPLC Traces of Benzylacrylale, 82. 
Following the successful solid phase synthesis of benzylacrylic acid, 82, the 
protocol was used to in the parallel, solid phase synthesis of a library of acrylic acids. 
2.5 Multiple Parallel Synthesis of Acrylic Acids 
The parallel synthesis of acrylic acids was attempted using the 4x2 array 
Diversomer apparatus, illustrated in Figure 1.32. This equipment allows the user to 
handle up to 100mg of resin per sample in one block, under inert atmospheric 
conditions if required. Unlike larger models, liquid handling is not automated using 
this equipment, and so the manual addition of reagents, as well as resin washing 
between steps, was required. 
It was envisaged that 40 compounds in all would be synthesised, as five 
sublibraries of eight compounds each. The targets were chosen from a pool of 10 
aromatic alkyl halides, including the gran -fine derivative, 48, and 10 benzaldehydes, 
including the salicylaldehyde derivative, 33 (Figure 2.40). These were arbitrarily 
chosen to cover a range of substitution patterns, and possible effects on polarity and 
electronic parameters. 
Included in the 40 compounds chosen for synthesis, were all the possible 
combinations of 91 where Ar was fixed as methylindolyl (from 48), and Ar' fixed as 
p-chlorophenol (from 33). This was to enable easy comparison of biological data, and 
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if possible, generate SAR data. The remainder of the 40 analogues were then to be 
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Figure 2.40: Proposed Substrates for the Acrylic Acid Library. 
2.5.1 Library 1. Indole Sublibrary 
The first sublibrary synthesised was that in which the final compounds each 
possessed the methylindolyl group and where the acrylic acids were derived from the 
aldehydes, A1-A8. Although the solid phase synthesis protocol had not been 
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same problems encountered during the solution phase syntheses of 29 would not be 
met in this solid phase library synthesis. Crucially, the aldehydes chosen did not 
possess the problematic ortho-phenol group, and so cleavage of the final products 
using TFA were not thought to be too harsh. A series of indoles have previously been 
synthesised on Wang resin, and cleaved using 50% TFA/DCM. 38 
The indole-phosphonate, 42, was synthesised in one batch, using the previously 
optimised alkylation procedure. The resin was then split into portions of 
approximately 100mg and the HWE reaction performed with each of the aldehydes 
A1-A8, and cleavage of the products from resin carried out with TFA (Figure 2.41). 
42 
o 	o 	0 CI 
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Figure 2.41: Synthesis of Methylindolylacrylic Acids in Library 1. 
After cleavage from the resin, the crude mixture of each compound was analysed 
by HPLC. Unfortunately, each sample showed a slight pink colouration, which, in 
previous experiments, has been associated with indole decomposition. Each cleavage 
mixture was washed with a small quantity of 0.5N NaOH solution in an attempt to 
remove excess TFA, and prevent further decomposition. A sample HPLC trace of the 
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cleavage mixture from the reaction of 42 with aldehyde, A5, is shown in Figure 2.42. 
The trace shows that two main products were formed; the trace was typical of that 
obtained for all of the samples, and the marked peaks were isolated by preparative 
HPLC in each case. 
Figure 2.42: HPLC Trace of Cleavage Mixture from Indole Library 1. 
The fact that two main products was observed was to be expected, as these could 
correspond to the E- and Z- isomers of the product acrylic acid. However, mass 
spectrometry (MS) on each of the samples, was inconclusive, and gave no idication as 
to the identity of the isolated products. The fact that each of the HPLC 
chromatograms was very similar, and that the MS profiles of the samples was very 
similar, indicated that the same products, common to all of the samples, was being 
isolated - perhaps a common synthetic intermediate. However, the mass of the 
unknown compound did not correspond to the most likely of these - the carboxylic 
acid which would form on resin-cleavage of unreacted phosphonate, 42. 
The unsuccessful conclusion to the synthesis of methylindolylacrylic acids, 
although disappointing, may still have been due to resin cleavage conditions which 
were too harsh for this range of substrate. It was hoped that other substrates would be 
inert to TFA, and present no obstacles to successful synthesis. 
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2.5.2 Library 2: Chiorophenol Sublibrary 
The second 4x2 sub-library attempted, involved a range of phosphonates formed 
from reaction of 41 with halides H1-H8, each then reacted with the MEM-protected 
salicylaldehyde, 67 (Figure 2.43). Concomitant resin and protecting group cleavage, 
using TFA, as illustrated by the solid phase synthesis of the benzylacrylic acid, 82, 
was expected to yield a library of eight chlorophenolacrylic acids. 
0 	0 	1. 1 .5eq NaHMDS, ))), THF, rt, 3h 
P(OEt)2 
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Figure 2.43: Synthesis of Chiorophenol Library 2. 
As expected, HPLC analysis of the crude reaction mixture indicated the presence 
of two compounds, which could be attributed to the acid and coumarin products 
(Figure 2.44). However, there was very little variation in the retention time of 
corresponding peaks between samples, and MS analysis after preparative. HPLC, 
again gave identical profiles. 
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Peaks iso 
by prep H 
Figure 2.44: HPLC Trace of Cleavage Mixture from Chiorophenol Library 2. 
As with the methylindolyl library, the products of the chlorophenol library could 
not be identified. No acrylic acid products were observed, and disappointingly, the 
benzylacrylic acid, 82, previously synthesised in isolation by SPOS (Section 2.4), and 
which should have been isolated from the well used to react H5, was not observed. 
2.6 Conclusions 
The efficient solution phase synthesis of acrylic acids, 29 and 82, via the HWE 
reaction, has been made possible by the thorough examination of suitable phenolic 
protecting groups. Reaction conditions have been shown to be viable with the solid 
phase synthesis, and isolation, of benzylacrylic acid, 82. Progression towards 
synthesising arrays of acrylic acid analogues on Wang resin using Diversomer 
apparatus, however, has not been achieved. 
The reasons behind the unsuccessful parallel array synthesis are unclear, although 
several possibilities exist. Phosphonate ester alkylation has been shown to furnish an 
unavoidable mixture of products using standard methods in the solution phase, 
although this did not appear to be carried through to trials on the solid phase, the 
reaction may be causing similar problems. More analysis of the reaction on resin may 
be required. The design of the Diversomer equipment itself may have influenced the 
passage of reactions, as difficulty was experienced in maintaining an inert atmosphere. 
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Questionable diffusion of reagents through the sintered pin, may also have reduced 
reaction efficiency, thus requiring greatly increased reaction times. 
With the successful solution phase synthesis of the methylindolylacrylic acid, 29, 
achieved using THP-protected phenol, different linker strategies may assist the solid 
phase synthesis. Since the THP group is relatively acid labile, a more acid-sensitive 
linker, such as SASRIN, may be more suitable, preventing the acid decomposition of 
products. Biological testing of the affinity of 29 and 82 to the receptor site of interest 
confirmed that 29 synthesised by the HWE route was of comparable reactivity to the 
previously tested material. No significant affinity was observed with the benzyl 
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Chapter 3: Charcoal as an Alternative Solid Support 
3.1 Tetrabenzola, c,g,z]fluorene 
Recently, solution-based methods of compound library synthesis have begun to be 
investigated as an alternative to using SPOS. 1 Synthetic limitations encountered when 
using polymeric supports have led to alternative methods of synthesis which maintain 
straightforward purification protocols (see Section 1.4). 
Ramage has recently reported the use of tetrabenzo[a,c,g,i]fiuorene (Tbf), 92, as a 
pendant group in the purification of peptides and proteins 2 and DNA . 3 This 
polyaromatic group, which is substituted for Fmoc as the N-terminus protecting group 
of the completed protein sequence, possesses several properties which assist in the 
purification of such synthetic molecules. These include the hydrophobicity of the 
group, as well as its characteristic uv absorbance at 364nm, greatly assist in target 
compound identification and isolation from deletion and truncation sequences by 
preparative HPLC. However, the property of greatest potential use in general organic 
synthesis, is the affinity which Tbf has for charcoal or porous graphitised carbon 
(PGC) (Figure 3.1). In protein purification, the target Tbf-bound sequence, is 
selectively adsorbed onto the carbon surface, contaminant sequences removed in the 
filtrate, and the desired protein cleaved from the Tbf anchor group back into solution. 
desorbed TV 	 adsorbed TV 
Figure 3.1: Adsorption-Desorption Equilibrium of Dissolved Thf With Carbon. 
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The adsorption of hydrophobic compounds onto carbon is a well known 
equilibrium process. 4  It has been observed that polar solvents and lower temperatures 
aid the equilibrium towards adsorption, whilst non-polar solvents and elevated 
temperatures assist desorption and solubilisation. It was proposed that the adsorption 
process could be used as a purification aid in general organic synthesis. 
Organic compounds, covalently bound to Tbf via a suitable linker group, could be 
reacted using traditional solution phase chemistry, and the product purified by 
exploiting the affinity of the Tbf group for carbon, with non-Tbf-bound compounds 
removed in the filtrate. As no covalent bonds are formed with the support, this may be 
described as a pseudo-solid phase purification step, and has all the associated 
purification advantages with SPOS. Recovery of Tbf-bound product can be achieved 
by simple desorption from the carbon, and the compound is then ready for the next 
synthetic step. 
Ciprofloxacin, 93, was selected as a suitable target for establishing a purification 
protocol using Tbf-anchored compounds. This quinolone antibacterial has been the 
subject of more conventional SPOS, 5  and it was hoped that the synthesis could be 
adapted to the solution phase by binding a precursor to a suitable Tbf-anchor group, 
and purifying the synthetic intermediates by carbon purification (Figure 3.2). 
00 
Tbf—R 










Figure 3.2: Synthesis of Ciprofloxacin by Carbon Purification of Intermediates. 
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3.2 Synthesis of the Tbf-Linker Group 
The success of a Tbf-based anchor group for tethering to the quinolone precursor 
as a potential purification aid, depends greatly on the design of the linker group. As 
with linkers in solid phase synthesis, the group must possess several qualities which 
are key to its role: appropriate functionality must be present in order that bonds may 
be formed with both Tbf and the quinolone backbone; the group must be stable to the 
proposed reaction conditions; the linker must provide sufficient separation of the Tbf 
and heterocyclic fragments so that the bulky Tbf group in no way sterically-hinders 
reactions; the group must cleave from the heterocyclic moiety under specifically 
defined conditions once all transformations have been completed. 
Ramage and Dutton6  have previously examined a number of Tbf-anchored chiral 
amines and their use as a stationary phase in the IIPLC resolution of chiral alcohols 
and protected Fmoc amino acids. The resolution was tested using amines tethered to 
Tbf via alkyl linkers of 3, 6 and 10 carbons in length, and suitable methods for their 
synthesis determined. These findings were considered when choosing the construction 
of a suitable linker group for the quinolone synthesis. 
It was envisaged that ethyl 4-(10-bromodecyloxy)benzoate, 94, would meet all the 
required criteria for a suitable linker group. The ten carbon alkyl chain would provide 
adequate separation of the Tbf group and organic fragment, and reduction of the ester 
functionality to the alcohol would ultimately provide a suitable point of anchorage for 
the quinolone backbone. Finally, the para-alkoxy functionality would aid cleavage 
from the final quinolone product in a manner similar to Wang resin (see Figure 1.5). 
Bromoester, 94, was synthesised from ethyl 4-hydroxybenzoate, 95, and 1,10-
dibromodecane, 96, in 63% yield (Figure 3.3) using a Williamson ether synthesis. The 
moderate yield was due to the excess of 96 required to encourage, as far as possible, 
only mono-etherification of the symmetrical substrate, and which made product 
purification less efficient. Unavoidable di-etherification also contributed to a lowering 
of the yield of 94. 
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CO2Et 	 CO2Et 
1. NaH, DMF, it, 2h 
II 	I 
	
2.0 	3eq Br(CH2)10Br, (96), ii, 19h, 63% 	II 
OH 	 O(CH2)10Br 
95 	 94 
Figure 3.3: Synthesis of Linker Group, 94. 
It is possible that, by altering the functionality of 96 to form an unsymmetrical 
compound, the requirement for a large excess of reagent would be diminished. One 
possible method could be to synthesise 10-bromodecan-1-ol, 97 and react this with 
95. The synthesis of 97 has been achieved by Tomohiro 7 et a!, from decan- 1,1 0-diol 
reacting with hydrobromic acid and continuous extraction using cyclohexane, in 74 % 
yield without further purification (Figure 3.4). However, the hydroxester, 100, would 
require further functional group modification before alkylation by Tbf would be 
possible. 
CO2Et 




50h, 74% 	 97 
O(CH2) 100H 
98 
Figure 3.4: Synthesis of] O-Bromodecan-]-o!, 97 
With suitable quantities of the linker group, 94, in hand, coupling to Tbf using 
Dutton' s method  was attempted. Tbf itself has received relatively little attention in 
the literature, but two syntheses of the polyaromatic have been reported by Martin. 8 
However, both of these have contained harsh, low-yielding steps, which were 
impractical for large scale preparation. The much more straightforward synthesis 
developed by Ramage and Wahl' was used to synthesise the 8bH- analogue of Tbf, 
99, in multi-gram quantities over only two steps (Figure 3.5). Two molar equivalents 
of the Grignard reagent of 9-bromophenanthrene, 100, were reacted with 
methylformate to form the bis-phenanthryl methanol product, 101. Elimination and 
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cyclisation using TFA formed 99 in good overall yield. The symmetrical polyaromatic, 
Tbf, could be formed by treatment of 99 with base, but this was not required for 
future synthetic steps. 
- 	 OH 
1. Mg, THF, rt, 2h 	 TFA, 0CM 
Br 0.5eq HCO 2CH3, 2h, 64% 	
30mins, 70% 
100 	 101 
/ 
99 










it, 2.5h, 94% 
represented by: 
OH 
Figure. 3.5: Synthesis and Alkylation of Thf. 
Coupling of the bromoester, 94, to Tbf was achieved by first forming the 
tetrabutylammonium salt of 8bH-Tbf, 102, using tetrabutylammonium hydroxide 
(TBAH) under anaerobic conditions. The bright yellow salt, was then isolated by 
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filtration and reacted immediately with 94, to form Tbf-ester, 103, in a good overall 
yield of 68%. The final anchor group, Tbf-alcohol, 104, was synthesised by reduction 
of 103 using diisobutylaluminium hydride (DIBAL-H). The anchor group was 
efficiently synthesised in multi-gram quantities and was suitable for direct binding to 
the precursor of Ciprofloxacin. 
3.3 Solution Phase Synthesis of Tbf-Ciprofloxacin 
Before any experiments could be performed to investigate the properties which 
influence the adsorption of Tbf-bound compounds onto charcoal, the suitability of the 
Tbf-anchor group to organic synthesis was examined. It is clear that the affinity of Tbf 
for carbon would only be a successful aid to the purification of organic compounds if 
the bulky, hydrophobic group had no detrimental effect on the solution phase 
synthesis. 
The quinolone precursor, 3-ketoester, 43, was synthesised in very high yield using 
acid chloride, 105 and potassium ethylmalonate in a synthesis described by Wemple 9 
(Figure3. 6). The methodology was developed in order that a variety of 13-ketoesters 
may be synthesised as precursors for quinolone antibacterials. The method employed 
the mild base, triethylamine and used anhydrous magnesium chloride to stabilise the 
enolate intermediate. 
0 0 0 	0 	1. MgCI, EI3N, CH3CN, rt, 2.5h 
EtO) 
EtO 	OK 	 0 
):::~ 
2. c1 F 	16h, 94% 	
F 
F 	F 
F L' F 	 43 
105 
Figure 3.6: Synthesis of J3-Ketoester, 43. 
The 13-ketoester, 43, existed as keto-enol tautomers in the ratio, easily observed by 
nmr, in a ratio of 2.7:1 (Figure 3.7). The enol protons at (8 12.69ppm, integral 
0.27 and ö 5.81ppm, integral 0.27) for 106, were easily distinguished from the 
methylene protons (ö 3 .92ppm, integral 1.46) of 43. 
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43 	 106 
Figure 3.7: Observed Keto-enol Tautomerism of/3-Ketoester, 43. 
Coupling of the quinolone precursor, 43, with the Tbf anchor group, 104, was 
performed in a transesterification reaction using catalytic DMAP in refiuxing toluene' ° 
(Figure 3.8). The product, Tbf-ketoester, 107, exhibited the same degree of keto-enol 
tautomerism as 43. 
106 	
3eq43,DMAP,toluene 
reflux, 40h, 70% 	
107 F):::~ F 
Figure 3.8: Synthesis of Thf-bound Quinolone Backbone. 
The quinolone template was synthesised from the backbone of 107, using a 
variation of the synthetic procedure described by MacDonald and Ramage 5 (Figure 
3.9). It was hoped that the method would be tolerant to direct transposition to the 
Tbf-bound analogues, but this was found not to be the case and a degree optimisation 
was required. 
The quinolone template was built upon the backbone using Meerwein' s reagent, 
dimethylformamide diacetal. 11 Both the diethyl and the dimethyl acetals (shown) were 
found to work equally efficiently in forming enamide 108, and in situ transamination 
with cyclopropylamine, followed by cyclisation in one pot using TMG, led to the Tbf-
bound quinolone, 109 in an excellent overall yield of 68%. The final synthesis of Tbf-
Ciprofloxacin was achieved in a good yield of 76% by nucleophilic aromatic 
substitution with piperazine. 
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0 0 
6eq, (CH3 )2 NCH(OCH 3 )2 , 
107 F 	F 	
THF, rt, 24h 	 N 	F 	F 
108 
12 eq, cyclopropylamine,  
01 
20eq TMG, 
THF rt. 20h 	 HN F a F 	THF, reflux 20h 
A 110 
0 0 	 00 
20eq piperazine, 
pyridine, reflux, 6h 
F 	 76% 
109 A 	 ill A 	LNH 
68% overall 
froml 07 
Figure 3.9: Synthesis of Thf-bound Ciprofloxacin. 
The one-pot synthesis of 109 was not the preferred method in the original synthesis 
of Ciprofloxacin, but it was found to be the most efficient route for the Tbf-bound 
substrates (Table 3.1). Enamide, 110, could be isolated, but consistently poor 
recovery after flash chromatography meant that product was obtained in, at best, a 
moderate 69% yield (entries 1 and 2). Cyclisation of 110 using pure material, led to 
109 in only 55% (38% overall, entry 3), whilst cyclisation of crude material (entry 4) 
led to recovery of the quinolone in only 18% overall yield. The one-pot method was 
clearly the most efficient method overall, both in terms of yield and time-scale (entries 
5 and 6), leading to recovery of 109 in an excellent overall yield of 68%. 
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Starting Material Reaction Conditions (Product) Yield 
107 - 7.5eqDMF-diethylaCetal, THY, rt, 20h; (110)41% 
2.7eq cyclopropylamine, THF, rt, 72h 
107 8eq DMF-diethylacetal, THF, rt, 18h; (110) 69% 
lOeq cyclopropylamine, THF, rt, 4h 
110 20eq TMG, DCM, reflux, 20h (109) 55% 
107 5.6eq DMF-diethylacetal, THF, rt, 24h; (109) 12% 
2.5eq cyclopropylamine, THF, rt, 72h; 
1 9eq TMG, DCM, reflux, 24h 
107 5eq DMF-diethylacetal, THF, rt, 3h; (109) 18% 
4.7eq cyclopropylamine, THF, rt, 20h; 
lOeq TMG, THF, reflux, 18h 
107 6eq DMF-diethylacetal, THF, rt, 22h; (109) 68% 
8eq cyclopropylamine, THF, rt, 24h; 
20eq TMG, THF, reflux, 18h 
Table 3.1: Optimisation of the Synthesis of Thf-Quinolone, 109. 
The completed synthesis of Tbf-Ciprofloxacin, 113, has shown that solution phase 
synthesis can be performed efficiently on compounds bound to the hydrophobic, and 
sterically demanding Tbf anchor group. Before attempting to use the anchor group to 
help purify the intermediates towards Ciprofloxacin, a greater understanding of the 
affinity which Tbf has for charcoal and PGC, as well as the factors which influence it, 
was required. 
3.4 Interaction of Tbf-derivatives with Carbon 
The use of carbon as a solid support in organic reactions may be employed in two 
ways. The reaction may be carried out in solution phase as normal, then at the end of 
the reaction sequence, charcoal added to adsorb all Tbf-derivatives. Alternatively, the 
Tbf-substrate may be pre-adsorbed onto carbon and the residue suspended in solvent. 
The Tbf-compound may then interact with dissolved reagents by two possible 
108 
mechanisms. Firstly, the Tbf-derivative may remain tightly adsorbed to the carbon, 
allowing only distant functional groups to remain in solution - much like the action of 
resins in SPOS. Reagents in solution are then free to react with these groups. 
Secondly, an equilibrium may exist, whereby some of the Tbf-derivative exists entirely 
in solution where it may react with reagents and re-adsorb onto carbon. Over a period 
of time, all of the substrate may react during the adsorption - desorption equilibrium. 
Initial studies into the adsorption process, investigated the adsorption of pure Tbf-
derivatives onto carbon. Factors investigated, included which solvents promoted 
adsorption and desorption, and how much carbon was required in order to achieve 
complete adsorption. Also investigated was the difference between using charcoal and 
porous graphitised carbon (PGC) as the adsorbent. Several compounds were 
adsorbed onto carbon using a variety of conditions (Table 3.2). 




Tbf-alcohol 104 charcoal DCM 92 0.02 
Tbf-ketoester 107 charcoal DCM 97 0.03 
Tbf-ketoester 107 charcoal DCM/MeOH 92 0.10 
(3:2) 
Tbf-ketoester 107 PGC DCM/MeOH 95 0.03 
(3:2) 
Tbf-quinolone 109 charcoal DCM!MeOH 90 0.10 
(3:2) 
Table 3.2: Adsorption of Thf-derivatives onto Carbon. 
The compound of interest was dissolved in the appropriate solvent, adsorbent 
added, then the suspension stirred in an ice bath (lower temperatures generally assist 
the adsorption of hydrophobic compounds4). Measurement of the uv spectrum of the 
supernatant was recorded after a period of time, with particular attention paid to the 
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?.max at 364nm - the Tbf chromophore. More adsorbent 
was added and stirring 
continued as required until the uv absorbance at 364nm was zero, indicating that no 
compound remained in solution. All samples were adsorbed within one hour of 
stirring: 
The results show that near quantitative adsorption ( ~!90%) of Tbf-bound 
compounds can be achieved under any solvent conditions. However, the quantity of 
carbon required to achieve these high levels of adsorption was variable. This is 
represented by the "Loading" column in Table 3.2 which quantifies the amount of 
compound adsorbed per gram of carbon. The figure is not meant to signify any level 
of functionalisation in the way that resin loadings are described, but merely indicates 
the efficiency of the adsorption process under the conditions described. For example, 
comparison of entries 2 and 3, shows that more than three times the quantity of 
charcoal was required to adsorb fully, the same quantity of Tbf-ketoester. This 
efficiency difference was due solely to the nature of the solvent - the polar solvent 
used in entry 3 permits greater efficiency of adsorption. Indeed, a DCMlmethanol 
mixture of 3:2 was the optimum solvent for adsorption, enabling solubilisation of the 
Tbf-derivatives, but with relatively high polarity to encourage adsorption. This finding 
was supported by the similarly efficient adsorption of Tbf-quinolone, 109, under the 
same conditions (entry 5). Direct comparison of charcoal and PGC as adsorbent 
(entries 3 and 4), showed that charcoal was almost four times as efficient as PG-C. 
With a reasonable understanding of the factors affecting the adsorption of Tbf 
compounds onto carbon, the conditions best afforded the desorption of the 
compounds back into solution were examined. The main factor expected to affect 
desorption was the nature of the solvent, and so several, including toluene, dioxane 
and THF were investigated. The charcoal residue was stirred in solvent at 40°C and 
the uv spectrum of the supernatant recorded at twenty minute intervals. If the uv 
spectrum of the supernatant indicated that desorption was occurring, the process was 
repeated with fresh portions of solvent until no further desorption was observed 
(Table 3.3). 
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Compound Loading 
(mmol/mg C) 
Solvent Desorption by UV 
 (%) 
Tbf-alcohol 104 0.02 toluene 19 
Tbf-alcohol 104 0.02 dioxane 0 
Tbf-ketoester 107 0.03 toluene 27 
Tbf-ketoester 107 0.03 dioxane 0 
Tbf-ketoester 107 0.10 toluene 85 
Tbf-ketoester 107 0.10 THF 10 
Tbf-quinolone 109 0.10 toluene 18 
Table 3.3: Desorption of Thf-derivatives From Charcoal. 
The superimposed uv spectra of Tbf-ketoester, 107, after charcoal adsorption and 
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Figure 3.10: Uv Spectra of Thf-Ketoester During Charcoal Adsorption and 
Desorption. 
Two main conclusions may be drawn from these results. Firstly, toluene is easily 
the most suitable solvent for desorbing Tbf-derivatives from carbon. This possibly 
gives a clue as to the nature of the binding of the Tbf to the charcoal surface. Since 
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other hydrophobic solvents do not permit such high levels of desorption as toluene, 
binding to charcoal is probably related to substrate planarity as well as 
hydrophobicity. This means that planar toluene is much a more effective solvent for 
desorption than dioxane, which has similar hydrophobicity. 
12 
The second conclusion which may be drawn from the reported data, is that the 
degree of desorption is dependent on the loading level of compound on the charcoal. 
The greater the loading (ie. the more concentrated the Tbf is on the charcoal surface), 
the greater the observed desorption. This implies that the charcoal surface has a non-
homogeneous nature, and that some sites are more tightly binding than others. In 
situations where the adsorption is "dilute" (low loading), more of the Tbf is situated in 
tightly binding sites, and so is less easily removed. 
3.5 Organic Reactions Using Carbon as Solid Support 
With a good understanding of the conditions which influence the interaction of 
Tbf-derivatives with charcoal developed, the synthesis of Tbf-Ciprofloxacin, 113, was 
repeated, but with the charcoal purification of each synthetic intermediate. Reactions 
were performed in solution as normal, and upon completion, charcoal was added to 
selectively adsorb Tbf-bound products from the crude reaction mixture. The option of 
pre-adsorbing substrates onto charcoal prior to heterogeneous reaction was rejected 
on the grounds that reaction monitoring would be more difficult, and unwanted 
charcoal-reagent interactions could not be avoided. 
The Tbf-bound intermediates, 107 and 109 were purified using the charcoal 
protocol (Figure 3.11). On completion of the reaction, solvent was removed, and the 
crude residue was dissolved in the polar solvent system which affords efficient 
adsorption to charcoal. An appropriate quantity of charcoal was added to the solution 
such that quantitative adsorption would give the optimum loading of compound of 
0. lmmol/g charcoal, and the suspension stirred in an ice bath. If TLC indicated that 
not all of the product had adsorbed, then more methanol and charcoal was added until 
this was achieved. Adsorbed compounds were recovered by stirring the charcoal 
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residue in warm toluene. All material was found to be recovered after three washes 
with fresh solvent. 
	
charcoal 	 F 
OH 	purification 














Figure 3.11: Synthesis of Ciprofloxacin by Charcoal Purification of Intermediates. 
As with any phase separation purification protocol, any unreacted starting material 
or by-products, which have the same affinity for the alternative phase as the desired 
product, will also be isolated with the product. This is observed in methods such as 
SPOS and fluorous phase synthesis, and is no different with this charcoal method of 
purification. Therefore, solely to compare reaction efficiency with the solution phase 
method, chromatography was performed to purify the products obtained in the 
toluene extracts. Thus, Tbf-ketoester, 107, was isolated in 60% yield and Tbf-
quinolone, 109, recovered in 59% yield. These compare very favourably with the 
yields obtained from solution phase synthesis and traditional work-up and purification 
procedures (70%, 107, and 68% 109). More importantly, TLC indicated that toluene 
extracts contained only Tbf-bound compounds and so the excess reagents used in 
these reactions did not interfere with the purification process. 
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The final synthesis of Ciprofloxacin, 93, was achieved by adsorbing the crude Tbf-
Ciprofloxacin, 111, onto charcoal in the normal manner. However, rather than 
treating the charcoal residue with toluene, the product was cleaved from the Tbf 
anchor using appropriate conditions determined by the linker design. Therefore, upon 
treatment of the residue with TFA, the anchor remained bound to the charcoal, and 
Ciprofloxacin was released into solution (along with any other Tbf-bound 
compounds). The product obtained from this procedure was analysed by HPLC, and 




Figure 3.12: HPLC Traces of Ciprofloxacin. 
The HPLC trace of the Tbf-cleaved sample of Ciprofloxacin demonstrates exactly 
how powerful a tool the charcoal purification tool is. As well as confirming the 
identity of the major product to be Ciprofloxacin, the levels of impurities are 
extremely low and so no further purification was required. 
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3.6 Conclusions 
The successful synthesis of Ciprofloxacin, 93 using Tbf-bound intermediates has 
demonstrated the applicability of an alternative purification strategy in organic 
synthesis. Validation of an efficient synthesis of the target molecule was carried out 
using substrates bound to the hydrophobic Tbf group via a specifically designed 
linker. A reproducible protocol of recovering Tbf-derivatives, efficiently adsorbed 
onto charcoal, led to the efficient purification of such compounds from crude reaction 
mixtures. 
The results obtained illustrate how Tbf can be used as an anchor group for organic 
molecules to assist in their purification. The method enables all the advantages of 
traditional solution phase synthesis to be available, but couples this with the ease of 
purification which few techniques can fulfil. The methodology, therefore, could make 
a valuable contribution to the field of combinatorial chemistry and parallel array 
synthesis. 
Future studies using electron microscopy could be carried out to determine the 
exact nature of the binding of Tbf to charcoal, and perhaps identify surfaces which 
may offer even more efficient and selective binding. The anchoring process could then 
be used in the multiple parallel syntheses of suitable substrates. 
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Chapter 4: Experimental 
4.1 Reagents and Instrumentation 
All chemicals and reagents were obtained from Aldrich chemical company, or 
Fisher Acros Organics and used without further purification unless otherwise stated. 
Solvents used in reactions were freshly distilled before use: THF over sodium and 
benzophenone as indicator; toluene over sodium; DCM over calcium hydride; and 
acetonitrile over calcium hydride. NaHN'IDS solutions in THF were titrated against 
pyreneacetic acid (yellow to purple), and butyllithium titrated against pivaloyl o-
toluamide (colourless to yellow) prior to use. 
All reactions were performed using oven or flame-dried glassware, under an 
atmosphere of dry nitrogen, unless otherwise stated. Thin layer chromatography 
(TLC) was performed on aluminium sheets coated with silica gel (Kieselgel 60 F254), 
and compounds were visualised using uv light at 254nm, potassium permanganate 
solution, or ammonium molybdate solution. Flash chromatography was carried out 
using silica gel 60 230-400 mesh. 
Melting points were determined in open capillaries using a Buchi 510 melting point 
apparatus. Nuclear magnetic resonance (nmr) spectroscopy was performed on 
250MHz Bruker AC 250, 200MHz Bruker WP 200, or a 600M14z Varian Inova, 
using tetramethylsilane (TMS) as external standard. Fourier Transform Infra Red 
(FTIR) Spectroscopy was performed on a Bio-Rad FTS-7 spectrometer. Ultraviolet-
visible (uv-vis) spectra were recorded on a Perkin Elmer Lambda 11. Fast atom 
bombardment (FAB) mass spectrometry was performed on a Kratos MS50 and 
electron impact (El) mass spectrometry performed on a Kratos MS902. Atmospheric 
pressure chemical ionisation (APCi) and electrospray (ES) mass spectrometry were 
both performed using a Micromass Platform II with Mass Lynx 2.3 Build 5 software. 




Multiple parallel solid phase synthesis was performed using DiversomerTM 4x2 
array, manual synthesis kit. The resin used was copoly(styrene-1%-divinylbenzene)-p-
benzyloxybenzyl alcohol resin with 1 .O7mmoIIg loading, supplied by Bachem. 
High Pressure Liquid Chromatography (HPLC) was performed using a Gilson 
modular system: 305 pump and programmer, 306 pump, 805 solvent delivery system, 
811C mixer, and a 118 uv-vis detector monitoring at 220nm. Reverse phase, C8 
columns were used at lm-1/min (analytical) and Smllmin (preparative) flow rates. The 
solvents used were 0. 1%TFAlwater (A) and 0. 1%TFAlacetonitrile (B) using two 
programmed gradients: 
Gradient 1: 0 min 10%B; 2 mins 10%B; 32 mins 90%B; 34 mins 10%B 
Gradient 2: 0 min 18%B; 2 mins 18%B; 23 mins 75%B; 25 mins 18%B 
All compounds synthesised reported satisfactory analytical data, including 
elemental analysis, accurate mass, or nominal mass with observed fragmentation 
patterns as appropriate. Elemental analysis of tetrabenzo[a,c,g,ifluorene compounds 
generally proved unsatisfactory, due to the high percentage of carbon present in these 
molecules, leading to incomplete combustion, hence inaccurate results. 
4.2 Acrylic Acids by Elimination Route 
Preparation of Gramine Methiodide, 48.1 
To freshly distilled methyl iodide (15mL) was added powdered gramine, 31 (0.88g, 
5.06mmol), over a period of 1 hour and the mixture stirred for a further 2 hours at 
room temperature. The mixture was then stored overnight at 4°C, and the precipitate 
formed, isolated by filtration. This was dissolved in the minimum volume of hot 
methanol (-8mL), and the precipitate formed on cooling then isolated and discarded 
(tetramethylamnionium iodide). The methanolic filtrate was combined with benzene 
(120mL), and stored at 4°C for 48h. The precipitate was isolated by filtration and 
washed with water (5x5OmL). The combined aqueous washes were concentrated to 
5-10mL and cooled to 4°C overnight. The desired product was collected as a white 




\ / 	 RI 0.34 (CHCI3/methanollacetic acid, 9:1:0.5). m.p. 
i 165-168°C (lit. 168169 0c'). FTIR v../cm -1 (Nujol) 3201 
(NH); 2916, 2851 (CH); 1613, 1539 (C=C). A 1 /nm (ethanol, 
H E/dm3moi'cm 1 ) 286 (8130), 276 (9590), 272 (9590). 'Hnmr 
(DMSO-d6, 250MHz, s/ppm) 11.65 (1H, s, NH); 7.84-7.80 (1H, m, Ar H); 7.69, 
(1H, d, 3J,=2.7Hz, Ar H); 7.50-7.46 (1H, m, Ar H); 7.22-7.10 (2H, m, Ar H); 4.68 
(2H, s, CH2), 3.03 (9H, s, N(CH3)3). 13C('H)nmr (DMSO-d 6 , 63MHz, ö/ppm) 
13 6.2, 127.8, 101.9 (q Ar C); 13 0.4, 122.0, 120.2, 118.6, 112.3 (Ar CH); 60.7 (CH 2); 
51.3 (CH3 ). fiRMS (FAB, M+/Z)  C 12H 17N2 (M) requires 189.1392, found 189.1385. 
Preparation 	of 	Ethyl 	2-(3-Methylindolyl)-3-(2,4,5-trifluorophenyl)-3- 
oxopropionate, 47. 
To ethyl 3-(2,4,5-trifluorophenyl)-3-oxopropionate, 43 (363.5mg, 1.48mmol), in 
acetonitrile (28mL) was added gramine methiodide, 48 (465.5mg, 1.48mmol). 
Triethylamine (265.9mg, 2.63mmol) was added via graduated pipette and the reaction 
mixture stirred at room temperature for 24hours. The mixture was then filtered 
through a pad of kieselguhr and solvent removed under reduced pressure. The crude 
residue was purified by flash chromatography (DCM) to yield ethyl 2-(3-
methylindolyl)-3-(2,4,5-trifluorophenyl)-3-oxopropionate, 47, as a pale yellow film 
(397.1mg, 1.06mmol, 72%). 
RI 0.39 (DCM). FTIR v..,,/cm' (DCM) 3465 (NH), 
F 3062 (Ar CH); 2984 (CH); 1739 (ester C=O); 1692 
F (ketone C=O); 1623, 1511 (CC). ?ai/nm (DCM, 
c/dm3mot'cm') 282 (9380), 229 (20300). 'Hnmr 
(CDCI3 , 250MHz, ö/ppm) 8.04 (1H, s, NH); 7.70-7.57 
(2H, m, Ar H); 7.35-6.86 (5H, m, Ar H); 4.62 (1H, t, 3J,.rj.,=6.8Hz, CH); 5.15 (2H, q, 
3J1.11.,7.lHz, OCH2); 3.60-3.37 (2H, m, diastereotopic CH 2); 1.16 (3H, t, 3J1*,=7.lHz, 
CH3). 13C{'H}nmr (CDCI3 , 63MHz, ö/ppm) 191.0 (ketone C0); 169.2 (ester 
C0); 158.9, 155.0, 151.3, 148.8, 145.1, 138.2 (Ar CF); 135.9, 126.9, 121.5, 111.0 
(q Ar C); 123.0, 121.9, 119.4, 118.3, 111.0 (indole Ar CH); 118.6, 106.4 (Ar CH); 
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61.4 (OCH2); 58.4 (CH); 24.1 (CH2); 13.8 (CH3). fiRMS (FAB, A4+/z) C20H16F3NO3 
(M) requires 375.1082; found 375.1086. 
Preparation 	of 	Ethyl 	2-(3-Methylindolyl)-3-(2,4,5-trifluorophenyl)-3- 
hydroxypropionate, 46. 
To ethyl 2-(3 -methylindolyl)-3 -(2,4,5 -trifluoro-phenyl)-3 -oxo-propionate, 47 
(304.2mg, 0.81mmol), in THF (35mL) was added sodium borohydride (61.3mg, 
1.61mmol), and the suspension was stirred room temperature for 4 hours. After this 
time, the mixture was cooled in an ice bath, and carefully quenched with HC1 (0.5N, 
20 ml). The organic products were extracted with DCM (30m1), washed with water 
(30m1), and dried over sodium sulphate. Solvent was removed under reduced pressure 
to yield a yellow residue. This was purified by flash chromatography (ethyl 
acetate/hexane, 2:3) to yield ethyl 2-(3 -methylindolyl)-3 -(2,4,5 -trifluoro-phenyl)-3 - 
hydroxypropionate, 46, as a pale yellow film (252.1mg, 0.67mmol, 83%). Spectra 
were consistent with a diastereomeric ratio of 1:1. 
0 OH 	
Rf 0.39 (ethyl acetate/hexane 2:3). FTIR vmax/cm 1 
EtO(y(F (DCM) 3603 (OH); 3479 (NH); 3032, 3012 (Ar CH); 
2929, 2857 (CH); 1706 (ester C=O), 1632, 1513 (C=C); 
0-:F  	F IL.max/nm (DCM, E/dm3mol'cm') 290 (4110), 273 
H 	 (6230), 230 (11840), 227 (8950). 1 llnmr (CDC13 , 
250MHz, ö/ppm) 8.06, 7.97 (1H, both br. s, NH); 7.58-6.79 (7H, m, Ar H); 5.3 1, 
5.13 (11-1, both s, CHOH); 3.97, 3.95 (214, both q, 3Jn=7.1Hz, OCH2); 3.82, 3.54 
(IIH, both br. s, OH, D 20 exchange); 3.31-2.95 (3H, m, CH and CH 2); 0.98, 0.96 
(31-1, both t, 3Ji.rj =7.1Hz). 13C{ 1 H}nmr (CDCI3, 63MHz, ö/ppm) 174.9, 174.7 
(CO); 156.1, 152.3, 151.4, 148.9, 147.2, 144.8, (Ar C-F); 136.1, 136.0, 127.1, 
126.3, 124.8, 112.5, 111.9 (q Ar C); 122.3, 122.1, 122.0, 121.9, 119.4, 119.2, 118.5, 
118.3, 111.0, 110.9 (Ar CH); 116.3, 115.6, 105.5 104.8 (Ar CH); 67.7, 67.5 
(CHOH); 60.8 (OCH2); 51.5, 51.0 (CH); 25.2, 22.1 (CH 2); 13.7, 13.6 (CH 3). MS 
(FAB, M41z) C20H1 8173NO3 (M) requires 377; found 377 (10%), 286 (10%), 170 




Attempted Preparation of Ethyl 2(3Methylindolyl)3(2,4,5-triflUOrOpheflyl) 
acrylate, 45. 
(i) Using Phosphorus Oxychloride2 
Ethyl 	2-(3 -methylindolyl)-3 -(2,4, 5-trifluoro-phenyl)-3 -hydroxypropionate, 	46 
(40.6mg, 0.1 immol), was stirred in dry pyridine (5mL) at 0°C. POC1 3 (83.5mg, 
0.55mmol) was added dropwise, and the mixture was then stirred at room 
temperature for 20 hours. The reaction was then quenched with careful addition of 
water and organic products extracted with ether (2x2OmL). The combined extracts 
were washed with brine (20mL) and water (20mL), dried over sodium sulphate and 
solvent remove under reduced pressure to yield a pale yellow residue. Two close 
running products were obtained after passing the residue through a silica plug. These 
were separated by flash chromatography (DCM) and subsequently identified as 
diastereoisomers of ethyl 2-(3 -methylindolyl)-3 -chloro-3 -(2,4,5 -trifluorophenyl)-
propionate, 49 (combined 12.0mg, 0.030mmol, 27%). 
Rf (49A) 0.63 (DCM)I FTIIIR vmax/cm 1 (DCM) 3468 
F (NH); 3052 (Ar CH); 2987, 2929, 2856 (CH); 1732 (ester 
F 
CO), 1631, 1521 (CC). 'Hnmr (CDCI3 , 200MHz, 
ö/ppm) 7.98 (1H, br. s, NH); 7.43-6.90 (7H, m, Ar H); 
5.41 (IIH, d, 3J9.7Hz, benzyl CH); 4.03 (2H, q, 
3J111 7.2Hz, OCH2); 3.52-3.40 (1H, m, CH); 3.03 (1H, dd, 3J14.2, 4.8Hz 
diastereotopic H); 2.74 (1H, dd, 3J}lJi"14.2, 10.2Hz diastereotopic H); 1.03 (3H, both 
t, 3J7.2Hz). MS (FAB, M+/Z) C20H 17C1F3NO3 (M) requires 395; found 395 (5%), 
359 (4%),286 (10%), 148 (16%),130 (100%). 
RI (49B) 0.70 (DCM). FTIR vmaxlcm' (DCM) 
F 3458 (NH); 3049 (Ar CH); 2986, 2930, 2859 (CH); 1729 
F 
(ester C0), 1630, 1520 (CC). 'Hnmr (CDCI3 , 
200MHz, &ppm) 7.79 (1H, br. s, NH); 7.53-6.83 (7H, 
m, Ar H); 5.09 (1H, d, 3J5.9Hz, benzyl CH); 4.22 (2H, 
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q, 3J1*i=7.2Hz, OCR2); 3.65-3.55 (1H, m, CH); 3.37 (1H, dd, 3J.g4 14.7, 8.6Hz 
diastereotopic H); 3.18 (1H, dd, 3J1 =14.7, 6.4Hz diastereotopic H); 1.29 (3H, both 
t, Jj*j=7.2Hz). 
Using DIvJAP/Methanesulphonyl chloride' 
Ethyl 2-(3 -methylindolyl)-3 -(2,4, 5-trifluoro-phenyl)-3 -hydroxy-propionate, 46 
(49.0mg, 0. l3mmol), was stirred in DCM (2mL) at room temperature, and a mixture 
of methanesuiphonyl chloride (37.0mg, 0.323mmo1) and DMAP (79.7mg, 0.65mmol) 
in DCM (4mL) was added to the mixture stirred at 35°C for 18 hours. The mixture 
was then cooled to room temperature and quenched with saturated ammonium 
chloride solution (20mL). Organic products were extracted with DCM (2x2OmL) and 
the combined extracts washed with water (20mL), dried over sodium sulphate, and 
solvent removed under reduced pressure to yield a pale yellow oil. Purification by 
flash chromatography (DCM) yielded ethyl 2-(3 -methylindolyl)-3 -chloro-3 -(2,4,5 - 
trifluorophenyl)propionate, 49B (29.2mg, 0.074mmol, 57%), and ethyl 2-(3-
methylindolyl)-3 -methanesulphonyl-3 -(2,4,5 -trifluorophenyl)propionate, 50 (19.8mg, 
0.044mmol 34%). 
RI (DCM) 0.37. 'Hnmr (CDCI3 , 250MHz, 6/ppm) 
0S0 	8.02 (1H, br. s, NH); 7.48-6.89 (7H, m, Ar H); 6.03 (1H, 
00 
OCR2); 3.46-3.28 (3H, 	, CHICH2); 2.93 (3H, s, 
d, 3J1z7.7  Hz, benzyl H); 3.84 (2H, q, 3J1 =7.0Hz. 
EtO 	
m  
S02CH3); 0.91 (3H, t, 3J=7.0Hz). MS (FAB, M/z) 
N 
H 	 C21H20F3N05 S (M) requires 455, found 455 (12%), 359 
(18%), 285 (40%), 230 (27%), 185 (100%), 130 (49%). 
Mitsunobu Conditions4 
To ethyl 2-(3 -methylindolyl)-3 -(2,4,5 -trifluoro-phenyl)-3 -hydroxypropionate, 46 
(86.7mg, 0.23mmol) and triphenyiphosphine (88.9mg, 0.33mmol) in THF (lOmL) at 
room temperature, was added diethyl azodicarboxylate (56.0mg, 0.32mmol), and the 
mixture was then stirred at room temperature for 3 hours. Solvent was then removed 
under reduced pressure, and the residue diluted with benzene (15mL) and filtered 
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through a small pad of silica gel, washing with toluene (30mL). Solvent was removed 
under reduced pressure, and the crude residue was purified by flash chromatography 
(DCM) yielding ethyl 2-(3 -methylindolyl)-3 -(2,4,5 -trifluorophenyl)acrylate, 45 
(21.2mg, 0.059mmol, 26%) as a single (undefined, but depicted K) geometric isomer. 
Rf (DCM) 0.69. 1 llnmr (CDCI3 , 250MHz, ö/ppm) 
I  
EtO 	




3JHJ.I=8.1Hz); 7.21-6.87 (5H, m, Ar H); 6.84 (1H, s, Ar 
	
II " 	 H); 4.15 (2H, q, 3JFn7.3Hz. 0C142); 3.86 (2H, s, CH2); 
N 
H 1.18 (3H, t, 3J1*i=7.3Hz). MS (FAB, M+/Z) C20H 16F3NO2 
(M) requires 359, found 359 (100%), 285 (89%), 185 (82%), 157 (41%), 130 
(41%). 
Preparation of 5-Chloro-2-hydroxybenzoyl Chloride, 52 
5-Chiorosalicylic acid, 53 (5.1g, 0.03moI), was stirred in methanol (40m1) and to 
the solution was added 2 drops of phenolphthalein indicator. Sodium hydroxide 
solution (2N) was added to the methanolic solution until a permanent pink colour 
formed. HCI solution (2N) was then added dropwise until the pink colour just 
disappeared. The solvent was then removed under reduced pressure, and the residue 
dried under vacuum 40°C (mp>300°C). The salt was suspended in dry benzene 
(80ml), and heated to 60-70°C. Thionyl chloride (3.9g, 0.033mol) was added slowly, 
and heating continued for 3h. The reaction mixture was then cooled to room 
temperature, and the insoluble material removed by centrifugation. The precipitate 
was washed with fresh benzene (30m1), and the supernatants combined. Solvent was 
removed under reduced pressure to yield 5-chloro-2-hydroxy-benzoyl chloride, 52, as 
a white solid (4.54g, 0.024mmol, 80%). 
0 	OH 	Rf 0.48 (CHCI 3/methanol, 9:1). m.p. 53-55°C (lit. 6 56.5-57°C) 
CI 	 FTJIR vmax/cm' (bromoform) 3706 (OH); 3021 (Ar CH); 1690 
(C=O); 1609, 1566 (C=C). ?.maxInm (DCM), c/dm3 mol 1 cm') 346 
CI 	
(4140), 257 (11500), 229 (14600). 'Hnmr (CDCJ3 , 200MHz, 
ö/ppm) 9.63 (1H, br. s, OH); 8.03 (1H, d, 3J2.5Hz, Ar H); 7.52 (1H, dd, 
3JFn=9.0, 2.5Hz, Ar H); 6.99 (1H, d, 3JHJ9.0Hz, Ar H). 13C{'H}nmr (CDCI3 , 
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63MHz, ö/ppm) 172.8 (C=O); 159.9, 125.0, 117.8 (q Ar C); 138.2, 132.5, 119.7 (Ar 
CH). HRMS (El, M 4 /z) C7144C1202 (M) requires 189.9588, found 189.9594. 
4.3 Synthesis of Alkylated Phosphonates 
Preparation of Triethyl Phosphonoacetate, 55•7 
Ethyl bromoacetate (10.0g, 0.060mo1) was heated at reflux in toluene (30mL). 
Triethylphosphite (10.0g. 0.060mol) was added via syringe, and reflux continued for 
18 hours. The reaction mixture was cooled to room temperature, and solvent 
removed under reduced pressure to leave a yellow oil. This was purified by distillation 
(74°C, 0.05mmHg; lit. 142°C, 9mmHg) to yield triethyl phosphonoacetate, 55, as a 
colourless oil (12.1g. 0.054mol, 90%). 
RI 0.72 (CHC13/methanol, 9:1). FTIR v./cm ' (liquid 
0 
	 film) 2985 (CH); 1738 (C=O); 1271 (PO); 1026 (P-O). 
Hnmr (CDCI3 , 250MHz, ö/ppm) 4.18-4.05 (6H, m, 
3xOCH2); 2.89 (2H, d, 2JPH=21.6Hz, CH2); 1.28 (6H, dt, 3J1*j=7.lHz, 4j .511z, 
2xPOCH2CH3); 1.22 (3H, t, 3JFJJ7.1Hz, CH3). 13C{'H)nmr (CDCI3 , 63Mhz, 
ö/ppm) 165.6 (d, 2Jpc=6Hz, C=O); 62.5 (d, 2Jpc=6.2Hz, POCH2); 61.3 (OCH2); 34. 1, 
(d, 'Jp=124Hz, CH 2); 16.1, (d, 3Jpc=6.3Hz, CH3); 13.8 (CH3). MS (El, M+/z) 
C 8H1705P (Mt) requires 224.0814; found 224.0810. 
Preparation of 1-Triisopropylsilylgramine, 56.8 
Sodium hydride (80% dispersion in oils, lOg, 33mmol) was THF (8mL) at 0°C. 
Gramine, 31 (lOg, 5.75mmol), was added as a solution in THF (5mL) and the 
suspension stirred at 0°C for 3 hours. Triisopropylsilyl chloride was added dropwise, 
and the resultant mixture stirred at 0°C under argon for 18 hours. The suspension was 
then carefully quenched with water (30mL) and organics extracted with ether 
(2x3OmL). The combined extracts were washed with water (2x4OmL), dried over 
sodium sulphate, and solvent removed under reduced pressure to yield a yellow oil. 
This was purified by flash chromatography to yield 1-triisopropylsilylgramine, 56, as 





RI 0.49 (CHC1 3/methanol, 9:1). FTIR v,,/cm' (liquid film) 
N 3046 (Ar CH); 2944, 2866 (CH); 2763 (N-CH 3); 1540, 1458. 
C- 6NN /nm (ethanol, /dm3moi'cm') 290 (4250), 279 (5820), 273 I 
'SK 	(5980), 223 (27800). 'Hnmr (CDCI3 , 250Mhz, 6/ppm) 7.69- 
7.65 (1H, m, Ar H); 7.50-7.46 (1H, m, Ar H); 7.15-7.09 (3H, m, 
Ar H); 3.65 (2H, s, CH2); 2.28 (6H, s, 2xNCH 3); 1.71 (3H, sept., 
3J1. 1=7.6Hz, 3xCH); 1.14 (18H, d, 3Jm7.6Hz, 6xCH3). 13C{'H}nmr (CDCI3 , 
63MHz, 6/ppm) 141.1, 131.2, 114.7 (q Ar C); 136.5, 130.4, 121.2, 119.4, 118.9 (Ar 
CH); 54.5 (CH2); 45.1 (2xNCH 3); 18.0 (6xCH3); 12.7 (3xCH). HRMS (FAB, M 4 /z) 
C20H3 5N2Si (MIH) requires 331.2564, found 331.2564. 
Preparation of 1-Triisopropylsilylgraminemethiodide, 579 
Methyl iodide (1.7g, 12mmol) was added dropwise to a solution of 1-
triisopropylsilylgramine, 56 (0.99g, 3.Ommol), in THF (20mL) and the resultant 
mixture stirred for 3 hours at room temperature. The precipitate formed was filtered, 
and recrystallised from DCMlether to form 1 -triisopropylsilylgramine-methiodide, 57, 
as a white powder (1.42g, 3.Ommol, 100%). 
\ 	/ Rf 0.22 (CHCI3/methanol, 9:1). 
m.p. 187-191°C. FTIR 
d vmax/cm ' (DCM) 3051 (Ar CH); 2953, 2868 (CH); 1606, 
I 	 1543 (CC). max/nm (ethanol, c/dm3mol'cm') 288 (5020), 
NI 
270 (8410). 'Hnmr (CDCI3 , 250MHz, 6/ppm) 7.89-7.85 (1H, 
I 	/ 	m, Ar H); 7.78 (1H, s, Ar H); 7.51-7.47 (1H, m, Ar H); 7.17- 
7.13 (2H, m, Ar H); 5.14 (2H, s, CH 2); 3.40 (9H, s, 3xCH3); 1.70 (3H, sept., 
3J7.614z, 3xCH); 1.06 (18H, d, 3J117.5Hz, 6xCH3). 13C{'H}nmr (CDC13 , 
63MHz, 6/ppm) 140.9, 130.2, 104.5 (qArC); 136.9, 122.4, 121.3, 118.9, 114.3 (Ar 
CH); 62.0 (CH2); 52.5 (3xNCH3); 17.8 (6xCH3); 12.4 (3xCH). HRMS (FAB, M+/z) 
C21H37N2Si (M) requires 345.2726, found 345.2725. 
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Preparation of Triethyl 2-(3-Methlylindolyl)phosphonoacetate, 59. 
Triethyl phosphonoacetate, 55 (2.08g, 9.28mmol), and TIPS-graminemethiodide, 
57 (4.38g, 9.28mmol), were stirred in THF (80mL) at 0°C. Tetrabutylammonium-
fluoride (l.OM in THY, 20mL, 20mmol) was added in one portion, and stirring 
continued for 1 hour. The mixture was quenched with saturated ammonium chloride 
solution (60mL) and organic products extracted with ether (2x5OmL). The combined 
organics were washed with saturated sodium thiosuiphate (50mL) and water (50mL) 
and dried over sodium sulphate. Solvent was removed under reduced pressure and the 
residue purified by flash chromatography (ethyl acetate/hexane, 1:1 to ethyl 
acetate/hexane, 5:1) to yield triethyl 2-(3-methlylindolyl)phosphonoacetate, 59, as a 
colourless oil (3.02g, 8.54mmol, 92%). 
RI 0.24 (ethyl acetate/hexane, 3:1). FTIR vmax/cm 1 
(liquid film) 3264 (NH); 3058 (Ar CH); 2980, 2931 (CH); 
1734 (C=O); 1239 (P0); 1023 (P0). max/nm (DCM, 
E 
N2 	
/dm3moi'cm') 290 (3740), 280 (4600), 274 (4490). 
H 'Hnmr (CDCI3, 250MHz, ö/ppm) 8.22 (lh, br. s, NH); 
7.61-7.57 (1H, m, ArH); 7.35-7.31 (1H, m, Ar H); 7.20-7.00 (3H, m, Ar H); 4.25-
4.01 (6H, m, 3xOCH2); 3.46-3.28 (3H, m, CH/CH2); 1.39-1.30 (6H, m, 2xCH 3); 1.11 
(3H, t, 3J 1=7.1Hz, CH3). 13C'H}nmr (CDCI3, 63MHz, s/ppm) 168.9 (C=O); 
136. 1, 126.7 (q Ar); 112.1 (d, 3J17Hz, q Ar); 122.3, 121.7, 119.0, 118.2, 111.1 
(Ar CH); 62.7 (d, 2Jpc=6.6Hz, POCH2); 61.1 (OCH2); 46.7 (CH, d, 'Jc=128Hz, CH); 
22.7 (d, 2J41I{z CH2); 16.1 (d, 3J=6.0Hz, POCH2çH3); 13.7 (CH 3). MS (FAB, 
M+/Z) C 17H25N0 5P (MH) requires 354.1470; found 354.1466. 
Preparation of Triethyl 2-(1-Triisopropylsilyl-3-methlylindolyl)phOSPhOflO-
acetate, 58. 
Triethyl 2-(3-methlylindolyl)posphonoacetate, 59 (572.1mg, 1 .62mmol), was 
stirred in TI-IF (lOmL) at room temperature. Sodium hydride (60% dispersion in oils, 
80.2mg, 2.01mmoI) was added as a suspension in THF (4mL) via syringe and the 
resultant mixture stirred for 1 hour. Triisopropylsilyl chloride (3 60mg, 1 .87mmol) was 
added and the mixture then stirred for 16 hours. The reaction was then quenched by 
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careful addition of water (30mL), and organic products were extracted with ether 
(2x4OmL). The combined extracts were washed with water (50mL), dried over 
sodium sulphate, and solvent removed under reduced pressure. The residue was 
purified by flash chromatography (ethyl acetate/hexane, 2:1) to yield triethyl-2-(1-
triisopropylsilyl-3_methlylindolyl)-phosPhOflOaCetate, 58, as a pale yellow oil 
(442.0mg, 0.867mmo1, 54%). 
RI 0.49 (ethyl acetate/hexane, 2:1). FTIR vmax/cm 1 
11 0 	
(DCM) 3054 (Ar CH); 2985, 293 (CH); 1730 (C0); 1248 
(P=O); 1023 (P-O). 'Hnmr (CDCI3 , 250MHz, ö/ppm) 
N 	
7.59-7.55 (1H, m, AM); 7.48-7.43 (1H, m, Ar H); 7.15-7.10 
(2H, m, Ar H); 7.04 (1H, s, ArH); 4.29-4.12 (4H, m, 
I 2xOCH2); 4.10-3.96 (2H, m, OCH2); 3.44-3.29 (3H, m, 
CHICH2); 1.66 (sept., 3H, 3J1=7.3Hz, 3xCH); 1.36 (6H, dt, 3J=7.0Hz, 
4JPH2.9HZ, 2xPOCH2CH3); 1.10 (18H, d, 3J11 1=7.3Hz, 6xCH3); 1.06 (311, t, 
3J 1=7.0Hz, CH3). 13C{1 H}nmr (CDCI3 , 63MHz, ö/ppm) 168.9 (d, 2Jpc=4.4Hz); 
141.0, 130.2 (q Ar); 114.4 (d, 3 Jpc=17.9Hz, q Ar); 129.0, 121.3, 119.3, 118.2, 113.8 
(Ar H); 62.9, 62.5 (both d, 2J=6.7, 7.0Hz, POCH2), 61.0 (OCH2); 46.5 (CH, d, 
1 J=128Hz, CH); 22.7 (d, 2Jp3.7Hz, CH2); 17.9 (6xCH3); 16.3, 16.2 (both d, 
3J=2.0, 2.4Hz, POCH2CH3) 13.8 (CH3); 12.6 (3xCH). HRMS (FAB, M/z) 
C26H45NO5PSi (ME) requires 510.2805; found 510.2806. 
Preparation of Triethyl 2-benzylphosphonoacetate, 61. 
Triethyl phosphonoacetate, 55 (502.7mg, 2.24mmol), was stirred in THF (lOmL) 
at room temperature. Sodium hexamethyldisilazide (NaHIVIDS, 1.OM in THF, 2.7mL, 
2.7mmol) was added, and the solution stirred for 1.5 hours. Benzyl bromide (544mg, 
3 .28mmol) was added, and stirring continued for 20 hours, after which time, a white 
precipitate had formed. The mixture was quenched with water (20mL), and organic 
products were extracted with ethyl acetate (2x25mL). The combined extracts were 
dried over sodium sulphate and solvent removed under reduced pressure. The residue 
was purified by flash chromatography (ethyl acetate/hexane, 3:1) to yield a mixture of 
co-eluting products (620.5mg). These were separated by preparative HPLC (Gradient 
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A), and identified as the desired compound triethyl-2-benzyl-phosphonoacetate, 61 
(420.1mg, 1.34mmol, 60%) and 2,2-dibenzyl-triethylphosphonoacetate, 62 (200.4mg, 
0.50mmol, 22%). 
0 0 	RI 6110  0.36 (ethyl acetate/hexane, 3:1). HPLC 
Retention Time (Gradient 1) 	21.5 minutes. FTILR 
I 	 v../cm' (DCM) 3026 (Ar CH); 2981, 2931, 2909 (CH); 
1730 (C=O); 1603, 1494 (C=C); 1027 (P-O). Xmax/nm 
(DCM, c/dm3 mor 1 cm 1 ) 226 (4600). 'Hnmr (CDCI3 , 250MHz, ö/ppm) 7.27-7.13 
(511, m, ArH); 4.21-4.09 (4H, m, 2xPOCH 2); 4.11-4.02 (2H, m, -OCH 2); 3,31-3.14 
(3H, m, CWCH 2); 1.32 (6H, t, 3J1-1=7. 1Hz, 2xPOCH 2Cf); 1.11 (3H, t, 3J=7. 1Hz, 
CH3). '3C{'H}nmr (CDC13 , 63MHz, ö/ppm) 168.3 (d, 2Jpc=4.8Hz, CO); 138.3 (d, 
3Jpc= 15.914z, q Ar); 128.4, 128.3, 126.5 (Ar CH); 62.7, 62.6 (both d, 2Jp=6.5, 
6.8Hz, OCH2), 61.1 (OCH2); 47.4 (d, 'Jpc=129Hz, CH); 32.6 (d, 2Jpc=4.5Hz, CH2); 
16.2, 16.1 (both d, 3J1.8, 2.31-1z, POCHH3) 13.8 (CH3 ). 31 Pnmr (CDCI3 , 
101MHz, ö/ppm) 22.6. MS (El, M/z) C 15H2305P (Mt) requires 314.1283; found 
314.1285. 
0 0 	 RI 62 0.36 (ethyl acetate/hexane, 3:1). HPLC Retention 
P- 	Time (Gradient 1) 25.6 minutes. FTIR vmax/cm 1 (DCM) 
3034 (Ar CH); 2982, 2931, 2909 (CH); 1726 (CO); 1603, 
1494 (C=C); 1055 (P0). ?max/nm (DCM, /dm 3mor'cm) 
275 (5010). 'Hnmr (CDCI3 , 250MHz, ö/ppm) 7.29-7.17 
(I OH, m, ArH); 4.21 (2H, q, 3Jinj7.lHz, OCH2); 4.03-3.80 (414, m, 2xPOCH 2); 3.28 
(2H, s, CH2); 3.22 (2H, d, 3JpH=2.5Hz, CH 2); 1.24 (3H, t, 3J1*i'7.lHz, CH3); 1.11 
(611, t, 3J=7. 1Hz, 2xPOCH2Cfl); 13C{'H)nmr (CDCI3 , 63Mhz, ö/ppm) 170.5 (d, 
2J=1.4Hz, C=O); 136.3 (d, 3Jpc 7.8Hz, q Ar); 130.7, 127.6, 126.5 (Ar CH); 62.1 
(d, 2Jpc 7.3Hz, POCH2), 61.2 (OCH2); 55.2 (d, 1Jpc'141Hz, q C); 39.8 (d, 
2Jpc2.9Hz, CH2); 16.0 (d, 3Jp6.4, 2.314z, POCH2CH3) 13.8 (CH3 ). 31Pnmr 




4.4 Synthesis of Phenol-protected 5-Chiorosalicylaldehydes. 
Preparation of 3-Methoxyethoxymethoxy-5-chlorosalicylaldehyde, 67. 
Sodium hydride (60% dispersion in oils, 0.57g, 14mmol) was suspended in THY 
(25mL) at 0°C. 5-Chlorosalicylaldehyde, 33, (2.0g, 13mmol) was then added 
dropwise as a solution in THF (5mL), and the suspension immediately turned bright 
yellow. The mixture was stirred at room temperature for 1 hour. 13-
Methoxythethoxymethylchloride (1 . 7g, 1 4mmol) was added, and the resultant mixture 
stirred at room temperature for 2 hours, by which time the yellow colour had 
disappeared. The mixture was then quenched at 0°C by addition of HCl (IN, 40mL). 
Organic products were extracted with DCM (2x5OmL), washed with water (2x5OmL) 
and dried over sodium sulphate. Solvent was removed under reduced pressure 
forming a pale yellow oil, which was purified by flash chromatography (ethyl 
acetate/hexane, 2:1) yielding 13-methoxy-ethoxymethoxy-5 -chi oro-salicylaldehyde, 67, 
as a pale yellow oil (2.78g, 1 1.4mmol, 89%). 
Rf 0.65 (ethyl acetate/hexane, 3:2). FTIR Vma / cm' 
(liquid film) 3073 (Ar CH); 2905, 2880 (CH); 1682 (CO); 
1596, 1479 (C=C); 1105 (C-O). Inm (DCM, /dm3moF 
'cm') 325 (3450), 250 (8780), 228 (8270). 'Hnmr (CDCI3 , 
CI 
250MHz, ö/ppm) 10.39 (1H, s, CHO); 7.75 (1H, d, 
3J=2.8Hz, Ar H); 7.44 (1H, dd, 3J=8.8, 2.8Hz); 7.22 (1H, d, 3Ji =8.8Hz); 5.36 
(2H, s, OCH20); 185-3.82 and 3.55-3.52 (both 2H, m, OCH2); 3.34 (3H, s, OCH3). 
13C{ 1 B)nmr (CDCI3 , 63MHz, ö/ppm) 188.2 (C=O); 158.0, 127.5, 126.2 (q Ar C); 
135.3, 127.7, 116.8 (Ar CH); 93.7 (OCH 20); 71.3, 68.2 (OCH 2); 58.9 (OCH3). 
HRMS (El, M+/Z) C 11H1304 (M) requires 244.0502, found 244.0507. 
Preparation of Methoxymethoxy-5-chlorosalicylaldehyde, 68. 
Sodium hydride (80% dispersion in oils, 45.9mg, 1.53mmol) was suspended in 
THF (5mL) at room temperature. 5-Chlorosalicylaldehyde, 33 (52.6mg, 0.34mmol) 
was added dropwise as a solution in TI-IF (5mL), and the suspension immediately 
turned bright yellow. The mixture was stirred at room temperature for 30 minutes. 
Methoxymethylchioride (84.8mg, 1 .O5mniol) was added, and the resultant mixture 
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stirred at room temperature for 20 minutes, by which time the yellow colour had 
disappeared. The mixture was quenched at 0°C by addition of water (lOmL). The 
organic products were then extracted with DCM (2xl5mL), washed with water 
(2xl5mL) and dried over sodium sulphate. Solvent was removed under reduced 
pressure forming a pale yellow oil, which was purified by column chromatography to 
yield methoxymethoxy-5-chloro-salicylaldehyde, 68, as a pale yellow oil (72.8mg, 
0.36mmol, 100%). 
RI' 0.34 (DCMlhexane, 1:1). FTIR Vmax/ cm' (liquid film) 3070 (Ar 
I 	 CH); 2956, 2869 (CH); 1681 (CO); 1595, 1478 (C=C); 1123 (C- 
I 0). A.max/nm (ethanol, e/dm3 mol'cm 1 ) 321 (1830), 249 (4970). 
CI 	'llnmr (CDCI3, 250MHz, 6/ppm)" 10.42 (1H, s, CHO); 7.79 (1H, 
d, 3 J,414 2.8Hz, Ar H); 7.47 (1H, dd, 3JFg=9.0, 2.8Hz); 7.19 (1H, d, 3Jjj=9.0Hz); 5.29 
(2H, s, OCH20); 3.52 (3H, s, OCH3). 13C{'H}nmr (CDCI3, 63MHz, 6/ppm) 188.3 
(C=O); 158.0, 127.5, 126.2 (q Ar C); 1353, 127.7, 116.7 (Ar CH); 94.7 (OCH 20); 
56.4 (CH3). MS (El, M-/z) C9H9C103 (M) requires 200.0240, found 200.0236. 
Preparation of 1-t-Butyldimethylsilyloxy-4-chloro-2-benzaldehyde, 69. 
5-Chlorosalicylaldehyde, 33 (365.9mg, 2.34mmol), was stirred with imidazole 
(939.6mg, 13.8mmol) in DIvIF (lOmL) at room temperature, forming a yellow 
solution. Meanwhile, t-butyldimethylsilyl chloride (TBSC1, 701.6mg, 4.66mmol) was 
sonicated with DMAP (lOmol%) in DMF (4mL). After 30 mins, the TBSC1 solution 
was added dropwise to the yellow reaction mixture. Stirring was continued for 20 
hours, after which time the mixture was diluted with ether (20mL) and quenched with 
HC1 (IN, 20mL). The organic layer was separated and the aqueous layer washed with 
more ether (2x20mL) and the combined organic extracts washed with 5% LiC1 
solution (40mL). The organic layer was then dried over sodium sulphate and solvent 
removed under reduced pressure. The crude residue was purified by flash 
chromatography (hexanefDCM, 2:1), to yield 1 -tert-butyldimethylsilyloxy-4-chloro-2-
benzaldehyde, 69, as a white crystalline solid (326.1mg, 1.20mmol, 51%). Starting 
material (94.4mg, 0.602mmol, 26%) was also recovered. 
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Rf 0.42 (DCMlhexane, 1:1). m.p. 65-67°C. FTIR Vm/ cm- ' 
	
o o 	( 	(DCM) 3063 (Ar CH); 
2953, 2862 (CH); 1684 (C0); 1595, 
I 	
1543, 1474 (C=C). ?,jnm (ethanol, c/dm3moi
1 cm 1 ) 325 
- 	(3710), 248 (9190). 'Hnmr (CDCI3 , 250MHz, ö/ppm) 10.35 (1H, 
CI s, CHO); 7.72 (1H, dd, 3JHi2.8, 0.4Hz, ArH); 7.37 (1H, dd, 
JHW8.8, 2.8Hz, ArH); 6.81 (1H, dd, 3J j "8.8, 0.4Hz. AM); 0.99 (9H, s, tBu); 0.25 
(6H, s, 2xCH3 ). 13C{'H}nmr (CDCI3 , 63MHz, ö/ppm) 190.6 (C=O); 157.2, 127.8, 
126.9 (q Ar C); 135.2, 127.7, 121.6 (Ar CH); 25.4 (3xCH 3); 18.2 (q C); -4.5 (CH3). 
MS (FAB, M+/z) C 13H20C102Si (MI-I) requires 271.0921, found 271.0923. 
Preparation of 5-Chloro-2-acetylbenzaldehyde, 70. 
5-Chiorosalicylaldehyde, 33 (262.2mg, 1.67mmol), was stirred in THF (lOmL) at 
room temperature and triethylamine (190mg, 1.88mmol) added, forming a yellow 
solution. A solution of acetic anhydride (390mg, 3.82mmol) in THF (2mL), was 
treated with DMAP (lOmol%) for 15 minutes before slow addition to the yellow 
solution via a cannula. The reaction mixture turned colourless on complete addition of 
the anhydride solution and stirring was continued for a further 90 minutes. The 
mixture quenched with HC1 (IN, 20mL) and the organic products were extracted with 
ether (3x25mL). The combined organics were washed with sodium bicarbonate 
solution (25mL), and dried over sodium sulphate. Solvent was removed under 
reduced pressure to yield 4-chloro-2-acetylbenzaldehyde, 70, as a white crystalline 
solid (330.7mg, 1 .66mmol, 99%). 
Rf 0.32 (DCMlhexane, 1:1). m.p. 56-58°C. FTIIR Vm/ cm' (liquid 
o 0)L.. film) 3066 (Ar CH); 2988, 2857 (CH); 1769 (CO 2CH3); 1692 (CO); 
I 1596, 1575, 1475 (CC). A max/nm (ethanol, g/dm3mol
1 cm') 301 
I - 	( 1830), 245 (8860). 'Hnmr (CDC13 , 250MHz, ö/ppm) 10.00 (1H, s, 
CI CHO); 7.78 (1H, d, 3J14j 2.6Hz, Ar H); 7.52 (1H, dd, 3J=8.7, 2.6Hz, 
Ar H); 7.10 (1 H, d, 3JHJI8.7Hz, Ar H); 2.33 (3H, s, CH 3). 13C('H)nmr (CDCI3 , 
63MHz, ö/ppm) 187.1 (CO); 168.8 (COCH3); 149.8, 132.0, 128.8 (q Ar C); 134.8, 
130.1, 124.8 (Ar CH); 20.5 (CH 3). MS (FAB, M/z) C9H7C103 (M) requires 
198.0084; found 198.0088. 
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Preparation of 5-Chloro-2-methoxybenzaldehyde, 7112 
5-Chlorosalicylaldehyde, 33 (2.60g, 16.6mmol), was dissolved in acetone (pre-
distilled over potassium carbonate, lOOmL) at room temperature. Potassium 
carbonate (9.10g. 65.9mmol) was added, and a yellow suspension formed 
immediately. The mixture was stirred for 1 hour, after which time methyl iodide 
(19.2g, 135mmol) was added. The resultant mixture was stirred for 6 hours, then 
filtered through a small pad of kieselguhr and washed with acetone. The filtrate was 
concentrated, and the residue was suspended in DCM (40mL) and filtered through a 
small pad of silica. The filtrate was concentrated to yield 5-chloro-2-
methoxybenzaldehyde, 71, as a pale yellow solid (2.53g, 14.8mmol, 89%). 
RI 0.47 (DCM). m.p. 78-80°C 
(lit.  12 8081°C). FTIR Vmax/ cm' (DCM) 
00 
I 	3015 (Ar CH); 2942, 2874, 2845 (CH); 1680 (C0); 1595, 1484 (Ar 
I C=C); 1127 (C0). A max/nm (ethanol, c/dm 3mol 1 cm 1 ) 331 (4570), 249 
ci 	(9320), 223 (21000). 'Hnmr (CDCI3, 250Mllz, ö/ppm). 10.36 (111, s, 
CHO); 7.73 (1H, d, 3J,.,n2.8Hz, AM); 7.45 (1H, dd, 3J,,=8.9, 2.9Hz, AM); 6.92 
(1H, d, 3J=8.9Hz, ArH); 3.90 (3H, s, OCH 3). 13C{'H}nmr (CDCI3 , 63MHz, 
ö/ppm) 188.3 (C=O); 160.1, 126.1, 125.4 (q Ar); 135.2, 127.8, 113.1 (Ar CH); 55.8 
(OCH3). fiRMS (El), M/z C 8H7002 (M) requires 170.0138; found 170.0135. 
Elemental Analysis C7H8C1O2 requires 56.32% C, 4.14% H; found 56.40% C, 
4.05% H. 
Preparation of Tetrahydro-2-(4-chlorophenoxy)-2H-Pyrafl, 8313. 
4-Chlorophenol (25. 1g, 0. 195mo1) and dihydropyran (33.5g, 0.398g) were stirred 
in dry chloroform at room temperature. para-Toluenesulphonic acid (10mg) was 
added, and the solution stirred for 2.5 hours (heat evolved). Chloroform was removed 
under vacuum and the crude product diluted with ether (1 OOmL) and washed with 
sodium hydroxide (IN, 3 x5OmL). The ether solution was then dried over sodium 
sulphate, and solvent removed under reduced pressure. The resultant yellow oil was 
distilled over sodium hydroxide pellets (95-98°C, 0.7mmHg) to give a white 
crystalline solid. This was recrystallised from hexane to yield tetrahydro-2-(4-
chlorophenoxy)-2H-pyran, 83, as a white crystalline solid (35.6g, 0. 167mol, 86%). 
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RI 0.80 (DCMlhexane, 3:2). m.p. 48-50°C (lit. 48-49°C' 3). FTIR 
Vmax/ em- ' (DCM) 3060 (Ar CH); 2948, 2873, 2854 (CH); 1596, 1489 
(C=C); 1120 (C0). A.max/nm (ethanol, c/dm 3mol 1 cm') 286 (1250), 
279 (1560), 226 (12200). 'Hnmr (CDCI3 , 250MHz, ö/ppm). 7.22 and I
ci 	6.98 (both 2H, m, Ar H); 5.36 (1H, t, 3Ji,3.2Hz, OCHO); 3.91-3.82 
and 3.63-3.55 (both 1H, m, OCH2); 2.05-1.89 (1H, alkyl H); 1.87-1.81 
(2H, m, alkyl H); 1.71-1.55 (3H, m, alkyl H). 13C{'H}nmr (CDCI3 , 63MHz, ö/ppm) 
155.5, 126.2 (q Ar); 129.0, 117.6 (Ar CH); 96.3 (OCHO); 61.8 (OCH 2); 30.0, 24.9, 
18.5 (CH2). HRMS (El), M/z C 11H 13Cl02 (M) requires 212.0603, found 212.0604. 
Elemental Analysis C 11H13C102 requires 62.12% C, 6.16% H; found 62.14% C, 
6.16% H. 
Preparation of 5-Chloro-2-(tetrahydro-2H-pyran-2yloxy)-benzaldehyde, 84.13 
To n-butyllithium (2.4M in hexanes, 6.8mL, 16.3mmLol) at 0°C was added 
TMIEDA (2.5mL, 16.6mmol) dropwise, and the mixture stirred for 30 minutes. 
Tetrahydro-2-(4-chlorophenoxy)-2H-pyran, 83 (3. 17g, 14.9mmol), was then added 
dropwise over a period of 20 minutes as a solution in THF (4mL). Stirring was 
continued for 2 hours after which time a white precipitate had formed. DMF (4.OmL, 
52mmol) was then added as a solution in dry toluene (5mL), the precipitate cleared, 
and stirring was continued for 12h. The mixture was then poured onto iced HCl (IN, 
lOOmL), and organics were extracted with ether (2xlOOmL), washed with brine 
(lOOmL), and dried over sodium sulphate. Solvent was removed under reduced 
pressure, and the crude residue was purified by flash chromatography to yield a pale 
yellow solid. This was recrystallised from hexane to yield 5 -chi oro-2-(tetrahydro-2H-
pyran-2yloxy)-benzaldehyde, 84, as a pale yellow solid (2.73g, 11 .4mmol, 76%). 
RI 0.66 (DCMlhexane, 3:2). m.p. 5456°C. FTIR Vmax/ cm' 
(DCM) 3060 (Ar CH); 2949, 2874 (CH); 1683 (C=0); 1595, 1475 
000 
I 	 (C=C); 1120 (C0). ?, max/nm (ethanol, /dm3mol 1 cm) 325 (3760), 
I 249 (9440). 'Hnmr (CDCI3 , 250MHz, ö/ppm). 10.42 (1H, s, 
cI 	CHO); 7.76 (1H, d, 3J1-11 2.8Hz, AM),7.40 (1H, dd, 3J,,=9.0, 
2.7Hz, ArH); 7.17 (1H, d, 3J,9.0Hz, Ar H); 5.50 (1H, t, 3J,3.7Hz, OCHO); 
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3.83-3.75 and 3.65-3.59 (both 111, m, OCH2); 1.95-1.87 (311, alkyl H); 1.75-1.59 
(3H, m, alkyl H). 13C{'H}nmr (CDC13 , 63MHz, ö/ppm) 188.2 (C0); 157.7, 126.9, 
126.0 (q Ar); 135.1, 127.2, 117.0 (Ar CH); 96.5 (OCHO); 61.9 (OCH 2); 29.7, 24.7, 
18.2 (CH2). HRMS (El), M7z C 1211 13003 requires 240.0553, found 240.0565. 
Elemental Analysis C 12H13C103 requires 59.88% C, 5.44% H; found 59.90% C, 
5.25% H. 
4.5 Horner-Wadsworth-Emmons Reactions 
Preparation of Ethyl 2-(3-Methylindolyl)-3-(2--methoxyethoxymethoxy-5-
chlorophenyl)acrylate, 72. 
To triethyl 2-(3-methlylindolyl)phosphonoacetate, 59 (483.6mg, 1 .37mmol), in 
THF (30mL) at room temperature, was added NaHIvI1DS (1.08M in THF, 1.29niL, 
1 .39mmol), slowly via syringe, and the resultant solution stirred for 30 minutes. 2- 13-
Methoxyethoxymethoxy-5 -chlorosalicylaldehyde, 67 (410.8mg, 0.211 mmol), was 
added as a solution in THY (5mL) via syringe, and the mixture then stirred for 16 
hours. The reaction was quenched with HCI (IN, 50mL), and organic products 
extracted with ether (2x5OmL). The combined extracts were dried over sodium 
sulphate and solvent was removed under reduced pressure. The crude residue was 
purified by flash chromatography (ethyl acetate/hexane, 1:2 to 1:1) to yield ethyl [2-
(3 -methylindolyl)-3 -(2-3-methoxyethoxymethoxy-5-chlorophenyl)]acrylate, 72, as a 
pale yellow oil (535.8mg, 1.21mmol, 88%). Spectra were consistent with an isomeric 
mixture in a 2.2:1 ratio. 
0 
RI 0.62 (ethyl acetate/hexane, 1:1). FTIR 
Vmax/ cm -1 (liquid film) 3382 (NH); 3058 (Ar 
CH); 2980, 2931 (CH); 1705 (C=O); 1622, 
1592, 1479 (C=C); 1097 (C0). Amax/nm 
(ethanol, /dm 3moF'cm') 289 (9100) 265 
(15000). 1Hnmr (CDCI3 , 250MHz, ö/ppm) 8.14 and 8.06 (111, both br. s, NH); 
7.82-6.73 (9H, m, Ar/olefin H); 5.23 and 5.15 (2H, both s, OCH20); 4.21 and 4.03 
(2H, both q, 3Ji-n'7. 1Hz, OCH2); 3.91 (2H, s, allyl CH2); 3.77-3.73 and 3.68-3.65 
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(2H, both m, MEM OCH2); 3.53-3.49 and 3.47-3.43 (2H, both m, MEM OCH 2); 
3.36 and 3.33 (3H, both s, OCH3) 1.23 and 1.01 (3H, both t, 3J1111=7.lHz, CH3). 
13C{'H}ninr (CDCI3, 63Mhz, s/ppm) 168.6, 168.1 (C=O); 153.8, 152.8, 136.3, 
136.1, 133.1, 128.4, 127.2, 127.0, 126.9, 126.5, 126.2, 113.7, 112.3 (q Ar/olefin C); 
133.8, 129.4, 129.2, 129.1, 128.3, 122.8, 121.9, 121.8, 121.7, 119.2, 119.1, 118.8, 
115.7, 111.0, 110.8 (Ar/olefin CH); 93.7 (OCH 20); 71.3, 67.7 (MEM OCH2); 60.8, 
60.4 (OCH2); 30.6, 23.4 (allyl CH 2); 14.0 (CH3). MS (FAB, M+/z) C241126C1N05 
(M) requires 443, found 443 (82%), 368 (52%), 294 (30%), 193 (37%), 154 (96%). 
Preparation of Ethyl 2-(3-Methylindolyl)-3-(2-methoxymethoxy-5-
chlorophenyl)acrylate, 73. 
To triethyl 2-(3-methlylindolyl)phosphonoacetate, 59 (38.3mg, 0. lO8mmol), in 
THY (5mL) at room temperature, was added potassium tert-butoxide (1 .OM in THF, 
0.22mL, 0.22mmol), slowly via syringe, and the resultant solution stirred for 30 
minutes. 2-Methoxymethoxy-5-chlorosaliCylaldehyde, 68 (21.5mg, 0.1 O7mmol), was 
added as a solution in THF (2mL) via syringe, and the mixture then stirred for 16 
hours. The reaction was quenched with HC1 (iN, 20mL), and organic products 
extracted with ether (2x2OmL). The combined extracts were dried over sodium 
sulphate and solvent was removed under reduced pressure. The crude residue was 
purified by flash chromatography (ethyl acetate/hexane, 1:1) to yield ethyl 2-(3-
methylindolyl)-3 -(2-methoxymethoxy-5 -chlorophenyl)acrylate, 73, as a pale yellow oil 
(20.5mg, 0.070mmol, 48%). Spectra were consistent with an isomeric mixture in a 
2.2:1 ratio. 
RI 0.62 (ethyl acetate/hexane, 1:1). FTIR Vmax/ cm' 
0 	0 0 
(CHCI3) 3478 (NH); 3036 (Ar CH); 2959, 2929, 2868 
I (CH); 1705 (C0); 1635, 1594, 1481 (C=C); 1091 (C-
I 	 ci 	0). 'Hnmr (CDCI3, 200MHz, ö/ppm) 8.06 and 7.99 
N 
H (1H, both br. s, NH); 7.84-6.73 (911, m, Ar/olefin H); 
5.15 and 5.06 (2H, both s, OCH 20); 4.21 and 4.03 (2H, both q, 3J,.7.0Hz, OCH2); 




Preparation of Ethyl 2(3-MethylindolyL)-3-(2-methoxy-5-chlorophenyl)aCrYlate, 
74. 
To 2-(3 -methlylindolyl)-triethylphosphonoacetate, 59 (108.6mg, 0.3 O7mmol), in 
THF (6rnL) at room temperature, was added NaHIvIDS (1.OM in THY, 0.38mL, 
0.38mmol), slowly via syringe, and the resultant solution stirred for 1 hour. 5-Chioro-
2-methoxybenzaldehyde, 71 (76.8mg, 0.450mmol), was added as a solution in THF 
(2mL) via syringe, and the mixture then stirred for 2 hours. The reaction was 
quenched with HC1 (IN, 20mL), and organic products extracted with ether 
(2x25mL). The combined extracts were dried over sodium sulphate and solvent was 
removed under reduced pressure. The crude residue was purified by flash 
chromatography (ethyl acetate/hexane, 1:1) to yield ethyl 2-(3-methylindolyl)-3-(2-
methoxy-5-chlorophenyl)acrylate, 74, as a pale yellow oil (70.9mg, 0.192mmol, 
63%). Spectra were consistent with an isomeric mixture in a 1.8:1 ratio. 
RI 0.52 (ethyl acetate/hexane, 1:1). FTIR VmaiI cm- ' 
(DCM) 3467 (NH) 3041 (Ar CH); 2985, 2935 (CH); 1706 
(C0); 1603, 1484 (C=C); 1091 (C0). max/flm (ethanol, 
c/dm3mot'cm') 267 (15100). 'llnmr (CDCI3 , 250MHz, 
H 	 ö/ppm) 8.19 and 8.13 (IH, both br. s, NH); 7.88-6.70 (9H, 
m, Ar/olefin H); 4.21 and 4.06 (21-1, both q, 3J1 =7.1Hz, OCH2); 3.94 and 3.92 (2H, 
both s, allyl CH2); 3.81 and 3.73 (311, both s, OCH 3); 1.24 and 1.3 (31-1, both t, 
J7.lHz, C143 ). 13C{'H}nmr (CDCI3, 63MHz, ö/ppm); 168.8, 168.1 (C=O); 156.0, 
155.1, 136.2, 136.1, 134.7, 132.8, 127.2, 126.9, 126.0, 125.1, 124.7, 113.6, 112.1 (q 
Ar/olefin C); 133.7, 129.3, 129.1, 128.6, 128.2, 122.8, 121.7, 119.1, 119.0, 119.0, 
118.7, 111.5, 111.2, 111.0, 111.9 (Ar/olefin CH); 60.8, 60.4 (OCH 2); 55.6, 55.5 
(OCH3); 30.6, 23.4 (allyl CH2); 14.0, 13.5 (CH3). HRMS (FAB, M 4 /z) C21H20C1NO3 
(M) requires 369.1132; found 369.1135. 
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Preparation of Ethyl 2-(1_Triisopropylsilyl-3-methylindolyl)-3-(2-methOxY-5-
chlorophenyl)acrylate, 75. 
To triethyl 2-( 1 -triisopropylsilyl-3 -methlylindolyl)phosphonoacetate, 58 (176.8mg, 
0.347mmo1), in THF (8mL) at room temperature, was added potassium tert-butoxide 
(1.OM in TFIF, 0.39mL, 0.39mmol), slowly via syringe, and the resultant solution 
stirred for 2 hours. 5-Chloro-2-methoxybenzaldehyde, 71(64.2mg, 0.376mmo1), was 
added as a solution in THF (2mL) via syringe, and the mixture then stirred for 2 
hours. The reaction was quenched with HCl (IN, 20mL), and organic products 
extracted with ether (2x25mL). The combined extracts were dried over sodium 
sulphate and solvent was removed under reduced pressure. The crude residue was 
purified by flash chromatography (ethyl acetate/hexane, 1:2 to 1:1) to ethyl 2-(1-
triisopropylsilyl-3 -methylindole)-3 -(2-methoxy-5 -chlorophenyl)acrylate, 75, as a pale 
yellow oil (176.0mg, 0.334mmo1, 96%). Spectra were consistent with an isomeric 
mixture in a 7:2 ratio. 
RI 0.88 (ethyl acetate/hexane, 1:1). FTIR Vmax/ CM -1 
(DCM) 3058 (Ar CH); 2985, 2949, 2868 (CH); 1705 (C=O); 
1638, 1595, 1484 (C=C). A.max/nm (ethanol, c/dm 3mol' 
C, CM -) 314 (4920), 291(7710), 267 (13500). 'Hnmr (CDCI3 , 
250MHz, ö/ppm) 7.85-6.69 (9H, m, Ar/olefin H). 4.14 and 
4.03 (2H, both q, 3J Ti,=7.1Hz, OCH2); 3.91 (2H, s, allyl 
CH2); 3.82 and 3.72 (3H, both s, OCH 3); 1.64 (3H, sept. 
3 J,,=7.7Hz, 3xCH); 1.17-1.02 (21H, m, TIPS 6xCH 3/CH3). 13C{'H}nmr (CDCI3 , 
63MHz, ö/ppm) 168.9, 168.1 (C0), 156.0, 155.2, 141.3, 134.9, 132.7, 132.3, 
130.5, 129.8, 127.3, 126.1, 1125.2, 124.7, 113.9(qAr/olefinC); 133.7, 130.8, 1293, 
129.1, 128.8, 128.7, 128.3, 128.2, 121.3, 119.3, 119.1, 118.9, 118.6, 115.6, 113.8, 
113.7, 111.5, 111.3 (Ar/olefin CH); 60.6, 60.3 (OCH2); 55.7, 55.5 (OCH3); 23.6, 
22.9 (allyl CH2); 18.0, 17.6 (6xCH 3); 14.1, 13.6 (3xCH), 12.6, 12.1 (CH 3). MS 
(FAB, M 4 1z) C30H40C1NO3 Si (M) requires 525.2466, found 525.2485. 
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Preparation of Ethyl 2-Phenyl-3-(2-methoxy-5-chlorophenyl)acrylate, 76. 
To triethyl 2-benzylphosphonoacetate, 61, (208.1mg, 0.660mmol), in THF (l5mL) 
at room temperature, was added NaH1IvI1DS (1.1M in THF, 0.73mL, 0.80mmol), 
slowly via syringe, and the resultant solution stirred for 1 hour. 5-Chloro-2-
methoxybenzaldehyde, 71 (174.3mg, 1.02mmol), was added as a solution in THF 
(2mL) via syringe, and the mixture then stirred for 2 hours. The reaction was 
quenched with HC1 (IN, 20mL), and organic products extracted with ether 
(2x25mL). The combined extracts were dried over sodium sulphate and solvent was 
removed under reduced pressure. The crude residue was purified by flash 
chromatography (DCMlhexane, 2:1) to yield ethyl 2-phenyl-3-(2-methoxy-5-
chlorophenyl)acrylate, 76, as a pale yellow oil (196.7mg, 0.595mmo1, 90%). Spectra 
were consistent with an isomeric mixture in a 3:1 ratio. 
RI 0.42 (DCMlhexane, 2:1). FTIR VmaX/ cm' (DCM) 3061 
(Ar CH); 2987, 2938, 2907 (CH); 1705 (C=O); 1636, 1595, 
1484 (C=C); 1092 (C-O). ? ax/nm (ethanol, c/dm3mol' cm 
CI 	) 315 (5150), 264 (10500), 227 (19100). 'Hnmr (CDCI3 , 
250MHz, ö/ppm) 7.90 and 6.72 (1H, both s, olefin H) 7.3 1- 
7.10 (8H, m, Ar H); 4.19 and 4.02 (2H, both q, 3Jjij7. 1Hz, OCH2); 3 .84 (2H, s, 
benzyl CH2); 3.82 and 3.78 (3H, both s, OCH3); 1.23 and 1.01 (3H, both t, 
3Jjj=7.1Hz, 6xCH3). 13C{'H}nmr (CDCI3 , 63MHz, ö/ppm); 168.2, 167.6 (C=O); 
156.0, 155.2, 139.5, 138.2, 132.5, 125.0 (q Ar/olefin C); 135.9, 134.9, 130.3, 129.4, 
129.2, 129.0, 128.8, 128.4, 128.3, 128.3, 127.9, 126.3, 125.9, 111.6, 111.3 (Ar/olefin 
CH); 60.8, 60.4 (OCH 2); 55.6, 55.5 (0C143); 41.0, 33.2 (benzyl CH2); 14.0, 13.5 
(CH3). HRMS (El, M+/z) C 1911 1 9003 (MI) requires 330.1023; found 330.1014. 
Preparation of Ethyl 2-Benzyl-3-(2-3-Methoxyethoxymethoxy-5-chloro-
phenyl)acrylate, 77. 
To triethyl 2-benzylphosphonoacetate, 61, (68mo1% by 'Hnmr 416.3mg, 
0.900mmol) in THF (15mL) at room temperature, was added NaHMIDS (1.1M in 
THF, 1.OmL, 1.Ommol), slowly via syringe, and the resultant solution stirred for 2 
hours. 5 -CMoro-2-3-methoxyethoxymethoxybenzaldehyde, 67 (336.9mg, 1.3 8mmol) 
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was added as a solution in THF (4mL) via syringe, and the mixture then stirred for 2 
hours. The reaction was quenched with HCI (IN, 25mL), and organic products 
extracted with ether (2x25mL). The combined extracts were dried over sodium 
sulphate and solvent was removed under reduced pressure. The crude residue was 
purified by flash chromatography (DCMlhexane, 2:1) to yield ethyl 2-benzyl-3-(2-13-
methoxyethoxymethoxy-5-chlorophenyl)acrylate, 77, as a pale yellow oil (276.2mg, 
0.682mmol, 76%). Spectra were consistent with an isomeric mixture in a 7:2 ratio. 
Rf 0.74 (ethyl acetate/hexane, 2:1). FTIIR 
0 
Vmax/ cm 1 (DCM) 3063 (Ar CH); 2929, 2895, 
2821 (CH); 1706 (CO); 1636, 1601, 1481 
EiiiI( C, (C=C); 1098 (C-O). L/nm (ethanol, 
c/dm3mor1 cm 1 ) 308 (4250), 262 (10100), 229 
(18600). 1 llnmr (CDCI3 , 250MHz, ö/ppm) 7.86 and 6.71 (1H, both s, olefin H) 
7.3 5-7.02 (814, m, Ar H); 5.25 and 5.22 (214, both s, OCH20); 4.19 and 4.00 (2H, 
both q, 3J1 =7.1Hz, OCH2); 3.80-3.74 and 3.54-3.49 (both 2H, m, OCH2); 3.82 (2H, 
s, benzyl CH2); 3.36 and 3.35 (3H, both s, OCH 3); 1.21 and 0.99 (3H, both t, 
3J1 =7.1Hz, CH3). 13C{ 1 H}nmr (CDCI3 , 63MHz, ö/ppm); 168.1, 167.6 (C=O); 
153.8, 152.9, 139.4, 138.1, 132.7, 126.7 (q Ar/olefin C); 135.1, 130.4, 129.4, 129.2, 
129.0, 128.8, 128.5, 128.3, 128.3, 127.9, 126.3, 125.9, 115.7 (Ar/olefin CH); 93.8 
and 93.6 (OCH20); 71.3, 67.7 (MEM-OCH2); 60.8, 60.4 (OCH2); 58.9 (OCH3); 40.9, 
33.2 (benzyl CH2); 14.0, 13.5 (CH3). HRMS (FAB, M+/z) C22H26005 (M) requires 
405.1468; found 405.1484. 
Preparation of Ethyl 2-(3-Methylindolyl)-3-(2-tetrahydro-2H-pyran-2yloxy)-5-
chlorophenyl)acrylate, 85. 
To triethyl 2-(3-methlylindolyl)phosphonoacetate, 59 (502.7mg, 1 .42mmol), in 
THF (8mL) at room temperature, was added Na.HMDS (1.OM in THF, 1.9mL, 
1 .6mmol), slowly via syringe, and the resultant solution stirred for 1.5 hours. 5-  
Chi oro-2-(tetrahydro-2H-pyran-2yloxy)-benzaldehyde, 84 (643.7mg, 2. 67mmol), 
was added as a solution in THF (3mL) via syringe, and the mixture then stirred for 2 
hours. The reaction was quenched with HC1 (IN, 20mL), and organic products 
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extracted with ether (2x25mL). The combined extracts were dried over sodium 
sulphate and solvent was removed under reduced pressure. The crude residue was 
purified by flash chromatography (DCMlhexane, 2:1 to DCM) to yield ethyl 2-(3-
methylindole)-3 -(2-tetrahydro-2H-pyran-2yloxy)-5 -chlorophenyl)acrylate, 85, as a 
pale yellow oil (388.3mg, 0.883nimol, 62%). Spectra were consistent with an 
isomeric mixture in a 5:1 ratio. 
RI 0.25 (DCMlhexane, 2:1). FTIR Vm/ cm' 
JJ (DCM) 3467 (NH); 3064 (Ar CH); 2947, 2861 (CH); 
1705 (CO); 1621, 1590, 1479 (C=C), 1093 (C-O). 
I 	A max/nm (ethanol, c/dm3mot'cm') 313 (5280), 266 
I 	 ci 	(15300), 222 (52800). 'Hnmr (CDCI3 , 250MHz, 
N 
H ô/ppm) 8.16 and 8.06 (1H, both s, NH); 7.96 and 6.77 
(1H, both s, olefin H) 7.51-6.91 (8H, m, Ar H); 5.42 and 5.30 (1H, both t, 
3J=2.9Hz OCHO); 4.22 and 4.08 (2H, both q, 3J,*i=7.lHz, OCH2) ; 3.97 and 3.92 
(2H, s, allyl CH2); 3.86-3.74 and 3.62-3.56 (both 1H, m, diastereotopic OCH 2); 2.00-
1.82 (3H, m, alkyl CH); 1.73-1.56 (3H, m, alkyl CH) 1.24 and 1.04 (3H, both t, 
3JHJ,=7.lHz). 13C{'H}nmr (CDCI3 , 63MHz, ö/ppm) [Major Isomer] 168.2, (C=O); 
153.4, 136.3, 132.6, 126.9, 126.8, 126.1, 113.7 (q Ar/olefin C); 133.8, 129.4, 129.0, 
121.8, 121.7, 119.1, 118.8, 116.0, 115.7 (Ar/olefin CH); 96.4 (OCHO); 61.8, 60.7 
(0CJ42); 30.0, 24.9, 18.3 (alkyl CH 2); 23.4 (allyl CH 2);14.0 (CH3). HRMS (FAB, 
M+/Z) C25H26C1N04 (Mt) requires 439.1550; found 439.1556. Elemental Analysis 
C25H26C1N04 requires 68.25% C, 5.96% H, 3.18% N; found 68.25% C, 5.89% H, 
2.98% N. 
4.6 Protecting Group Cleavages 
MEM-ether Cleavage of Ethyl 2-Benzyl-3-(2--Methoxyethoxymethoxy-5-
chlorophenyl)acrylate, 77. 
To ethyl 2-benzyl-3 -(2-3-methoxyethoxymethoxy-5 -chi orophenyl)acrylate, 77 
(alkene ratio, 7:2, 404.9mg, 0.540mmol), in dry DCM (9mL) at room temperature, 
was added TFA (90% aqueous, 6mL), and the mixture stirred for 2 hour. The mixture 
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was then diluted with water (15mL), and the organic products were extracted with 
DCM (2x2OmL). The combined extracts were washed with water (3x2OmL), dried 
over sodium sulphate, and solvent removed under reduced pressure. The crude 
residue purified by flash chromatography (DCM), to yield to yield two products. 
These were identified as 6-chloro-3-ben.zylcoumarin, 80 (32.8mg, 0.12 immol, 23%) 
and ethyl 2-ben.zyl-3 -(2-hydroxy-5 -chiorophenyl)-E-acrylate, 79 (127.3mg, 
0.402mmol, 77%). 
0 	OH 	RI' (79) 0.18 (DCM). FTIR Vmai/ cm' (DCM) 3564 (OH); 
EtO 	
-v 	
3330 (br OH); 3065, 3028 (Ar CH); 2986, 2931, 2868 (CH); 
I 	
1718 (C=O); 1635, 1600, 1480 (CC). Ainax/nm (ethanol, 
CI 	c/dm3moF'cm') 313 (4650), 262 (9510), 229 (18200). 'Hnmr 
(CDCI3 , 250MHz, ö/ppm) 7.90 (lh, s, olefin CH); 7.29-7.10 (7H, m, Ar H); 6.91 
(1H, br. s, OH); 6.78 (1H, d, 3J 1=8.5Hz, Ar H); 4.20 (2H, q, 3JF,j"7.1Hz, OCH2) 
3.86 (2H, s, benzyl CH2); 1.21 (3H, t, 3Ji =7.114z). 13C{'H}nmr (CDCI3 , 63MHz, 
ö/ppm) 168.4 (C=O); 152.8, 139.0, 133.3, 124.8, 123.7 (q Ar/olefin C); 134.8, 
129.7, 128.7, 128.3, 127.9, 126.1, 117.0 (Ar/olefin CH); 61.3 (OCH 2); 33.3 (benzyl 
CH2); 13.9 9CH3). fiRMS (FAB, M+/z) C 18H 17003 (Mt) requires 316.0866; found 
316.0872. 
Rf (80) 0.56 (DCM). mp 138-140°C (lit. 14 140-142°C) 
ko  FTIR Vmax/ cm' (DCM) 3050 (Ar CH); 2984, 2921 (CH); 
I 	I 	
1717 (CO); 1604, 1570, 1481 (C=C). ?max/nm (ethanol, 
I 
E/dm3mol t cm) 320 (5170), 269 (1330), 265 (11800), 262 
CI (12100). 'Hnmr (CDCI3, 250MHz, ö/ppm) 7.41-7.16 (9H, m, 
Ar H); 3.88 (214, d, 4JHj-=0.9Hz). 13C'll)nmr (CDCI3 , 63MHz, ö/ppm) 160.9 
(CO); 151.2, 137.0, 130.7, 129.3, 120.3 (q Ar C); 137.8, 130.5, 129.3, 128.7, 
128.2, 126.8, 126.5, 117.7 (Ar CH); 36.4 (CH 2). fiRMS (FAB, M+/Z) C 16H,2C1O2 
(MM) requires 271.0526; found 271.0529. 
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Attempted Methylether Cleavage of Ethyl 2-(1-Triisopropylsilyl-3-
methylindolyl)-3-(2-methoxy-5-chlorophenyl)acrylate, 75. 
To ethyl 2-( 1 -triisopropylsilyl-3 -methylindolyl)-3 -(2-methoxy-5 -chlorophenyl)
acrylate, 75 (alkene ratio, 7:2, 79.5mg, 0.15mmol), in dry DCM (4mL) at 0°C, was 
added boron tribromide (1.OM in DCM, 0.6mL, 0.6mmol), and the mixture stirred for 
1 hour. The reaction was then stirred at room temperature for 16 hours, followed by 
quenching with the careful addition of water (15mL). The organic products were 
extracted with DCM (2x20mL), and the combined extracts were washed with water 
(20mL) and dried over sodium sulphate. Solvent was removed under reduced 
pressure and the crude residue purified by flash chromatography (DCM - ethyl 
acetate/hexane, 3:1). Two compounds were isolated, which were identified as ethyl 
2-(3 -methylindole)-3 -(2-hydroxy-5 -chlorophenyl)-E-acrylate, 34 (23.9mg, 
0. O67mmol, 45%) and 6-chloro-3 -(3 -methylindolyl)coumarin, 81 (17.4mg, 
0.056mmol, 37%). 
Rf (34) 0.54 (ethyl acetate/hexane, 1:1). FTI1R Vmax/ cm' 
(DCM) 3566 (OH); 3467 (NH) 3300 (br. OH) 3063 (Ar 
CH); 2982, 2957, 2932, 2860 (CH); 1706 (C=O); 1602, 
1481 (CC). Xtnax/nm (ethanol, c/dm3moF'cm 1 ) 323 
(5560), 269 (17100). 'Hnmr (CDCI3 , 600MHz, ö/ppm) 
8.07 (1H, br. s, NH) 7.81 (1H, s, olefin H, NOE with 6 4.34ppm) 7.53 (11-1, d, 
3Jiin7.9Hz Ar H); 7.45 (1H, d, 3J,*,8.OHz, Ar H) 7.33 (1H, s, Ar H, NOE with 6 
4.02ppm); 7.29 (2H, m, Ar H); 7.20 (1H, m, Ar H) 7.04 (1H, m, Ar H); 6.94 (1H, d, 
3J=8.6Hz); 5.29 (1H, br. s, OH); 4.34 (2H, q, 3J,-i 7. 1Hz, OCH2, NOE with 6 
7.81ppm); 4.02 (2H, s, allyl CH 2, NOE with 6 7.33ppm); 1.37 (3H, t, 3J,=7.1Hz). 
13C{'H}nmr (CDC13, 63MHz, ö/ppm) 168.5 (C=O); 153.1, 136.1, 133.6, 126.9, 
124.6, 124.0, 113.4 (q Ar/olefin C); 133.4, 129.5, 128.9, 121.8, 121.8, 119.20 118.7, 
116.9, 110.9 (Ar/olefin CH); 61.0 (OCH 2); 23.4 (allyl CH2); 14.0 (CH3). MS (FAB, 
M+/Z) C20H19C1NO3 (MH) requires 356.1054; found 356.1047. 
142 
Experimental 
0 	RI (81) 0.54 (DCM). FTIR Vmax/ cm' (DCM) 3466 
(NH) -
' 
 3063 (Ar CH); 2929, 2865 (CH); 1726 (C=O); 1604, 
1570, 1481 (CC). A.max/nm (ethanol, c/dm 3mot'cm') 320 
(1390), 273 (3450). 'Hnmr (DMSO-d 6 , 250MHz, 3/ppm) 
CI 11.00 (1H, br. s, NT-I) 7.70 (1H, s, Ar H); 7.61 (1H, s, Ar H); 
7.56-7.36 (4H, m, Ar H); 7.26 (1H, d, 3J-'2.2Hz, Ar H); 7.11-6.93 (2H, m, Ar H); 
3.91 (1H, s, 1CH2). 13C{'H}nmr (CDCI3, 63MHz, ö/ppm) 160.6 (C0); 151.2, 
13 6,5, 13 0.0, 128.3, 120.8, 110.0 (q Ar C); 13 7.7, 13 0.5, 127.1, 124.4, 121.2, 118.7, 
118.5, 117.9, 111.7 (Ar CH); 26.0 (CH2). HRMS (FAB, M'/z) C 1811 13 C1NO2 (MEt) 
requires 310.0635; found 310.0638. 
Attempted Methylether Cleavage 
chlorophenyl)acrylate, 77. 
of Ethyl 2-Benzyl-3-(2-methoxy-5- 
To ethyl 2-benzyl-3-(2-methoxy-5-chlorophenyl)acrylate, 77 (alkene ratio, 7:2, 
299.1mg, 0.904mmol), in dry DCM (lOmL) at 0°C, was added boron tribromide 
(1.OM in DCM, 1.8mL, 1.8mmol), and the mixture stirred for 1 hour. The reaction 
was then stirred at room temperature for 16 hours, followed by quenching with the 
careful addition of water (15mL). The organic products were extracted with DCM 
(2x2OmL), and the combined extracts were washed with water (20mL) and dried over 
sodium sulphate. Solvent was removed under reduced pressure and the crude residue 
purified by flash chromatography (DCM), to yield 6-chloro-3-ben.zylcoumarin, 80 
(212.6mg, 0.785mmo1, 87%). 
THP-ether Cleavage of Ethyl 2-(3-Methylindolyl)-3- [(2-tetrahydro-2H-pyran-
2yloxy)-5-chlorophenyllacrylate, 85. 
Ethyl 2-(3 -methylindolyl)-3 -[(2-tetrahydro-2H-pyran-2-yloxy)-5 -chiorophenyl] - 
acrylate, 85 (alkene ratio, 5:1, 263.0mg, 0.598mmo1), was stirred in methanol (6mL) 
at room temperature. Oxalic acid (10,% aqueous, 4n -d, 4.4mmol) was added and the 
resultant mixture stirred at 80°C for 90mins. The mixture was cooled then methanol 
removed under reduced pressure. The residue was diluted with water (lOmL) then 
organic products extracted with ether (2x2OmL), washed with saturated 
sodiumbicarbonate solution (20mL) and water (20mL) and solvent removed under 
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reduced pressure. The residue was purified by flash chromatography (ethyl 
acetate/hexane, 1:1) to yield ethyl 2-(3-methylindole)-3-(2-hydroxy-5 -chi orophenyl)-
E-acrylate, 34 (179.8mg, 0.505mmol, 84%) and 6-chloro-3-(3-
methylindolyl)coumarin, 81 (23.9mg, 0. O77mmol, 13%). 
4.7 Carboxylic Ester Hydrolysis 
Preparation of 2-Benzyl-3-(2-hydroxy-5-chlorophenyl)-E-acrylic acid, 82. 
To ethyl 2-benzyl-3 -(2-hydroxy-5 -chlorophenyl)-E-acrylate, 79 (155.2mg, 
0.490mmo1), in 50% aqueous ethanol (8mL) was added lithium hydroxide 
monohydrate (103.6mg, 2.47mmol). The mixture was heated at reflux for 4 hours, 
then cooled to room temperature and the ethanol was removed under reduced 
pressure. Organic products were extracted with ether (10mL) from the basic solution 
which was then acidified forming a white precipitate. This was removed by filtration 
to yield 2-benzyl-3 -(2-hydroxy-5 -chiorophenyl)-E-acrylic acid, 82 (122.1mg, 
0.423mmo1, 86%). 
0 	OH 	Rf 0.45 (DCMlmethanol, 9:1). RP-HPLC (Gradient 1) 
HO 	- 	21.9 minutes. m.p. 204207°C. FTIR Vmax/ cm' (KBr) 3448 
I 	
(OH); 3088 (Ar CH); 2990, 2922, (CH); 2690, 2550 (CO 2H); 
CI 	1670 (C=O); 1618, 1560, 1495 (CC). X max/nm (ethanol, 
E/dm3mor 1 cm 1 ) 319 (5770), 263 (11400). 'Hnmr (CD30D, 250MHz, ölppm) 8.09 
(1H, s, olefin H); 7.38-7.19 (7H, m, Ar H); 6.90 (1H, dddç 3J=9.0, 1.3, 1.311z, Ar 
H); 5.03 (br. s, CD 30H); 3.93 (2H, s, benzyl CH2). 13C{ 1 H}nmr (CD30D, 63MHz, 
ö/ppm) 169.5 (C=O); 154.0, 139.1, 130.4, 123.6, 122.9 (q Ar/olefin C); 135.0, 
128.9, 127.8, 127.6, 127.0, 125.2, 115.8 (Ar/olefin CH); 32.2 (benzyl CH 2). MS 
(FAB, M/z) C 16H 14C10 3 (MH) requires 289.0632; found 289.0634. MS (APCI, 
+20V) C 16H 14C103 (NH) requires 289 found 271 (MEl4 -H20). 
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Preparation of 2-(3-Methylindolyl)-3-(2-hydroxy-5-chlorophenyl)acrylic Acid, 
29. 
To 	ethyl 	2-(3 -methylindole)-3 -(2-hydroxy-5-chlorophenyl)-E-acrylate, 	34 
(191.6mg, 0.542mmo1), in 50% aqueous ethanol (lOmL) was added lithium hydroxide 
monohydrate (120.0mg, 2.86mmol). The mixture was heated at reflux for 4 hours, 
then cooled to room temperature and the ethanol was removed under reduced 
pressure. Organic products were extracted with ether (15mL) from the basic solution 
which was then acidified forming a white precipitate. This was removed by filtration 
to yield 2-methylindolyl-3 -(2-hydroxy-5-chlorophenyl)-E-acrylic acid, 29 (142.7mg, 
0.436mmo1, 80%). 
0 	OH 	Rf 0.37 (DCMlmethanol, 9:1). m.p. 200-201°C (lit." 
HO 	 202205°C). FTIR Vmax/ cm' (KBr) 3442 (NHIOH); 3053 
- 	
(Ar CH); 2989, 2918 (CH); 2625, 2550 (CO 2H); 1664 
N 	
CI 	(C=O); 1603, 1570, 1486 (C=C). 	max/nm (ethanol, 
H 
s/dm3mor'cm) 319 (4630), 265 (11500). 'Hnmr (CD30D, 
250MHz, ö/ppm) 8.04 (1H, s, olefin H); 7.55 (1H, d, 3J=7.0Hz, Ar H); 7.42 (1H, 
d, 3J18.0Hz, Ar H); 7.34 (1H, d, 3J=2.6Hz, Ar H); 7.22-704 (4H, m, Ar H); 6.91 
(1H, d, 3J8.7Hz, Ar H); 4.00 (2H, s, allyl CH 2). 13C{'H}nmr (CD30D, 63MHz, 
ö/ppm) 162.6 (C=O); 146.5, 128.7, 124.0, 118.9, 116.2, 115.5, 104.6 (q Ar/olefin 
C); 125.9, 121.3, 120.7, 113.6, 113.0, 110.2, 110.0, 108.2, 102.7 (Ar/olefin CH); 
15.2 (allyl CH2). MS (FAB, M+/Z) C 18H14C1NO3 (M) requires 327.0662; found 
327.0667. Elemental Analysis C, 8H14C1NO3 requires 65.96% C, 4.3 1% H, 4.27% N; 
found 65.80% C, 4.44% H, 3.99% N. 
4.8 Solid Phase Synthesis of 2-Benzyl-3-(2-hydroxy-5-chlorophenyl)acrylic Acid. 
Synthesis of Copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyl bromo-
acetate, 86. 
To bromoacetic acid (0.52g, 3.7mmol) in DMF (15mL), was added 
diisopropylcarbodiimide (0.24g, 1 .9mmol) and the mixture sonicated under argon for 
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1 hour. A catalytic quantity of DMAP followed by copoly(styrene-1%-
divinylbenzene)-p-benzyloxybenzyl alcohol resin (0.84g, 1 .O7mmollg, 0.90mmol), 
was added to the mixture and sonication was then continued for 18 hours. The resin 
was then filtered, washed with copious quantities of DMF, DCMlmethanol (1:1), 
THF and DCM, and then dried in a vacuum dessicator for 2 hours to yield 
copoly(styrene- 1 %divinylbenzene)-p-ben.zyloxybenzyl bromoacetate, (0.86g), 86, as 
a pale yellow solid. 
FTIR vm /cm'(DCM) 1734 (C0). Elemental Analysis 
1.07nimollg Br requires 7.67%, found 5.33% (±0.6%), hence 
resin loading is 0.67mmollg (±0.07mmol/g). 
Synthesis of Cópoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyldiethyl 
Phosphonoacetate, 41. 
To copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyl 	bromoacetate, 86 
(0.69g, 0.67mmollg, 0.46mmol), in toluene (lOmL), was added triethylphosphite 
(lOg, 5.8mmol), and the mixture was heated at reflux for 24 hours. The resin was 
then filtered, washed with copious quantities of DMF, DCMlmethanol (1:1), THF and 
DCM, and then dried in a vacuum dessicator for 2 hours to yield copoly(styrene-1%-
divinylbenzene)-p-benzyloxybeflzyldiethyl phosphonoacetate (0.68g, 0. 64mmollg), 
41, as a pale yellow solid. 
o o 	FTIR v.,./cm' (DCM) 
1735 (C0). Gel Phase 
11 
1LP(OE02 13C{'H}nmr (CD2Cl2 , 63MHz, 6/ppm) 158.8 (C=O); 
67.0, 62.6 (OCH2); 34.2 (d, 'Jpc133Hz, C14 2); 16.2 (CH3). 
Gel Phase 31 Pnmr (CD 202 , MIELz, 6) 20.2ppm. Elemental Analysis no Br present. 
Synthesis of Copoly(styrene-1 %-divinylbenzene)-p-benzyloxybenzyldiethyl 2-
Benzyl-phosphonoacetate, 88. 
To copoly(styrene- 1 %divinylbenzene)-p-benzyloxybenzyldiethyl phosphono-
acetate, 41, (0.68g, 0.64mmol/g, 0.44mmol), in THF (lOmL), was added NaHrvIIDS 
(1.1M in THF, 0.43mL, 0.47mmol), and the mixture sonicated for 1 hour. 
Ben.zylbromide (0.19g. 1.lmmol) was added as a solution in THF (2mL) and 
sonication was then continued for 20 hours. The resin was filtered, washed with 
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copious quantities of DMF, DCMlmethanol (1:1), THF and DCM, and then dried in a 
vacuum dessicator for 2 hours to yield copoly(styrene-1%-divinylbenzene)-p-
ben.zyloxybenzyldiethyl 2-benzyl-phosphonoacetate (0.68g, 0.60mmolIg) 88, as a pale 
yellow solid. 
o 0 	FTLR v../cm' (DCM) 1732 (CO). Gel Phase 
11 
13C{ 1 H}nmr (CD2Cl2 , 63MHz, &ppm) 67.0, 63.1 
(OCH2); 36.4 (benl CH 2); 16.4 (CH3). Gel Phase 31 Pnmr 
(CD2Cl2, MHz, ö) 5.2ppm. 
Synthesis of Copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyl 2-Benzyl-3-
(23-Methoxyethoxymethoxy-5-chloropheflyl)aCrYlate, 89. 
To 	copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyldiethyl 	2-benzyl- 
phosphonoacetate, 88 (0.60mmol/g, 0.33g. 20mmol), in THF (5mL), was added 
Na.HMDS (1.OM in THY, 0.40mL, 0.40mrnol) and the mixture was then sonicated for 
1 hour. 3-Methoxyethoxymethoxy-5-ch1orosalicy1aIdehyde (0.19g, 0.76mmol), 67, as 
added as a solution in TI-IF (2mL) and sonication was then continued for 20 hours. 
The resin was filtered, washed with copious quantities of DMF, DCM/methanol (1:1), 
THF and DCM, and then dried in a vacuum dessicator for 2 hours to yield 
copoly(styrene- 1 %-divinylbenzene)p-ben.zyloxybenzyl 2-benzyl-3 -(2-3-methoxy-
ethoxymethoxy-5-chlorophenyl)acrylate, (0.33g, 0.57mrnol/g) 89, as a pale yellow 
solid. 
0 
	 FTIR Vmax/ cm' (DCM) 1734 (C=O). 
Gel Phase 13C 1 H)nmr (CD2Cl2, 63MHz, 
ö/ppm) 190.2 (C0); 93.6 (OCH20); 71.2, 
67.7, 65.9 (OCH2); 61.8 (OCH3); 33.4 




Resin Cleavage to form 2-Benzyl-3-(2-hydroxy-5-chlorophenyl)acrylic acid, 82. 
To sonicating copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyl 2-benzyl-3 - 
(2--methoxyethoxymethoxy-5-cMorophenyl)acrylate, 89 (0.10g, 0.57mmolIg), in 
DCM (3mL) was added TFA (90% aqueous, 2mL) dropwise. The mixture was 
sonicated for 2 hours. After which time, the resin was filtered, and washed with DCM 
(5mL). TFA was removed from the filtrate by washing with NaOH (IN, 3mL), and 
concentration of the resin products gave a residue which was dissolved in 0.1% 
TFAlacetonitrile. Preparative HPLC (Gradient 1) yielded 2-benzyl-3-(2-hydroxy-5-
chlorophenyl)-acrylic acid, 82, as a cream coloured solid (4.8mg, 0.017mmol, 30% 
overall, based on resin loading). RP-HPLC (Gradient 1) 21.5 minutes MS (APC1, 
+20V) C 16H14003 (MIH) requires 289 found 271 (MH -1-1 20). 
4.9 4x2 Array Multiple Parallel Synthesis of Acrylic Acids 
General Resin Washing Procedure 
Resin portions were washed using the following protocol, allowing drainage by 
gravity between each solvent portion: DIVIF(4x2mL), DCMlmethanol (4x2mL), THF 
(4x2mL), DCM (4x2mL). 
General Procedure for the Homer-Wadsworth Emmons Reaction 
To each DiversomerTM  pin containing alkylated copoly(styrene-l%-
divinylbenzene)-p-benzyloxybenzyldiethyl phosphonoacetate swollen in THF (4mL), 
was added NaHMDS (l.OM in THF). More THF (2mL) was added, and the entire 
reactor block sonicated for 1 hour. Each aromatic alkyl halide was added to an 
individual pin as a solution in THF (2mL), and sonication was continued for 18 hours. 
The resins were then washed using the general washing procedure, and dried in a 
vacuum dessicator for 2 hours. 
General Procedure for Resin Cleavage 
To each DiveromerTM pin containing resin from the HWE reaction, swollen in 
DCM, was added aqueous TFA. The entire reactor block was sonicated for 2 hours 
and the resins were then washed with DCM (2x2mL), with the filtrates from 
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individual pins combined. TFA was removed from each filtrate by washing with 
NaOH (0.5N, 2mL), and concentration of the resin products gave a residue which 
was dissolved in 0.1% TFAlacetonitrile prior to purification by preparative HPLC. 
The isolated resin products were analysed by chemical ionisation or fast atom 
bombardment mass spectrometry. 
4.9.1 Library 1: 4x2 Array of Methylindolylacrylic Acids 
Synthesis of Copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyldiethyl 2-(3-
Methylindolyly)phosphonoacetate, 43. 
To copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyldiethyl phosphono-
acetate, 41 (0.95g, 0.64mmolIg, 0.61mmol), in TI-IF (20mL), was added 1-
triisopropylsilylgramine-methiodide, 5 (0.71g, 1.51 mmol), and the mixture sonicated. 
Tetrabutylanimoniumfluoride (1.OM in THF, 2.lmL, 3.1mmol) was added and 
sonication continued for 3 hours. The resin was then filtered, washed with copious 
quantities of DMF, DCM/methanol (1:1), THF and DCM, and then dried in a vacuum 
dessicator for 2 hours to yield copoly(styrene-1%-divinylbenzene)-p-
benzyloxybenzyldiethyl 2-(3-methylindolyly)phosphonoacetate, 42 as a pale yellow 
solid (0.95g. 0.59mmol/g). The resin was then used immediately in the 4x2 array 
synthesis. 
Horner Wadsworth Emmons Reaction 
The general procedure was followed using approximately 100mg of 
copoly(styrene- 1 %-divinylbenzene)-p-benzyloxybenzyldiethyl 	2-(3 -methylindolyl)
phosphonoacetate, 42, in each DiversomerTM  pin, 0.12mmoI of NaHMDS, and 
approximately 0.25mmol of aldehyde in the following array addresses: Al 
benzaldehyde (27mg, 0 .26mmol); A2 3 -pyridinecarrboxaldehyde (28mg, 0. 27mmol); 
A3 3 -chloro-4-hydroxybenzaldehyde (39mg, 0. 2Smmol); A4 3 -thiophene-
carboxaldehyde (27mg, 0. 24mmol); B! 4-isopropylbenzaldehyde (38mg, 0. 26mmol); 
B2 3-fluorobenzaldehyde (31mg, 0.25mmol); B3 4-nitrobenzaldehyde (3 6mg, 




The general procedure for resin cleavage was followed for the resin in each of the 
eight DiversomerTM pins. Two products were isolated from each sample by 
preparative HPLC using Gradient 1: Al (14.0mins, 23.4mins); A2 (14.Omins, 
23.4mins); A3 (13.3mins, 23.8mins); A4 (13.6mins, 23.8mins); B1 (15.5mins, 
23.4mins); B2 (14.4mins, 23.4mins); B3 (13.4mins, 23.8mins); B4 (14.8mins, 
23.4mins). No positive product identification was obtained by APC1MS or FABMS. 
4.9.2 Library 2: 4x2 Array ofp-Chlorophenolacrylic acids 
Phosphonate Alkylation Reaction 
To each DiversomerTM pin containing copoly(styrene-1%-divinylben.zene)-p-
benzyloxybenzyldiethyl phosphono-acetate, 41 (100mg, 0.64mmolIg, 0.064mmol), 
swollen in THF (4mL), was added NaHM1DS (I. OM in THF, 0.1mL, 0.1mmol), and 
the entire reactor block sonicated for 3 hours. Aromatic alkyl halides were added as a 
solution in THF (1 mL) in the following spatial addresses (to those samples purchased 
as hydrochloride salts, the appropriate quantity of NaHMDS was added prior to 
addition to the pins): Al benzyl bromide (46mg, 0.27mmol); A2 3-picolyl chloride 
hydrochloride (40mg, 0.24mmol); A3 2-(chloromethyl)benzimidazole (42mg, 
0.25mmol); A4 2-hydroxy-5-nitrobenzyl bromide (53mg, 0.23mmol); B! 2-methoxy-
5-nitrobenzyl bromide (57mg, 0.23 mmol); B2 cx-bromo-2, 3,4,5, 6-pentafluorotoluene 
(6 1mg, 0.23mmol); B3 2-chloromethylquinoline hydrochloride (53mg, 0.25mmol); 4-  
(chi oromethyl)-biphenyl B4 (49mg, 0.24mmol). Sonication was continued for 16 
hours, then the resins were washed using the general washing procedure, and dried in 
a vacuum dessicator for 2 hours. 
Homer Wadsworth Emmons Reaction 
The general procedure was followed, treating each of the dry resins from the 
phosphonate alkylation reaction with NaHMIDS (0.2mL, 0.2mmol) and 2-3-




The general procedure for resin cleavage was followed for the resin in each of the 
eight Diversomerrm pins. Two products were isolated from each sample by 
preparative HPLC using Gradient 2: Al (9.4mins, 14.5mins); A2 (9.7mins, 14.5mins); 
A3 (9.0mins, 14.5mins); A4 (10.1mins, 14.9mins); B! (9.7mins, 14.5mins); B2 
(8.6mins, 14.5mins); B3 (9.7mins, 14.5mins); B4 (9.7mins, 14.5mins). No positive 
product identification was obtained by APCiMS. 
4.10 Synthesis of Tbf-bound Ciprofloxacin 
Preparation of Ethyl 4-(1 0-Bromodecyloxy)benzoate, 94. 
To sodium hydride (1.55g, 61mmol) in DMF (150mL), was added ethyl-4-
hydroxybenzoate, 95 (5.06g, 30mmol), as a solution in DMF (30mL). The reaction 
mixture was then stirred at room temperature for 2 hours, before adding 1,10-
dibromodecane, 96 (30.84g, 103mmol), as a solution in DMF (50mL) via syringe. 
The reaction mixture was then stirred at room temperature for 19 hours. The reaction 
was quenched with water (200mL) and the organic products extracted with ether 
(4x 1 50mL), dried over MgSO4 and solvent removed under reduced pressure to form 
a colourless oil. This was purified by flash chromatography (DCMlhexane, 1:1 to 
DCMlhexane, 3:1) forming ethyl 4-(10-bromodecyloxy)benzoate, 94 (7.38g, 
19. immol, 63%), as a white crystalline solid, which was recrystallised from ethanol. 
0 	 RI 0.65 (DCM). m.p. 41-42'C. FTIR, v../cm' 
(bromoform) 3023 (Ar CH); 2927, 2855 (CH); 
Br( )0 1708 (C=O); 1605, 1509 (C=C); 1105 (C-O). 
A.max/nm (DCM, E/dm3mol 1 cm) 257 (24600). 'Hnmr (CDCI3 , 250MHz), ö/ppm 
7.96 and 6.87(both 2H, m, ArH); 4.32 (2H, q, 3J=7.1Hz, OCCH3); 3.97 (2H, t, 
3J=6.5Hz, OCflCH2); 3.38 (211, t, 3J=6.9Hz, CH213r); 1.80 (4H, m, OCH2Cfl 
and CjjCH2Br); 1.42-1.27 (12H, m, 6xCH 2); 1.35 (311, t, 3J=7.1Hz, CH3 ). 
13C{'H}nmr (CDCI3 , 63MHz), s/ppm 166.2 (C=O); 152.6 and 122.4 (q Ar C); 
131.3 and 113.8 (ArCH); 67.9 and 60.4 (OCH2); 33.9, 32.6, 29.2, 29.1, 29.0, 28.9, 
28.5, 28.0, 25.8 (CH2); 14.2 (CH3). HRMS (FAB), M'Jz C 19H30BrO3 (MH1) requires 
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385.1378, found 385.1374. Elemental Analysis C 19H29BrO3 requires 59.22% C, 
7.59% H, 20.74% Br; found 58.92% C, 7.45% H, 20.87% Br. 
Preparation of Bis-(phenanthren-9-yl)methanol, 10116 
To magnesium turnings (4.7g, 0. 196mo1) and a crystal of iodine, in a three-necked 
flask fitted with a dropping funnel and condenser, was added 9-bromophenanthrene 
(50.6g, 0. 197mo1), as a solution in THF (80mL), dropwise, over a period of twenty 
minutes. Heat evolved and the reaction mixture turned into a green liquid. After 2.5 
hours, methylformate (5.95g, 0.099mo1) was added as a solution in THF (25mL) over 
a period of 20 minutes. The reaction mixture turned yellow/brown and was stirred at 
room temperature for a further 2 hours. The reaction mixture was then poured onto 
HC1 (2M, lOOmL), forming a white precipitate. Excess magnesium was destroyed 
with more HC1, and the white precipitate was filtered, washed with ether (200mL) 
and collected as bis-(phenanthren-9-yl)methanol, 101 (24.5g, 0.063mo1, 64%). 
nw 	
RI 0.50 (CHC1 3). m.p. 236-238°C (Lit. 238-239°C' 6) 
FTIR, vmax/cm' (bromôform) 3466 (OH), 3018 (Ar 
CH), 1603, 1492 (C=C). 'Hnmr (CDCI3 , 250MHz), 
ö/ppm 8.79-8.67 (4H, m, Ar H); 8.13-8.10 (2H, m, Ar 
H); 7.80-7.50 (12H, m, Ar H); 7.31 (1H, s, CHOH); 2.76 
(1H, s, OH) . 13C{ 1 11}nmr (CDCI3 , 63MHz), ö/ppm 136.3, 131.2, 130.8, 130.3, 
130.0 (q Ar C); 129.0, 126.9, 126.8, 126.6, 126.4, 126.0, 124.3, 123.1, 122.3 (Ar 
CH); 69.6 (CHOH). HRMS (FAB), M/z C29H200 (M) requires 384.1514; found 
384.1498. 
Preparation of 8bH-Tetrabenzo a,c,g, i]fluorene, 9916 
To bis-(phenanthren-9-yl)methanol, 101 (24.5g, 63mmoI), in DCM (lOOmL), was 
added TFA (40mL), dropwise, over a period of 10 minutes. The yellow suspension 
formed was stirred at room temperature for 20 minutes after which time solvent was 
removed under reduced pressure. The resulting yellow solid was reconcentrated five 
times from DCM (lOOmL), and the residue was then washed with ether, yielding 8bH-
tetrabenzo[a,c,g,i]fluorene, 99, as a bright yellow solid (16.4g, 45mmol, 70%). 
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Rf 0.84 (CHC1 3/methanol, 9:1). m.p. 276-278°C (Lit. 
280-282°C' 6). FTIR, vmax/cm' 3019 (Ar CH); 1608, 1495 
(CC). X/nm (DCM, e/dm3mol'cm') 374 (11700), 
358 (9880), 301 (31800), 254 (62200). 'Hnmr (CDCI3 , 
250MHz), ö/ppm 8.81-8.76 (2H. m. Ar H) 8.28-7.08 (15H, m, Ar H); 5.39 (1H, s, 
CH). 13C{'H}nmr (CDCI3 , 63MHz), ö/ppm 148.3, 141.3, 137.2, 135.2, 134.0, 
133.2, 130.7, 130.3, 129.3, 127.5, (qArC); 128.3, 128.2, 127.1, 126.9, 126.9, 126.6, 
126.5, 126.3, 126.2, 125.8, 125.1, 124.9, 124.6, 123.6, 123.5, 123.2, 121.2, (Ar CH); 
53.1 (CH). HRMS (FAB), M/z C29H 18 requires 366.-1409, found 366.1396. 
Preparation of Ethyl 4-11  O-( 17 '-Tetrabenzo Ia,c,g, i] fluorenyl)decyloxyj benzoate, 
103.' 
To 8bH-Tetrabenzo[a,c,g,i]fluorene, 99 (2.08g, 5.68mmol), in degassed dioxane 
8OmL) heated at reflux, was added tetrabutyl-ammonium hydroxide (40% w/w in 
H20, 3.50g, 5.41mmol) as a solution in degassed dioxane (20mL) via syringe, 
immediately forming a yellow precipitate. This was filtered under nitrogen and washed 
with warm dioxane (lOOmL) and ether (lOOmL). The salt was resuspended in dioxane 
(lOOmL) and to it added ethyl 4-(10-bromodecyloxy)benzoate, 94 (2.08g, 5.40mmol), 
and the mixture heated to reflux for 2 hours. Solvent was removed from the darkened 
solution, forming a residue which was dissolved in ether (50mL), and the supernatant 
removed to leave a yellow slurry which was washed with ether (2x3OmL). The 
combined extracts were dried over magnesium sulphate, and solvent removed under 
reduced pressure, forming a residue which was purified by flash chromatography 
using (DCMlhexane, 1:1). The product was isolated as a pale yellow airy solid which 
was triturated from ether, to yield ethyl 4-[10-(17'-tetrabenzo[a, c,g, i]- 
fluorenyl)decyloxy]benzoate, 103, as a pale yellow powder (2.46g, 3.67mmol, 68%). 
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RI 0.71 (DCM). m.p. 122-124°C. 
FTIR, v.,,.,,/cm' (bromoform) 3072 (Ar 
CH); 2922, 2850 (CH); 1702 (C0); 
1605, 1505 (CC); 1105 (C-O). X/nm 
(DCM, c/dm3mol'cm') 381 (20700), 
365 (21000), 301(45800), 256 (86900). 
'Hnmr (CDCI3 , 200MHz), ö/ppm 8.81 and 8.68 (both 6H, m, Ar H); 8.23-8.18 (2H, 
m, Ar H); 8.06-7.98 (2H, m, ArH); 7.72-7.58 (8H, m, Ar H); 6.93-6.82 (2H, m, Ar 
H); 4.92 (1H, t, 3J=4.2Hz, fluorenyl CH); 4.39 (2H, q, 3J=7. 1Hz, OCflCH3 ); 
3.86 (2H, t, 3J1.n46.514z, OCH2); 2.60-2.52 (2H, m, OCH2CII2);  1.76-1.53 (2H, m, 
CH2); 1.23-0.71 (12H, m, 6xCH 2); 1.42 (3H, t, 3J=7.1Hz, CH3); 0.32-0.28 (2H, m, 
CH2). 13C{'H}nmr (CDCI3 , 50MHz), ö/ppm 166.3 (C0); 162.7, 122.4 (q Ar C); 
131.3, 113.8 (Ar CH); 144.2, 136.6, 131.1, 130.2, 128.6, 127.9 (q Tbf Ar C); 127.3, 
126.6, 125.7, 125.4, 124.8, 124.3, 123.3, 123.3 (Tbf Ar CH); 67.9, 60.4 (OCH 2), 
47.0 (fluorenyl C); 33.4, 29.2, 28.9, 28.8, 28.6, 25.5, 22.0 (CH 2); 14.2 (CH3). HRMS 
(FAB), M/z C48H4603 (Mt) requires 670.3447, found 670.3447. 
Preparation 4-[10-(1 7'-Tetrabenzo Ia,c,g,i1fluorenyl)decyloxy benzyl Alcohol, 
104. 
To ethyl 4-[ 1 0-( 1 7'-tetrabenzo [a, c,g,i]fluorenyl)decyloxy]benzoate, 105 (2.03g, 
3.03mmol), in TI-IF (40mL) was added diisobutyl aluminium hydride (1.OM in THF, 
12.0mL, 12.Ommol) via syringe and the resulting mixture stirred at room temperature 
for 2 hours. The reaction was quenched at 0°C with the careful addition of HCI (2M, 
40mL) and the organic products were extracted with ethyl acetate (3 x5OmL), washed 
with saturated Na2CO3 (40mL) and water (40mL) and dried over MgSO 4 . Solvent 
was removed under reduced pressure to yield 4-[10-(17'-tetrabenzo[a,c,g,i]fluorenyl)-
decyloxy]benzyl alcohol, 104, as a yellow solid (1.7765g. 2.82mmol, 94%). 
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RI 0.35 (DCM). m.p. 64-66°C. FTIR, 
- 	 OH 	
v.../cm' (bromoform) 3460 (OH); 3016 
. 	 I (Ar CH); 2920, 2853 (CH); 1609, 1583, 
1510 (C=C); 1142 (C-O). 	(DCM, 
6/dm3mor'cm) 381 (18400), 365 (18800), 
301 (41400), 254 (70700). 'Hnmr (CDCI3 , 
250Mllz), ö/ppm 8.82-8.77 (41-1, m, Tbf Ar H); 8.77-8.69 (211, m, TbfArH); 8.24-
8.20 (2H, m, Tbf Ar H); 7.72-7.60 (8H, m, Tbf Ar H); 7.27-7.24 (211, m, Ar H); 
6.86-6.83 (211, m, Ar H); 4.93 (1H, t, 3JHj4.3Hz, fluorenyl CH); 4.59 (1H, s, 
CflOH); 3.81 (2H, t, 3Ji.n6.5Hz, OCfl); 2.61-2.56 (21-1, m, OCH2Cfl); 1.87 (111, 
s, OH); 1.64-1.58 (2H, m, CH2); 1.30-0.72 (12H, m, 6xCH 2); 0.42-0.30 (2H, m, 
CH2). ' 3C'H}nmr (CDCI3 , 63MHz) ö/ppm 15 8.5, 132.6 (q Ar C); 128.4, 114.2 (Ar 
CH); 144.2, 136.6, 131.0, 130.2, 128.6, 127.8 (q Tbf Ar C); 127.3, 126.6, 125.7, 
125.4, 124.8, 124.3, 123.3, 123.3 (Tbf Ar CH); 67.7 (OCH 2); 64.8 (CH20H); 47.0 
(fluorenyl C); 33.3, 29.2, 29.0, 28.9, 28.6, 25.6, 22.0 (CH2). HRMS (FAB), M/z 
C46FL1402 (M+) requires628.3341, found 628.3339. 
Preparation of Ethyl 3-(2,4,5-Trifluorophenyl)-3-oxopropionate, 4318 
Magnesium chloride and potassium ethyl malonate were dried over silica in a 
vacuum dessicator overnight prior to use. 
To potassium ethyl malonate (3.66g, 21.5mmol) in freshly distilled acetonitrile 
(70mL) at 10-15°C was added anhydrous magnesium chloride (2.44g, 25.7mmol) and 
triethylamine (2.05g, 20.3mmol). The mixture was then stirred at room temperature 
for 2.5 hours, followed by cooling the resultant white slurry to 0°C, and subsequent 
addition of 2,4,5-trifiuorobenzoyl chloride (2.00g, 10.3mmol) over a period of fifteen 
minutes, followed by more triethylamine (0.23g. 2.3mmol). The mixture was then 
stirred at room temperature for 16 hours. Acetonitrile was removed under reduced 
pressure and toluene (30mL) added. The mixture was reconcentrated and further 
toluene (60mL) added. HC1 (1.5M, 40mL) was cautiously added, ensuring that the 
temperature did not exceed 25°C, and the aqueous layer separated. The organic 
fraction was washed with 1.5M HCI (2x25mL) and water (2x25mL), dried over 
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MgSO4, and solvent removed under reduced pressure to yield ethyl 3-(2,4,5-
trifluorophenyl)-3-oxo-propionate, 43, as a pale orange solid (2.35g. 9.55mmol, 
94%). 
Ri' 0.55 (DCM). m.p. 57-59°C. FTIR, v../cm' 
EtO 	
F (bromoform) 3018 (Ar CH); 2990 (CH); 1735 (ester C=O); 
F 	F 1687 (CO)- 1622, 1514 (C=C). ? ax/nm (DCM, c/dm3mol 
'cm') 295 (4781), 281 (3962), 240 (5191). 'Hnmr (CDCI3 , 
250MHz), 6/ppm [12.69 (s), 5.81 (s) and 3.92 (d, 3Ji-ij 3.9Hz)] (2H, keto-enol 
tautomers); 7.74 (1H, m, Ar H); 6.98 (1H, m, Ar H); 4.24 and 4.17 (2H, both q, 
3J=7. 1Hz); 1.31 and 1.24 (3H, both t, 3JHJ7.  1Hz). 13C{'H}nmr (CDCI3 , 63MHz), 
6/ppm 187.8 (C=O); 173.0 (HC=c); 166.9 (CO2Et); 163.7, 159.8, 155.9, 151.8, 
149.0, 145.3, 120.9 (q Ar C); 118.7, 106.6 (Ar CH); 92.9 (HC=C); 61.4 and 60.6 
(OCH2); 49.4 (CH2); 14.0 (CH 3). ' 9Fnmr (CDCI3 , 235MHz) 6/ppm; -110.6 and - 
111.7 (m, Ar F); -123.5 and -129.0 (m, Ar F); -140.5 and -141.7 (m, Ar F). HRMS 
(El), M/z C 11 H9F303 (M) requires 246.0504; found 246.0514. Elemental Analysis 
C 11H9F303 requires 53.67% C, 3.68% H; found 53.97% C, 3.77% H. 
Preparation of 4-[1 0-(1 7'-Tetrabenzo [a, c,g,i] fluorenyl)decyloxy] benzyl 3-(2,4,5-
Trifluorophenyl)-3-oxopropionate, 107. 
To 	4-[ 1 0-( 1 7'-Tetrabenzo[a,c,g,i]-fluorenyl)decyloxy]ben.zyl 	alcohol, 	104 
(508.8mg, 0.81mmol), in toluene (40mL), was added DMAP (30mg, 0.25mmol), and 
ethyl 3-(2,4,5-trifluorophenyl)-3-oxopropionate, 43 (532.0mg, 2. 16mmol), and the 
mixture heated to reflux for 40 hours. The reaction was then cooled to room 
temperature and filtered through a small pad of silica. The filtrate was washed with 
saturated ammonium chloride solution (20mL) and brine (20mL) and the organic 
phase dried over MgSO4. Solvent was removed under reduced pressure to yield an 
orange oil, which was purified by flash chromatography (DCM), to yield 4-[10-(17'-
tetrabenzo-[a, cg, i]fluorenyl)decyloxy]ben.zyl 3 -(2,4, 5-trifluorophenyl)-3 -oxo-




RI 0.53 (DCM). m.p. 58- 
60°C. 	FTIR 	Vmax/cm 1 
FF (CHCI3) 3089, 3062 (Ar 
CH); 2933, 2853 (CH); 1737 
(CO2Ar); 1690 (C=O); 1620, 
1514 (CC). max/nm (DCM, 
c/dm3moi 1 cm 1) 381 (4950), 365 (4950), 301 (14000), 288 (13200), 254 
(22700).'Bnmr (CDC13 , 250Mllz), ö/ppm [12.69 (s), 5.86 (s) and 3.95 (d, 
3J=3.9Hz)] (2H, keto-enol tautomers); 8.82-8.76 (4H, m, Ar H); 8.72-8.68 (2H, m, 
Ar H); 8.25-8.22 (214, m, Ar- H); 7.82-7.59 (9H, m, Ar H); 7.33-7.22 (214, m, Ar H); 
6.95-6.80 (314, m, Ar H); 5.13 (214, s, OCH 2Ar); 4.97 (1H, t, 3Ji*"4.3Hz, fluorenyl 
H); 3.83 (214, t, 3J=6.6Hz, OCH2); 2.64-2.55 (21-1, m, OCH2Cfl); 1.67-1.56 (2H, 
m, CH2); 1.30-0.73 (12H, m, 6xCH2); 0.42-0.34 (2H, m, CH 2). 13C{ 1 H}nmr (CDCI3 , 
63MHz), ö/ppm 187.6 (CO); 172.8 (enol HC=C); 166.7 (CO 2Ar); 159.2, 126.8 (q 
Ar C); 163.7, 159.8, 155.9, 151.8, 149.0, 145.3, 120.9 (q Ar C [C-F]); 144.2, 136.6, 
131.1 1  130.2, 128.7, 127.9 (TbfqArC); 130.0, 114.3 (ArCH); 118.4, 106.5 (ArCH 
[C-F]); 127.3, 126.6, 125.7, 125.5, 124.9, 124.3, 123.4, 123.3 (Tbf Ar CH); 92.9 
(HC=C); 67.8 (OCH2); 67.0 and 66.2 (OCH2Ar); 49.4 (OCcH2CO); 47.0 (fluorenyl 
C); 33.4, 29.2, 29.0, 28.9, 28.6, 25.6, 22.0 (CH2). HRMS (FAB), M/z C5 51-147F304 
(M) requires 828.3426; found 828.3424. Elemental Analysis C551447F304 requires 
79.69% C, 5.71% H; found 79.59% C, 5.82% H. 
Preparation of 4-I10-(1  7'-Tetrabenzo [a,c,g,ilfluorenyl)decyloxy] benzyl 3-Cyclo-
propylamino-2-(2,4,5-trifluorobenzoyl)acrylate, 110. 
To 4-[ 1 0-( 1 7'-tetrabenzo- [a, c,g, i]fluorenyl)decyloxy]benzyl 3 -(2,4,5 -trifluoro-
phenyl)-3-oxopropionate, 107 (51.7mg, 0.062mmol) in THF(2mL), was added N,N-
dimethylformamide dimethyl acetal (60.0mg, 0.50mmol) as a solution in THF (lmL) 
via syringe, and the mixture was stirred at room temperature for 18 hours. 
Cyclopropylamine (35.4mg, 0.62mmol) was added as a solution in THF (lmL) and 
the mixture stirred at room temperature for 4 hours. The reaction was quenched by 
the addition of saturated ammonium chloride solution (20mL) and then filtered 
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through a small pad of silica. Organic products were extracted with ethyl acetate 
(2x2OmL), dried over MgSO4 and solvent removed under reduced pressure to yield a 
dark yellow oil. This was purified by flash chromatography (DCM) to yield 4-[10-
(1 7'-tetrabenzo [a, c,g,i]fluorenyl)decyloxy]benzyl 3 -cyclopropylamino-2-(2,4, 5 -tn-
fluorobenzoyl)acrylate, 110, as a pale yellow solid (38.9mg, 0.043mmol, 69%). 
Spectra were consistent with an isomeric ratio of 8:3. 
Rf 0.44 (DCM). m.p. 
F 7072°C. FTIR, v../cm' 
(CHCI3) 3082 (Ar CH); 
F 2930, 2854 (CH); 1738 
(CO2Ar); 1677 (C=O) 1623, 
1561 1511 (CC). Ainax/nm 
(DCM, 6/dm3mol t cm') 381 (17900), 364 (189), 316 (21700), 301 (56100), 289 
(44800), 254 (81100), 239 (69300). 'Hnmr (CDC13 , 250MHz), ö/ppm 10.82 and 
9.43 (1H, both d, 3JH]1=1 1.8Hz, NH); 8.83-8.78 (4H, rn, Ar H); 8.71-8.66 (2H, m, Ar 
H); 8.28-8.23 (3H, m, Ar H); 7.74-7.59 (8H, m, Ar H); 7.09-6.61 (6H, m, Ar H); 
5.05 (1H, t, 3Ji=4.4Hz, fluorenyl H); 4.95 and 4.88 (2H, both s, OCH 2Ar); 3.83 (2H, 
t, 3J=6.6Hz, OCH2); 2.94-2.91 (1H, m, N-CH); 2.65-2.5 1 (2H, m, OCH2C); 
1.68-1.60 (2H, m, CH 2); 1.26-1.19 (4H, m, 2xCH2); 1.06-0.74 (14H, m, 7xCH 2); 
0.38-0.34 (2H, m, CH2). 13C{'H}nmr (CDCI3 , 63MHz), ö/ppm 168.0 (CO2Ar); 
166.4 (C=O); 160.8 (CH=C); 159.0, 127.4 (q Ar C); 155.9, 152.3, 148.4, 117. 1, (q 
ArC [C-F]); 144.3, 13 6.7, 131.1, 13 0.3, 128.7, 127.9, (TbfqArC); 129.9, 114.1 (Ar 
CH); 116.3, 105.0 (Ar CH [C-F]); 127.4, 127.0, 125.8, 125.5, 124.9, 124.4, 123.4, 
(Tbf Ar CH); 101.4 (cH=c); 67.8 (OCH 2); 65.7 and 65.5 (OCH2Ar); 47.1 (fluorenyl 
C); 33.4, 29.3, 29.1, 29.0, 28.6, 25.7 5 22.0 (CH2); 30.4 and 30.0 (N-CH); 6.42 
(CHCH2CH2). 19Fnmr (CDCI3 , 235MHz) ö/ppm -116.4 and -117.2 (Ar F); -131.7, - 
132.3 (m, Ar F); 143.5 and 143.7 (m, Ar F). HRMS (FAB) M'iz C59H52F3N04 (M) 
requires 895.3848; found 895.3816. 
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Preparation of 4- [10-(l 7'-Tetrabenzo Ia,c,g,ilfluorenyl)decyloxy] benzyl 1-Cyclo-
propyl-6,7-difluoro- 1 ,4-dihydro-4-oxo-3-quinohne Carboxylate, 109. 
From 	4-f1 O-(l 7'-Tetrabenzo[a, c,g, iJfluorenyl)decyloxy]benzyl 	3-Cyclo- 
propylamino-2-(2, 4, 5-trfluorobenzoyl)acrylate, 110. 
To 4-[ 1 0-( 1 7'-Tetrabenzo [a, c,g, i]-fluorenyl)decyloxy]benzyl 3 -cyclopropylamino-
2-(2,4,5-trifluorobenzoyl)acrylate, 110 (80.7mg, 0.09mmol), in DCM (8mL), was 
added 1,1,3,3 -tetramethylguanidine (207.5mg, 1. 8Ommol), and the reaction mixture 
was heated at reflux for 20 hours. The mixture was then cooled to room temperature, 
quenched with water (20mL), and the aqueous layer separated and washed with DCM 
(2x2OmL). The combined extracts were washed with 2M HCI (20mL), saturated 
sodium carbonate solution (20mL), water (20mL) and brine (20mL), dried over 
MgSO4, and solvent removed under reduced pressure to yield an orange oil. This was 
purified by flash chromatography (ethyl acetate/hexane, 3:1) to yield 4-[10-(17'-
tetrabenzo[a, c,g,i]fluorenyl)decyloxyjbenzyl 1 -cyclopropyl-6, 7-difluoro- 1 ,4-dihydro-
4-oxo-3-quinoline carboxylate, 109, as a yellow solid (43.4mg, 0.049mmol, 55%). 
From 	4-[10-(] 7 '-Tetrabenzo-[a, c,g, i]fluorenyl)decyloxy]benzyl 	3-(2,4,5- 
trifluorophenyl)-3-oxopropionate, 107. 
To 	4-[ 1 0-( 1 7'-tetrabenzo [a, c,g, i]fluorenyl)decyloxy]benzyl 	3-(2,4,5 - 
trifluorophenyl)-3-oxopropionate, 107 (200.4mg, 0.242rnmoI), in THF (15mL), was 
added NN-dimethylformamide diethyl acetal (214.6mg, 1 .46mmol), and the mixture 
was stirred at room temperature for 22 hours. Cyclopropylamine (110.4mg, 
1 .93mmol) was added as a solution in TI-IF (2mL) and the resultant mixture was 
stirred at room temperature for 24 hours. TMG (550.8mg, 4.79mmol) was added as a 
solution in THF (2mL) and the reaction mixture heated at reflux for 18 hours. The 
solution was cooled to room temperature and quenched with saturated ammonium 
chloride solution (20mL), then filtered through a pad of silica. Organic products were 
extracted with ethyl acetate (40mL), washed with brine (30mL), dried over MgSO 4 , 
and solvent removed under reduced pressure to yield a dark oil. This was purified by 
flash chromatography (ethyl acetate/hexane, 3:1) to yield 4-[10-(17'- 
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tetrabenzo[a, c,g,i]fluorenyl)decyloxy]benzyl 1 -cyclo-propyl-6, 7-difluoro- 1 ,4-dihydro-
4-oxo-3-quinoline carboxylate, 109, as a yellow solid (143.5mg, 0.164mmol, 68%). 
RI 	0.65 	(ethyl 
F acetate/hexane, 3:1). m.p. 
F 7173°C. FTIR, v..,/cm' 
3071 (Ar CH); 2987, 2932, 
2854 (CH); 1726 (CO 2Ar); 
1690 (C=O); 1643, 1513, 
1494 (CC). Xmax/nm (DCM, c/dm3mol 1 cm) 380 (7370), 364 (7830), 331 (9210), 
317 (8290), 301 (22100), 289 (19300), 257 (39200), 238 (33200). 'Hnmr (CDC13 , 
250MHz), 6/ppm 8.80-8.75 (4H, m, Ar H); 8.68-8.64 (2H, m, Ar H); 8.41 (1H, s, 
unsat. H); 8.26-8.15 (4H, m, Ar H); 7.71-7.56 (9H, m, Ar H); 7.41-7.38 (2H, m, Ar 
H); 6.86-6.82 (2H, m, Ar H); 5.03 (1H, t, 3Jw4.1Hz, fluorenyl H); 4.92 (2H, s, 
OCH2Ar); 3.83 (2H, t, 3J6.5Hz, OCH2); 3.27-3.21 (1H, m, N-CH); 2.62-2.56 
(2H, m, OCH2CJ:12); 1.71-1.55 (4H, m, 2xCH 2); 1.35-1.11 (4H, m, 2xCH 2); 1.04-0.72 
(12H, m, 6xCH2); 0.36-0.32 (2H, m, CH 2). 13C{ 1 H}nmr (CDCI3 , 63MHz), 6/ppm 
172.4 (CO2Ar); 164.8 (C=O); 158.9, 127.9, (q Ar C); 148.7 (CH=C); 155.7, 150.8, 
146.5, 137.3, (q Ar C [C-F]); 144.2, 136.6, 131.1, 130.2, 128.6, 127.8, (Tbfq Ar C); 
129.9, 114.3 (ArCH); 127.3, 126.7, 125.7, 125.5, 124.9, 124.3, 123.4, 123.3 (TbfAr 
CH); 115.3, 105.4 (Ar CH [C-F]); 110.5 (-CH=c); 67.7 (OCH2) ).  66.2 (OCH2Ar); 
47.1 (fluorenyl C); 34.5 (N-CH); 33.3, 29.1, 29.0, 28.9, 28.5, 25.6, 21.9 (CH2); 7.9 
(CHcH2cH2). 19Fnmr (CDCI3 , 235MHz) 6/ppm -127.6 (m, Ar F); 139.1 (m, Ar F). 
HRMS (FAB), M 4 1z C 59H52F2N04 (MW) requires 876.3864; found 876.3860. 
Preparation of 4- [1 0-(1 7 '-Tetrabenzo Ia,c,g,i jfluoreny1)decyIoxyjI benzyl 1 -Cyclo-
propyl-6-fluoro- 1 ,4-dihydro-4-oxo-7-( 1-piperazinyl)-3-quinoline Carboxylate, 
111. 
To 4-[ 1 0-( 1 T-tetrabenzo[a, c,g,i]fluorenyl)decyloxy]benzyl 1 -cyclo-propyl-6, 7-
difluoro- 1 ,4-dihydro-4-oxo-3 -quinoline carboxylate, 109, (49.6mg, 0.05 7mmol) in 
pyridine (distilled over sodium, 8m1), was added piperazine (recrystallised from 
ethanol, 99.1mg, 1.15 mmol)  and the mixture heated at reflux for 6 hours. The mixture 
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was then cooled to room temperature, and quenched with saturated ammonium 
chloride solution (15mL) and organic products extracted with DCM (2x2OmL). The 
combined extracts were washed with water (25mL), dried over sodium sulphate, and 
solvent removed under reduced pressure. The crude residue was purified by flash 
chromatography (CHC1 3/methanol, 9:1) to yield 4-[ 1 0-( 1 'T-tetrabenzo[a, c,g, i]
fluorenyl)decyloxy]benzyl 	1 -cyclopropyl-6-fluoro- 1 ,4-dihydro-4-oxo-7-( 1- 








RI 0.24 (CHC1 3/methanol, 9:1). FTIR, v../cm-1 3679 (NH); 3074 (Ar CH); 
2927, 2852 (CH); 1724 (CO 2Ar); 1689 (C=O); 1619, 1523, 1494 (C=C). A.ax/nm 
(DCM, E/dm3mol 1 cm 1) 380 (11400), 364 (11400), 336 (15800), 323 (14400), 302 
(36600), 290 (41200), 281 (33900), 254 (60400). 'Hnmr (CDCI3 , 250MHz), ö/ppm 
8.81-8.76 (4H, m, Ar H); 8.68-8.65 (2H, m, Ar H); 8.42 (1H, s, unsat. H); 8.27-8.24 
(214, m, Ar H); 8.00 (1H, d, 3J j 13.3Hz, Ar H); 7.72-7.57 (8H, m, Ar H); 7.44-7.40 
(2H, m, Ar H); 7.15 (1H, d, 3J=7.1Hz, Ar H); 6.86-6.83 (2H, m, Ar H); 5.29 (2H, 
s, OCH2Ar); 5.05 (1H, t, 3J1 =4.4Hz, fluorenyl H); 3.84 (2H, t, 3J=6.5Hz, OCH2); 
3.28-3.23 (1H, m, N-CH); 3.19-3.15 (414, m, 2xCH 2); 3.06-3.03 (4H, m, 2xCH 2); 
2.62-2.56 (2H, m, OCH2Cj); 1.66-1.57 (2H, m, CH2); 1.35-0.72 (18H, m, 9xCH 2); 
0.36-0.30 (2H, m, CH2). ' 9Fnmr (CDCI3 , 235MHz) ö/ppm -123.9 (s, Ar F). HRMS 
(FAB), MIz C63H61FN304 (M) requires 942.4646; found 942.4649. 
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4.11 Adsorption of Tbf Derivatives onto Charcoal 
General Procedure 
A solution of the Tbf-derivative was prepared in 25mL of the appropriate solvent 
(c = 5x10 5M), and the uv-visible spectrum of the solution measured in the region 
320-420nm. The adsorbent was added and the suspension stirred in an ice bath for 
twenty minutes. The uv-visible spectrum of the supernatant was measured, and more 
adsorbent added if necessary with stirring, until the uv-visible spectrum indicated that 
no compound remained in solution (Xmax 0). 
Desorption was monitored by stirring the carbon residue in fresh solvent (25mL) 
for periods of 20 minutes at 40°C. Uv-visible spectra of the supernatant were 
recorded until no more desorption was detected. 
4- 1 1  0-( 17 '-Tetrabenzo Ia,c,g,iI fluorenyl)decyloxyl beuzyl Alcohol, 104 
The general procedure was followed to adsorb 104 (0.55mg, 88mmol) onto 
charcoal (40mg) using DCM as solvent. The uv-visible spectrum indicated an 
adsorbance of 92% (0.02mmolIg carbon). Attempted desorption with dioxane and 
toluene, and monitoring by uv-visible spectroscopy, indicated a desorption of 0% and 
19% respectively 
4- 1 1  0-( 1 7'-Tetrabenzo Ia,c,g, 1] fluorenyl)decyloxyJ benzyl 	3-(2,4,5-Trifluoro- 
phenyl)-3-oxopropionate, 107. 
The general procedure was followed to adsorb 107 (0.54mg, 0.66mmol) onto 
charcoal (21.3mg) using DCM as solvent. The uv-visible spectrum indicated an 
adsorbance of 97% (0.03mollg carbon). Attempted desorption with dioxane and 
toluene, and monitoring by uv-visible spectroscopy, indicated a desorption of 0% and 
27% respectively. 
The general procedure was followed to adsorb 107 (0.52mg, 0.63mmol) onto 
charcoal (5.8mg) using DCM/methanol (3:2). The uv-visible spectrum indicated an 
adsorbance of 92% (0. lmollmg carbon). Attempted desorption using THY, and 
monitoring by uv-visible spectroscopy, indicated a desorption of 10%. Re-adsorption 
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to the same charcoal, followed by desorption using toluene and monitoring by uv-
visible spectroscopy, indicated a desorption of 85%. 
3. The general procedure was followed to adsorb 107 (0.7mg, 845nmo1) onto PGC 
(28.9mg) using DCMlmethanol (3:2) as solvent. The uv-visible spectrum indicated an 
adsorbance of 95% (0.03mmol!mg carbon loading). Desorption was not attempted. 
4- [1 0-(1 7'-Tetrabenzo (a,c,g,ilfluorenyl)decyloxyl benzyl 	1-Cyclo-propyl-6,7- 
difluoro-1,4-dihydro-4-oxo-3-quinoline Carboxylate, 109. 
1. The general procedure was followed to adsorb 109 (1.4mg, 1.6mmol) onto 
charcoal (14.2mg) using DCMimethanol (3:2) as solvent. Uv-visible spectrum 
indicated an adsorbance of 90% (0. lOmol/g carbon). Desorption was attempted using 
toluene as the solvent. The maximum level of desorption by uv spectoscopy was 18%. 
4.12 Synthesis of Ciprofloxacin by Charcoal Purification of Intermediates. 
General Charcoal Purification Protocol 
To the crude product residue in DCM (1 5mL) at 0°C, was added methanol and 
charcoal (prewashed with toluene) in portions, until TLC indicated that all of the 
desired product had been adsorbed. The charcoal was isolated by centrifugation and 
stirred in portions of toluene (40mL) at 40°C, until TLC indicated that no more 
desorption was occurring. Product identity was confirmed by uv-vis spectroscopy. 
Preparation of 4-(1 0-(1 7'-Tetrabenzo (a, c,g, i] fluorenyl)decyLoxy benzyl 3-(2,4,5-
trifluorophenyl)-3-oxopropionate, 107. 
To 4- [1 0-( 1 7'-tetrabenzo [a,c,g,i]-fluorenyl)decyloxy]benzyl alcohol, 104 (44.9mg, 
0.071mmol), in toluene (8mL), was added DMAP (3mg, 0.025mmol), and ethyl 3-
(2,4,5-trifluorophenyl)-3-oxopropionate, 43 (46.2mg, 0.19mmol), and the mixture 
heated to reflux for 20 hours. The reaction was then cooled to room temperature and 
solvent removed under reduced pressure. The crude residue was treated with the 
general charcoal purification protocol using 45m1L methanol, and 510mg charcoal, 
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yielding a yellow oil, which was further purified by flash chromatography (DCM) to 
yield 4-[ 1 0-( 1 7'-tetrabenzo-[a, c,g, i]fluorenyl)-decyloxy]benzyl 3-(2,4,5- 
trifluorophenyl)-3-oxopropionate, 107, as a yellow solid (35.2mg, 0.043mmoI, 70%). 
RI 0.53 (DCM) A.max/nm (DCM, /dm3moI 1 cm') 381 (4500), 365 (4500), 301 
(12700), 288 (11300), 254 (20500). 
Preparation of 4-I10-(1  7'-Tetrabenzo Ia,c,g,il flu orenyl)decyloxyl benzyl 1-Cyclo-
propyl-6,7-difluoro- 1 ,4-dihydro-4-oxo-3-quinoline Carboxylate, 109. 
To 4-[ 1 0-( 1 7'-tetrabenzo[a, c,g, i]fluorenyl)decyloxy]benzyl 3-(2,4,5- 
trifluorophenyl)-oxopropionate,  107 (50.1mg, 0.06 immol), in THY (8mL), was added 
N,N-dimethylformamide diethyl acetal (53.6mg, 0.365mmo1), and the mixture was 
stirred at room temperature for 24 hours. Cyclopropylamine (28.4mg, 1 .93mmol) was 
added as a solution in THF (lmL) and the resultant mixture was stirred at room 
temperature for 22 hours. TMG (138mg, 1.20mmol) was added as a solution in TI-IF 
(lmL) and the reaction mixture heated at reflux for 20 hours. The solution was cooled 
to room temperature and solvent removed under reduced pressure. The crude residue 
was treated with the general charcoal purification protocol using 40mL methanol, and 
400mg charcoal, yielding a yellow oil, which was further purified by flash 
chromatography (ethyl acetate/hexane, 3:1) to yield 4-[ 1 0-( 1 'T-tetrabenzo-
[a, c,g, i]fluorenyl)-decyloxyjbenzyl I -cyclopropyl-6, 7-difluoro- 1 ,4-dihydro-4-oxo-3 - 
quinoline carboxylate, 109, as a yellow solid (31.4mg, 0.036mrnol, 59%). Rf 0.68 
(ethyl acetate/hexane, 3:1), A. max/nm (DCM, c/dm3mot'cm 1 ) 380 (6650), 364 
(7000), 331 (8350), 317 (7400), 301 (20400), 289 (17300), 257 (3520), 238 (30100). 
Preparation of 1 -Cyclo-propyl-6-fluoro- 1 ,4-dihydro-4-oxo-7-(1-piperazinyl)-3-
quinoline Carboxylic Acid, Ciprofloxacin, 93. 
To 	4-[ 1 0-( 1 7'-tetrabenzo[a,c,g,i]fluorenyl)decyloxy]benzyl 	1 	-cyclopropyl-6, 7- 
difluoro- I ,4-dihydro-4-oxo-3 -quinoline carboxylate, 109, (75.2mg, 0. O86mmol) in 
pyridine, was added piperazine (147.5mg, 1.72mmol) and the mixture heated at reflux 
for 6 hours. The mixture was then cooled to room temperature, and adsorbed onto 
charcoal (860mg) using 40mL methanol as described in the general procedure. The 
charcoal residue was treated with DCMJTFAIH 20 (18:11:1 mL) at room temperature 
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for 15 minutes, the charcoal removed by centrifugation, and the product was 
precipitated by the addition of cold ether, to yield 1-cyclopropyl-6-fluoro-1,4-
dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid, 93, as a yellow solid 
(16.3mg, 0.049mniol, 57%). 
	
0 0 	 RP-HPLC (Gradient 1) 18.lmins m.p. 228-230°C 
HO 	
F 	
(dec.). Xmax/nm (ethanol, c/dm 3mol'cm 1) 283 
N 	N 	(24600), 254 (7300). 'Hnmr (CD30D, 250MHz), 
L" NH 6/ppm 8.95 (114, s, unsat. H); 8.13 (1H, d, 
JHJI- 13.OHz, Ar H); 7.76 (1 H, d, 3Jjj 6.9Hz, Ar H); 3.92-3.87 (114, m, N-CH); 
3.71-3.67 (4H, m, 2xCH2); 3.55-3.53 (4H, m, 2xCH2); 1.52-1.49 (1H, m, CH2); 1.37-
1.33 (1H, m, CH2). ' 9Fnmr (CD30D, 235MHz) 6/ppm -73.3 (s, Ar F). MS (ES! 
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Phase Synthesis of Ciprofloxaci n .® 
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Abstract: The affinity of tetrabenzo[a, c,g, i]fluorene for charcoal has been applied successfully to provide an alternative to existing 
solid phase synthesis methodology. In a synthesis of the quinolone antibacterial, Ciprofloxacin,® traditional solution phase synthesis 
has been coupled with efficient pseudo-solid phase purification. 
Keywords: Affinity Purification; Solid/Solution Phase; Quinolone Antibiotics 
With the advent of combinatorial synthesis [1], the focus of much academic and industrial research has been 
directed towards solid phase organic synthesis (SPOS) [2]. Conducting chemistry on molecules covalently bound 
to an insoluble polymeric resin has accessed large numbers of individual compounds for the potential use in drug 
lead discovery and optimisation. However, an inherent problem with the use of polymers in synthesis is their 
questionable compatibility with many reagents and reaction conditions. We sought to design a system which 
would combine the versatility of solution phase synthesis (homogeneous phase) with the ease of purification 
afforded by SPOS (heterogeneous phase). 
The affinity of tetrabenzo[a,c,g,i]fluorene (Tbf), 1, for charcoal has been utilised in the purification of 
peptides and proteins [3] and DNA [4] at Edinburgh. In general, the choice of solvent will influence the 
adsorption-desorption equilibrium [5] (Figure 1). It was proposed that a similar protocol be developed for 




















Organic compounds, covalently bound to Tbf via a suitable linker group could be reacted using traditional 
solution phase chemistry and the product purified by exploiting the affinity of the TV group for charcoal. Non-
Tbf-bound compounds can be removed in the filtrate. As no covalent bonds are formed with the support, this 
may be described as a pseudo-solid phase purification step, and recovery of Tbf-bound product can be achieved 
by simple desorption from the carbon. The compound is then ready for the next synthetic step. Methodology was 
first developed (Figure 2) incorporating the Tbf-group for the solution synthesis of the antibacterial agent 
Ciprofloxacin,® 2, which has been the subject of more conventional SPOS [6]. 
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Successful synthesis of a suitable anchor group, 3 (Figure 3), was achieved in good yield following an 
established procedure [7]. The linker group was designed to possess suitable benzyl alcohol functionality to 
permit binding to a precursor in the quinolone synthesis and also include para-alkoxy functionality to allow 
TFA-cleavage of the final product from the anchor system in a manner analogous to Wang resin [8]. 
.0—c--CH201­1 	c, 	= 
3 
(CH2) 1 0-- 
Figure 3. 
Tbf-bound Ciprofloxacin, ® 7, was synthesised in solution phase with traditional work-up and 
chromatographic purification in order to optimise reaction conditions (Figure 4). The quinolone precursor, 13-
ketoester, 4, was synthesised [9] and bound to the anchor group, 3, via a transesterification reaction. One-pot 
enamide formation [10], transamination and base cyclisation, yielded the Tbf-bound quinolone, 6. Synthesis of 7 




+ Eto ]( F 
F 	F 
4 
i P. Q-0—aCH20 " 
F 
70% 	
F )::::( F 




:eei O_Q_ cH2oj 	
F 76% 
from 5 	 6 A 7 A 	NH 
(i) cat. DMAP, toluene, reflux, 40h; (ii) (CH 3) 2NCH(OCH3)2 , 6eq., THF, rt., 24h; (iii) cyclopropylamine, 
12eq., THF, it, 20h; (iv) tetramethylguanidine, THF, 20eq., reflux, 20h; (v) piperazine, pyridine, reflux, 6h. 
Figure 4. 
Extensive studies of the factors 
influencing 	the 	adsorption-desorption 	0.60 
equilibrium of pure Tbf-bound compounds 
with charcoal developed those conditions 	0.50 	 1. ORIGINAL SOLUTION 
which yielded the greatest recovery of 
material. Analysis by ultraviolet (UV) 	°° 
spectrometry (364nm) indicated that 
EN 
A °3° adsorption of the substrate onto charcoal 
was quantitative using DCMlmethanol 	0.20 	/3. ONDITI 
DESO
ONS 
(3:2) as the polar solvent. Isolating the 
carbon residue by centrifugation and 	0.10 
stirring in toluene at 40 °C afforded 2. AThR ADSORPTION CONDITIONS 
desorption of Tbf-bound compounds with 	000  






Of crucial importance to the success of this procedure was the quantity of charcoal used for adsorption. It 
was observed that addition of charcoal in excess of lgIO.lmmol Tbf-compound reduced the recovery of material 
after the desorption step. It was reasoned that this may be due to undesired adsorption processes occurring as 
larger quantities of charcoal were added. Recovery of Tbf-bound material was enhanced by pre-washing the 
charcoal with toluene, possibly preventing excessive adsorption occurring. 
The reproducible protocol for recovering pure Tbf-compound adsorbed onto charcoal was tested as a 
purification method by trials on crude samples of compounds 5 and 6. Solution phase synthesis of these 
compounds was performed as normal, but instead of traditional work-up and purification, the crude residue was 
subjected to the described charcoal protocol. The excellent selectivity of the procedure was confirmed by TLC 




washings. In order to compare directly the efficiency of the process with traditional methods, chromatography 
was performed to isolate the desired compound (e.g. from unreacted starting material). The new purification 
protocol compared highly favourably with traditional methods and furnished 5 and 6 in 60% and 59% 
respectively (70% and 67% by normal work-up and chromatography). 
The synthesis and isolation of 
Ciprofloxacino 2, was completed 
using a similar procedure. After 
adsorption of 7 onto charcoal from the 
crude mixture, cleavage of the 
quinolone from the Tbf-anchor group 
with 90% aqueous TFA in DCM 
yielded the desired product in 57% 
yield from 6. This was observed to be 
>95 % pure by reverse phase HPLC 
(Figure 6). 
Figure 6. 
The successful synthesis of Ciprofloxacin®  2, has shown that traditional solution phase synthesis can be 
performed efficiently on molecules covalently bound to a Tbf anchor group. More importantly, however, the 
high affinity of Tbf for charcoal has enabled a pseudo-solid phase purification protocol of organic molecules to 
be developed. This has allowed us to take maximum advantage of solution phase chemistry whilst also capturing 
the undoubted benefits which heterogeneous purification methods afford. Furthermore, it is envisaged that this 
technique will make a valuable contribution to the multiple parallel synthesis of arrays of compounds. 
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